ACUTE
PANCREATITIS A M EDICAL D ICTIONARY , B IBLIOGRAPHY , AND A NNOTATED R ESEARCH G UIDE TO I NTERNET R E FERENCES
J AMES N. P ARKER , M.D. AND P HILIP M. P ARKER , P H .D., E DITORS
ii
ICON Health Publications ICON Group International, Inc. 4370 La Jolla Village Drive, 4th Floor San Diego, CA 92122 USA Copyright 2004 by ICON Group International, Inc. Copyright 2004 by ICON Group International, Inc. All rights reserved. This book is protected by copyright. No part of it may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without written permission from the publisher. Printed in the United States of America. Last digit indicates print number: 10 9 8 7 6 4 5 3 2 1
Publisher, Health Care: Philip Parker, Ph.D. Editor(s): James Parker, M.D., Philip Parker, Ph.D. Publisher's note: The ideas, procedures, and suggestions contained in this book are not intended for the diagnosis or treatment of a health problem. As new medical or scientific information becomes available from academic and clinical research, recommended treatments and drug therapies may undergo changes. The authors, editors, and publisher have attempted to make the information in this book up to date and accurate in accord with accepted standards at the time of publication. The authors, editors, and publisher are not responsible for errors or omissions or for consequences from application of the book, and make no warranty, expressed or implied, in regard to the contents of this book. Any practice described in this book should be applied by the reader in accordance with professional standards of care used in regard to the unique circumstances that may apply in each situation. The reader is advised to always check product information (package inserts) for changes and new information regarding dosage and contraindications before prescribing any drug or pharmacological product. Caution is especially urged when using new or infrequently ordered drugs, herbal remedies, vitamins and supplements, alternative therapies, complementary therapies and medicines, and integrative medical treatments. Cataloging-in-Publication Data Parker, James N., 1961Parker, Philip M., 1960Acute Pancreatitis: A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References / James N. Parker and Philip M. Parker, editors p. cm. Includes bibliographical references, glossary, and index. ISBN: 0-497-00022-9 1. Acute Pancreatitis-Popular works. I. Title.
iii
Disclaimer This publication is not intended to be used for the diagnosis or treatment of a health problem. It is sold with the understanding that the publisher, editors, and authors are not engaging in the rendering of medical, psychological, financial, legal, or other professional services. References to any entity, product, service, or source of information that may be contained in this publication should not be considered an endorsement, either direct or implied, by the publisher, editors, or authors. ICON Group International, Inc., the editors, and the authors are not responsible for the content of any Web pages or publications referenced in this publication.
Copyright Notice If a physician wishes to copy limited passages from this book for patient use, this right is automatically granted without written permission from ICON Group International, Inc. (ICON Group). However, all of ICON Group publications have copyrights. With exception to the above, copying our publications in whole or in part, for whatever reason, is a violation of copyright laws and can lead to penalties and fines. Should you want to copy tables, graphs, or other materials, please contact us to request permission (E-mail:
[email protected]). ICON Group often grants permission for very limited reproduction of our publications for internal use, press releases, and academic research. Such reproduction requires confirmed permission from ICON Group International, Inc. The disclaimer above must accompany all reproductions, in whole or in part, of this book.
iv
Acknowledgements The collective knowledge generated from academic and applied research summarized in various references has been critical in the creation of this book which is best viewed as a comprehensive compilation and collection of information prepared by various official agencies which produce publications on acute pancreatitis. Books in this series draw from various agencies and institutions associated with the United States Department of Health and Human Services, and in particular, the Office of the Secretary of Health and Human Services (OS), the Administration for Children and Families (ACF), the Administration on Aging (AOA), the Agency for Healthcare Research and Quality (AHRQ), the Agency for Toxic Substances and Disease Registry (ATSDR), the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), the Healthcare Financing Administration (HCFA), the Health Resources and Services Administration (HRSA), the Indian Health Service (IHS), the institutions of the National Institutes of Health (NIH), the Program Support Center (PSC), and the Substance Abuse and Mental Health Services Administration (SAMHSA). In addition to these sources, information gathered from the National Library of Medicine, the United States Patent Office, the European Union, and their related organizations has been invaluable in the creation of this book. Some of the work represented was financially supported by the Research and Development Committee at INSEAD. This support is gratefully acknowledged. Finally, special thanks are owed to Tiffany Freeman for her excellent editorial support.
v
About the Editors James N. Parker, M.D. Dr. James N. Parker received his Bachelor of Science degree in Psychobiology from the University of California, Riverside and his M.D. from the University of California, San Diego. In addition to authoring numerous research publications, he has lectured at various academic institutions. Dr. Parker is the medical editor for health books by ICON Health Publications. Philip M. Parker, Ph.D. Philip M. Parker is the Eli Lilly Chair Professor of Innovation, Business and Society at INSEAD (Fontainebleau, France and Singapore). Dr. Parker has also been Professor at the University of California, San Diego and has taught courses at Harvard University, the Hong Kong University of Science and Technology, the Massachusetts Institute of Technology, Stanford University, and UCLA. Dr. Parker is the associate editor for ICON Health Publications.
vi
About ICON Health Publications To discover more about ICON Health Publications, simply check with your preferred online booksellers, including Barnes&Noble.com and Amazon.com which currently carry all of our titles. Or, feel free to contact us directly for bulk purchases or institutional discounts: ICON Group International, Inc. 4370 La Jolla Village Drive, Fourth Floor San Diego, CA 92122 USA Fax: 858-546-4341 Web site: www.icongrouponline.com/health
vii
Table of Contents FORWARD .......................................................................................................................................... 1 CHAPTER 1. STUDIES ON ACUTE PANCREATITIS .............................................................................. 3 Overview........................................................................................................................................ 3 The Combined Health Information Database................................................................................. 3 Federally Funded Research on Acute Pancreatitis....................................................................... 13 E-Journals: PubMed Central ....................................................................................................... 27 The National Library of Medicine: PubMed ................................................................................ 28 CHAPTER 2. NUTRITION AND ACUTE PANCREATITIS .................................................................... 73 Overview...................................................................................................................................... 73 Finding Nutrition Studies on Acute Pancreatitis ....................................................................... 73 Federal Resources on Nutrition ................................................................................................... 78 Additional Web Resources ........................................................................................................... 79 CHAPTER 3. ALTERNATIVE MEDICINE AND ACUTE PANCREATITIS .............................................. 81 Overview...................................................................................................................................... 81 National Center for Complementary and Alternative Medicine.................................................. 81 Additional Web Resources ........................................................................................................... 86 General References ....................................................................................................................... 87 CHAPTER 4. DISSERTATIONS ON ACUTE PANCREATITIS ................................................................ 89 Overview...................................................................................................................................... 89 Dissertations on Acute Pancreatitis ............................................................................................ 89 Keeping Current .......................................................................................................................... 89 CHAPTER 5. PATENTS ON ACUTE PANCREATITIS ........................................................................... 91 Overview...................................................................................................................................... 91 Patents on Acute Pancreatitis...................................................................................................... 91 Patent Applications on Acute Pancreatitis.................................................................................. 97 Keeping Current ........................................................................................................................ 100 CHAPTER 6. BOOKS ON ACUTE PANCREATITIS ............................................................................ 101 Overview.................................................................................................................................... 101 Book Summaries: Federal Agencies............................................................................................ 101 Chapters on Acute Pancreatitis ................................................................................................. 104 CHAPTER 7. PERIODICALS AND NEWS ON ACUTE PANCREATITIS............................................... 107 Overview.................................................................................................................................... 107 News Services and Press Releases.............................................................................................. 107 Newsletter Articles .................................................................................................................... 109 Academic Periodicals covering Acute Pancreatitis .................................................................... 110 APPENDIX A. PHYSICIAN RESOURCES .......................................................................................... 113 Overview.................................................................................................................................... 113 NIH Guidelines.......................................................................................................................... 113 NIH Databases........................................................................................................................... 115 Other Commercial Databases..................................................................................................... 117 APPENDIX B. PATIENT RESOURCES ............................................................................................... 119 Overview.................................................................................................................................... 119 Patient Guideline Sources.......................................................................................................... 119 Finding Associations.................................................................................................................. 122 APPENDIX C. FINDING MEDICAL LIBRARIES ................................................................................ 125 Overview.................................................................................................................................... 125 Preparation................................................................................................................................. 125 Finding a Local Medical Library................................................................................................ 125 Medical Libraries in the U.S. and Canada ................................................................................. 125 ONLINE GLOSSARIES................................................................................................................ 131
viii Contents
Online Dictionary Directories ................................................................................................... 134 ACUTE PANCREATITIS DICTIONARY ................................................................................. 137 INDEX .............................................................................................................................................. 197
1
FORWARD In March 2001, the National Institutes of Health issued the following warning: "The number of Web sites offering health-related resources grows every day. Many sites provide valuable information, while others may have information that is unreliable or misleading."1 Furthermore, because of the rapid increase in Internet-based information, many hours can be wasted searching, selecting, and printing. Since only the smallest fraction of information dealing with acute pancreatitis is indexed in search engines, such as www.google.com or others, a non-systematic approach to Internet research can be not only time consuming, but also incomplete. This book was created for medical professionals, students, and members of the general public who want to know as much as possible about acute pancreatitis, using the most advanced research tools available and spending the least amount of time doing so. In addition to offering a structured and comprehensive bibliography, the pages that follow will tell you where and how to find reliable information covering virtually all topics related to acute pancreatitis, from the essentials to the most advanced areas of research. Public, academic, government, and peer-reviewed research studies are emphasized. Various abstracts are reproduced to give you some of the latest official information available to date on acute pancreatitis. Abundant guidance is given on how to obtain free-of-charge primary research results via the Internet. While this book focuses on the field of medicine, when some sources provide access to non-medical information relating to acute pancreatitis, these are noted in the text. E-book and electronic versions of this book are fully interactive with each of the Internet sites mentioned (clicking on a hyperlink automatically opens your browser to the site indicated). If you are using the hard copy version of this book, you can access a cited Web site by typing the provided Web address directly into your Internet browser. You may find it useful to refer to synonyms or related terms when accessing these Internet databases. NOTE: At the time of publication, the Web addresses were functional. However, some links may fail due to URL address changes, which is a common occurrence on the Internet. For readers unfamiliar with the Internet, detailed instructions are offered on how to access electronic resources. For readers unfamiliar with medical terminology, a comprehensive glossary is provided. For readers without access to Internet resources, a directory of medical libraries, that have or can locate references cited here, is given. We hope these resources will prove useful to the widest possible audience seeking information on acute pancreatitis. The Editors
1
From the NIH, National Cancer Institute (NCI): http://www.cancer.gov/cancerinfo/ten-things-to-know.
3
CHAPTER 1. STUDIES ON ACUTE PANCREATITIS Overview In this chapter, we will show you how to locate peer-reviewed references and studies on acute pancreatitis.
The Combined Health Information Database The Combined Health Information Database summarizes studies across numerous federal agencies. To limit your investigation to research studies and acute pancreatitis, you will need to use the advanced search options. First, go to http://chid.nih.gov/index.html. From there, select the “Detailed Search” option (or go directly to that page with the following hyperlink: http://chid.nih.gov/detail/detail.html). The trick in extracting studies is found in the drop boxes at the bottom of the search page where “You may refine your search by.” Select the dates and language you prefer, and the format option “Journal Article.” At the top of the search form, select the number of records you would like to see (we recommend 100) and check the box to display “whole records.” We recommend that you type “acute pancreatitis” (or synonyms) into the “For these words:” box. Consider using the option “anywhere in record” to make your search as broad as possible. If you want to limit the search to only a particular field, such as the title of the journal, then select this option in the “Search in these fields” drop box. The following is what you can expect from this type of search: •
Serial Computed Tomography Is Rarely Necessary in Patients with Acute Pancreatitis: A Prospective Study in 102 Patients Source: Journal of the American College of Surgeons. 193(2): 146-152. August 2001. Contact: Available from Journal of the American College of Surgeons. P.O. Box 2127, Marion, OH 43306-8227. (800) 214-8489 or (740) 382-3322. Fax (740) 382-5866. Summary: Computed tomography (CT) has proved to be helpful in patients with acute pancreatitis for differentiating between mild and severe forms. Follow up of acute pancreatitis with CT has been advocated but rarely studied. This article reports on a study undertaken to determine if late CT performed at day 7 might be helpful in establishing the prognosis or the type of complications, and to select a subgroup of
4
Acute Pancreatitis
patients with pancreatitis in whom CT could be beneficial. Contrast enhanced CT was performed at the admission day and 7 days after admission in 102 patients admitted for acute pancreatitis. The extent of pancreatic inflammation was classified according to Balthazar grade, and intrapancreatic necrosis (tissue death) on these examinations was prospectively assessed and compared with clinical and biologic data and with patient outcomes. Among 102 patients, complications developed in 24 (23 percent). Complications developed in only 8 percent of patients with Ranson score less than 2, making routine early CT unnecessary. For the patients with Ranson score less than 2 and Balthazar grades A and B at day 1 CT, late CT seemed to be useless. Complication was suspected by clinical and biologic tests before day 7 in 22 of 24 complicated patients (94 percent), suggesting that CT could be proposed only in cases of clinical or biologic deterioration. Late CT was correlated with a complicated course in patients with Balthazar grades D and E or intrapancreatic necrosis greater than 50 percent. Late CT was predictive of complications in cases of intrapancreatic necrosis enlarging since the first examination. The authors conclude that in cases of acute pancreatitis, there is little justification for systematic early CT, especially in patients with Ranson score less than 2, and late CT does not need to be performed routinely, but only in cases of clinical or biologic worsening. 2 figures. 4 tables. 26 references. •
Managing Acute Pancreatitis: New ACG Recommendations Source: Journal of Critical Illness. 12(8): 508-510, 511. August 1997. Summary: In early 1997, the American College of Gastroenterology (ACG) issued guidelines for the diagnosis and treatment of acute pancreatitis. The guidelines included the clinical terminology for acute pancreatitis and its complications, the appropriate criteria for determining the severity of the disorder, and the indications for medical and surgical treatment. This article provides summaries of these guidelines and includes recommendations for practical patient care. Topics include diagnostic guidelines, symptoms, laboratory findings, severity criteria, supportive care, and additional interventions. The goals of medical therapy for acute pancreatitis are to provide supportive care and to prevent systemic complications, pancreatic necrosis, and pancreatic infection. In a patient with mild pancreatitis, supportive care and monitoring for complications often are all that is required. However, when severe pancreatitis is present, ICU admission is indicated for the management of systemic complications, and additional diagnostic tests are needed to rule out pancreatic necrosis. A detailed patient care algorithm is provided. 1 figure. 1 table. 1 reference. (AA-M).
•
Acute Pancreatitis: Diagnosis and Management Source: American Family Physician. 52(2): 435-443. August 1995. Summary: In this article, the authors outline the steps in the diagnosis and management of acute pancreatitis, a clinical syndrome characterized by midepigastric pain, nausea, and vomiting. Topics include definitions; etiology; medications associated with acute pancreatitis; pathophysiology; clinical presentation; laboratory tests; diagnostic tests, including serum amylase level, lipase, abdominal radiographs, ultrasonography, and computed tomography; prognostic criteria for acute pancreatitis; treatment; and the role of surgery. The authors note that, once a diagnosis of pancreatitis is confirmed, supportive therapy with intravenous hydration and close observation is effective in the majority of patients. Lack of improvement may indicate the need to search for a local complication such as pseudocyst or abscess. They stress that evidence of the systemic complications of pancreatitis mandates intensive care monitoring. 4 figures. 4 tables. 41 references. (AA-M).
Studies
•
5
Acute Pancreatitis in Peritoneal Dialysis and Haemodialysis: Risk, Clinical Course, Outcome, and Possible Aetiology Source: Gut. 46(3): 385-389. March 2000. Contact: Available from BMJ Publishing Group. P.O. Box 590A, Kennebunkport, ME 04046. (800) 236-6265. Summary: It has been suggested that the incidence of acute pancreatitis (pancreas infection) in patients with end stage renal disease (ESRD, kidney failure) is increased. This article reports on a study undertaken to assess the risk of acute pancreatitis in patients on long term peritoneal dialysis (PD) and long term hemodialysis (HD) compared with the general population, to evaluate its clinical course and outcome, and to identify possible etiological factors. All patients from a large general hospital in The Netherlands who were maintained on long term PD or HD (total dialysis time more than six weeks) from January 1989 to March 1998 were included. In 269 patients on HD (total of 614 person years), one patient developed an attack of acute pancreatitis. Patients on hemodialysis did not show an increased risk for acute pancreatitis compared with the general population. In 128 patients on PD (total of 241 person years), seven patients had nine attacks of acute pancreatitis. Patients on PD had a significantly and highly increased risk for acute pancreatitis. Mortality in this series of nine attacks was 11 percent. No single etiological risk factor could be identified. The authors conclude that the risk of acute pancreatitis in patients on long term PD is significantly and highly increased compared with the general population. 3 tables. 22 references.
•
Acute Pancreatitis: Systemic Complications and Prognostic Assessment Source: Practical Gastroenterology. 15(8): 22, 27-30, 32. Summary: Once a diagnosis of acute pancreatitis (AP) has been made, its severity may range from mild, with abdominal pain, nausea and vomiting, to severe, with multisystem involvement. This article reviews the systemic complications and prognostic assessment of acute pancreatitis. The authors note that the management of AP has paralleled the understanding of the effects of the pancreatic gland's capacity to release hormones, enzymes, and peptides and their clinical manifestations. Advances in critical care permit survival of patients with severe fulminating pancreatitis. Death is primarily due to multisystem failure early on, or sepsis later, as secondary infection sets in. The authors discuss system complications (cardiac, renal, respiratory, and metabolic), infrequent system complications, measuring the severity of AP, peritoneal lavage, computed tomography, and the value of prognostic assessment. 5 tables. 27 references. (AA-M).
•
Recurrent Acute Pancreatitis: An Algorithmic Approach to Identification and Elimination of Inciting Factors Source: Gastroenterology. 120(3): 708-717. February 2001. Contact: Available from W.B. Saunders Company. 6277 Sea Harbor Drive, Orlando, FL 32887-4800. (800) 654-2452. Website: www.gastrojournal.org. Summary: Recurrent acute pancreatitis represents a challenging clinical problem associated with significant morbidity, impairment in quality of life, and expense. The evaluation of patients with recurrent acute pancreatitis requires systematic identification or elimination of correctable inciting factors. This article provides a comprehensive yet concise overview of the causes of recurrent acute pancreatitis; a detailed review of data relevant to implicated medications, the controversial issues of
6
Acute Pancreatitis
pancreas divisum and sphincter of Oddi dysfunction, and the role of genetic testing; a guideline for the evaluation of patients during the initial episode of acute pancreatitis; and a consensus algorithm within which putative inciting factors may be identified and eliminated. The guidelines offered pertain only to patients with recurrent acute pancreatitis in the absence of obvious evidence of chronic pancreatitis. Future advances in the treatment of these patients will almost certainly depend on improved imaging modalities, prospective clinical trials assessing the efficacy of endoscopic and surgical intervention, a better understanding of mutations and pathophysiologic mechanisms responsible for recurrent acute pancreatitis, and the development of novel, effective preventive and therapeutic strategies. 2 figures. 6 tables. 96 references. •
Acute Pancreatitis After Abdominal Vascular Surgery Source: Journal of the American College of Surgeons. 191(4): 373-380. October 2000. Contact: Available from Journal of the American College of Surgeons. P.O. Box 2127, Marion, OH 43306-8227. (800) 214-8489 or (740) 382-3322. Fax (740) 382-5866. Summary: Retroperitoneal dissection and ischemia (lack of blood to a body part) have been proposed as risk factors for postoperative pancreatitis. This study was undertaken to determine the incidence and outcomes of pancreatitis after abdominal vascular surgery. The authors collected data on 21 patients who developed pancreatitis after abdominal vascular operations; 21 controls undergoing identical operations were also randomly identified from the authors' operative log. The incidence of pancreatitis among all patients undergoing abdominal vascular operations during the 6 year study period was 1.8 percent. Pancreatitis was diagnosed a mean of 9.8 days (plus or minus 8 days) after operation and was associated with 3 or less Ranson signs in all 21 study subjects. Although there was a trend towards longer hospitalization in the subjects, there was no difference in complication rates between the two groups. Sixteen subjects (76 percent) had no complications. Three developed severe complications, two of whom died of causes unrelated to pancreatitis. One developed a pseudocyst that resolved spontaneously. Cholelithiasis (gallstones) was a causative factor in two subjects; no cause was established in the remaining 19. There was no difference in operative details between the two groups. The authors conclude that pancreatitis is a rare and self limited complication of abdominal vascular surgery. Pancreatitis is costly and inconvenient but rarely serious after abdominal vascular operations. 3 tables. 26 references.
•
Pancreatic and Biliary Disease: Laboratory Diagnostic Tests in Acute Pancreatitis Source: Journal of Clinical Gastroenterology. 34(4): 459-462. April 2002. Contact: Available from Lippincott Williams and Wilkins, Inc. 12107 Insurance Way, Hagerstown, MD 21740. (800) 638-3030 or (301) 714-2300. Summary: The diagnosis of acute pancreatitis (inflammation of the pancreas) depends on a combination of clinical assessment and laboratory testing. This article reviews the laboratory diagnostic tests in acute pancreatitis. Although the serum amylase is the cornerstone laboratory test used in establishing the diagnosis of acute pancreatitis, there are limitations in the sensitivity and specificity that may be important for the clinician to recognize. The serum lipase level may be especially useful in patients with alcoholinduced acute pancreatitis. A new urinary test strip that uses trypsinogen-2 may have a role in establishing the diagnosis of acute pancreatitis. In addition, several new laboratory tests and new interpretations of old laboratory tests may assist in establishing the etiology (cause) and severity of acute pancreatitis. The authors summarize important aspects of standard laboratory tests and new laboratory approaches in
Studies
7
establishing the diagnosis, etiology, and severity of acute pancreatitis. 1 table. 36 references. •
Evaluation of Factors That Have Reduced Mortality from Acute Pancreatitis Over the Past 20 Years Source: Journal of Clinical Gastroenterology. 35(1): 50-60. July 2002. Contact: Available from Lippincott Williams and Wilkins, Inc. 12107 Insurance Way, Hagerstown, MD 21740. (800) 638-3030 or (301) 714-2300. Summary: The mortality (death) associated with acute pancreatitis varies markedly in different studies, with most frequently reported mortality rates of 10 to 15 percent for all cases and 15 to 90 percent for attacks regarded as 'severe.' This article reports on a study undertaken to investigate whether there has been a reduction in mortality associated with acute pancreatitis over the past 20 years and the reasons for this reduction. The study featured the authors' 20 year prospective assessment of mortality as it relates to the severity of the disease, complications, and current therapy. The results showed that the initial reduction in mortality related to acute pancreatitis coincided with the recognition and application of the signs of severity. These signs dictated admission to intensive care unit (ICU) therapy, the intensity of ICU monitoring, and the importance of organ specific emergency therapy. Further mortality reduction in the 1990s could be attributed to either a more select study sample or earlier and more selective endoscopic or surgical debridement of infected tissue, endoscopic cyst drainage, and angiographic control of gastrointestinal bleeding. Improved nutritional support by jejunal feeding, earlier use of antibiotic therapy, gut sterilization, early endoscopic retrograde cholangiopancreatography (ERCP) for common bile duct stones, and necrosectomy (removal of dead tissue) for noninfected necrosis have reduced the overall mortality associated with acute pancreatitis to a mean of 5 percent for all cases and 20 percent for severe cases. 1 figure. 7 tables. 44 references.
•
Clinical Highlights: Medical Treatment of Acute Pancreatitis Source: Hospital Medicine. 28(1): 63. January 1992. Summary: This article consists of a chart that summarizes the medical treatment of acute pancreatitis. Grouped into supportive and specific nonoperative techniques, the chart covers intravascular volume, indications for pain relief and nutrition, nasogastric suction, percutaneous peritoneal lavage, and the use of antibiotics. 1 figure.
•
Acute Pancreatitis in the Elderly Source: Practical Gastroenterology. 19(1): 10-12, 14-16, 21-22. January 1995. Contact: Available from Shugar Publishing, Inc. 99B Main Street, Westhampton Beach, NY 11978. (631) 288-4404. Fax (631) 288-4435. E-Mail:
[email protected]. Summary: This article focuses on acute pancreatitis (AP) in the elderly. The authors note that the initial considerations in managing patients with acute pancreatitis are etiology and severity of the underlying inflammatory process. Drugs and biliary causes are the primary etiologies among elderly patients. Topics include the clinical presentation of AP in the elderly; etiological considerations; prognostic indicators, including single biochemical factors and multiple prognostic criteria; peritoneal lavage; computed tomography; therapy; development of systemic complications; pancreatic necrosis; and biliary pancreatitis. The authors conclude that laparoscopic cholecystectomy with intraoperative cholangiography and common bile duct
8
Acute Pancreatitis
exploration is the treatment of choice in the presence of cholelithiasis; preoperative endoscopic retrograde cholangiopancreatography (ECRP) reserved for severe cases. 5 tables. (AA-M). •
Acute Pancreatitis: Which Route Is Better for Nutritional Support? Source: Journal of Critical Illness. 15(1): 10-11. January 2000. Contact: Available from Cliggott Publishing Company. 55 Holly Hill Lane, Greenwich, CT 06831-0010. (203) 661-0600. Summary: This article is an entry from a regular column in which physicians answer specific clinical problems. In this column, the question concerned the nutritional management of patients with acute pancreatitis and the preferred method of nutritional support (enteral or parenteral route). The author answers by noting that the optimal route and timing of nutritional support in patients with acute pancreatitis is controversial. Deciding when to start nutritional support depends on the patient's nutritional history and severity of pancreatitis. If a patient has adequate nutritional reserve and has mild or moderate pancreatitis, it is appropriate to wait 7 to 10 days before starting either enteral or parenteral nutrition and to give intravenous fluids only. There is insufficient evidence that shows nutrition alone positively affects the outcome of acute pancreatitis. Nutritional support simply supplies fluid, macronutrients (proteins, carbohydrates, and fats) and micronutrients (electrolytes, trace elements, and vitamins) while the patient takes nothing by mouth to minimize pancreatic stimulation. After 7 to 10 days without nutrition, negative nitrogen balance occurs, increasing a patient's risk of infection. At this point, nutritional support should be started if the patient is unable to take adequate oral nutrition. The author briefly summarizes two studies that support enteral over parenteral nutrition in the management of acute pancreatitis. The author cautions that in clinical practice, however, the choice is not always that easy. Patients frequently refuse nasal tubes and often do not tolerate the feedings. The author stresses that each case needs an individualized approach and that enteral nutrition should be used whenever possible. 5 references.
•
Octreotide Treatment in Patients with Severe Acute Pancreatitis Source: Digestive Dieseases and Sciences. 45(11): 2247-2251. November 2000. Contact: Available from Kluwer Academic/Plenum Publishers. 233 Spring Street, New York, NY 10013-1578. (212) 620-8000. Fax (212) 807-1047. Summary: This article reports on a study that investigated the effect of octreotide (Sandostatin) in the treatment of severe acute pancreatitis in a case control study. Experimental and clinical studies on the effect of octreotide in the treatment of acute pancreatitis have shown controversial results. The authors report on their prospective randomized study (begun in 1992) on the effect of octreotide in severe acute pancreatitis, undertaken in three hospitals in Israel. Patients were randomly assigned to conservative treatment either with or without octreotide (0.1 mg subcutaneously three times a day). Of 50 patients, 25 were assigned to octreotide (treatment group) and 25 to conservative treatment only (control group). The two groups were matched with regard to age, sex, etiology, and severity of the disease. The complication rate was lower in the treatment group with regard to sepsis and adult respiratory distress syndrome (ARDS). These decreases could be explained by the immunomodulatory effects of octreotide. The hospital stay was shorter in the treatment group. Two patients died in the treatment group and eight in the control group. These results suggest that octreotide may have a beneficial effect in the treatment of severe acute pancreatitis. 4 tables. 36 references.
Studies
•
9
Acute Pancreatitis in Chronic Renal Failure Source: American Journal of Gastroenterology. 91(12): 2477-2482. December 1996. Summary: This article reports on a study to estimate the frequency and severity of acute pancreatitis (AP) associated with chronic renal failure (CRF) and to find out whether CRF causes AP. The authors studied 532 patients with a first episode of AP during the period of 1982 to 1994. Twenty-one patients had CRF; 511 patients without CRF served as controls. AP was diagnosed clinically and by elevation of amylase and lipase. CT or sonographic confirmation of diagnosis was made in all CRF patients. The cause of AP in the non-CRF group was significantly different from that seen in the CRF group. Incidence of severe AP in the two groups was 47.6 percent in the CRF group versus 21 percent in the non-CRF group. By simplified prognostic criteria, it was 38 versus 10.3 percent, respectively. Overall, CRF patients had more complications compared with non-CRF. CRF patients with severe AP had high mortality when stratified by either Ranson's or simplified prognostic criteria. The authors conclude that AP in CRF is frequently of unknown cause, suggesting the role of either CRF or other factors. Irrespective of cause, AP in CRF is a serious disease, associated with a high morbidity and mortality. 1 figure. 3 tables. 38 references. (AA-M).
•
Diagnosis and Management of Acute Pancreatitis Source: American Family Physician. 62(1): 164-174. July 1, 2000. Contact: Available from American Academy of Family Physicians. 11400 Tomahawk Creek Parkway, Leawood, KS 66211-2672. (800) 274-2237. Website: www.aafp.org. Summary: This article reviews the diagnosis and management of acute pancreatitis, which usually occurs as a result of alcohol abuse or bile duct obstruction. A careful review of the patient's history and appropriate laboratory studies can help the physician identify the etiology (cause) of the condition and thus guide management. Serum (blood) amylase and lipase levels are still used to confirm the diagnosis of acute pancreatitis. Although not routinely available, the serum trypsin level is the most accurate laboratory indicator for pancreatitis. Ultrasonography, computed tomography, and endoscopic retrograde cholangiopancreatography (ERCP) are additional modalities that can help the family physician choose the best treatment approach. Prompt identification of patients who need intensive care referral or subspecialty consultation is crucial. The APACHE II and the multiple organ system failure scales provide prognostic information at the time of admission and may be repeated daily to monitor disease progression. Therapies such as nasogastric suctioning, anticholinergics, and histamine H2 receptor blockers have not been shown to decrease symptoms or hospital stays in patients with acute pancreatitis. Systemic antibiotics have been found to improve outcome in patients with severe disease. With supportive care, most patients have a good clinical outcome. 4 figures. 8 tables. 39 references.
•
Etiology and Pathogenesis of Acute Pancreatitis: Current Concepts Source: Journal of Clinical Gastroenterology. 30(4): 343-356. June 2000. Contact: Available from Lippincott Williams and Wilkins, Inc. 12107 Insurance Way, Hagerstown, MD 21740. (800) 638-3030 or (301) 714-2300. Summary: This article reviews the etiology and pathogenesis of acute pancreatitis, a disorder that has numerous causes and an obscure pathogenesis. Bile duct stones and alcohol abuse together account for about 80 percent of acute pancreatitis. Most episodes of biliary pancreatitis are associated with transient impaction of the stone in the ampulla
10
Acute Pancreatitis
(that causes obstruction of the pancreatic duct, with ductal hypertension) or passage of the stone through and into the duodenum. Other causes of acute pancreatitis are various toxins, drugs, other obstructive causes (such as malignancy [cancer] or fibrotic sphincter of Oddi), metabolic abnormalities, trauma, ischemia, infection, and autoimmune diseases. In 10 percent of cases of acute pancreatitis, no underlying cause can be identified; this condition is known as idiopathic acute pancreatitis. Intra acinar activation of trypsinogen plays a central role in the pathogenesis of acute pancreatitis, resulting in subsequent activation of other proteases, causing the subsequent cell damage. Ischemia (fluid) or reperfusion injury is increasingly recognized as a common and important mechanism is the pathogenesis of acute pancreatitis and especially in the progression from mild edematous to severe necrotizing form of the disease. Increased intracellular calcium concentration also mediates acinar cell damage. Oxygen derived free radicals and may cytokines (e.g., interleukin 1, tumor necrosis factor alpha, platelet activating factor) are considered to be principal mediators in the transformation of acute pancreatitis from a local inflammatory process into a multiorgan illness. The damage to pancreatic cells and blood vessels that the different enzymes and inflammatory substances cause can result in tissue hypoxia (lack of oxygen) and further cellular necrosis (cell death), resulting in a vicious circle in which more pancreatic enzymes are released and more pancreatic injury occurs. 4 figures. 2 tables. 155 references. •
Role of Imaging in Acute Pancreatitis Source: European Journal of Gastroenterology and Hepatology. 9(2): 106-116. February 1997. Contact: Available from Rapid Science Publishers. 400 Market Street, Suite 750, Philadelphia, PA 19106. (800) 552-5866 or (215) 574-2210. Summary: This article reviews the roles of ultrasound, computed tomography, and magnetic resonance imaging (MRI) in the evaluation and management of acute pancreatitis. The author notes that pancreatitis can remain localized to the pancreas and immediate peripancreatic tissues or can affect structures remote from the pancreatic bed. Thus, the imaging techniques chosen need to cover all organs and pathways likely to be affected. The author reviews the importance of imaging in the diagnosis of pancreatic necrosis, acute fluid collections, pancreatic abscess, pseudocysts, and vascular complications. Ultrasound is useful in the detection of gallstones and any associated compromise to the biliary tree; and in the detection of pancreatic and peripancreatic fluid collections. The role of MRI in the imaging of acute pancreatitis remains uncertain, with supporters of the technique suggesting that MRI is complementary to CT with definite advantages in certain situations. Other authors contend that the role of MRI has not been fully evaluated and currently offers no advantage over CT. The use of interventional techniques as opposed to surgical intervention is also discussed. 8 figures. 35 references (32 annotated).
•
Acute Pancreatitis: Principles of Management Source: Practical Gastroenterology. 20(6): 26, 28, 33-36, 38-39. June 1996. Contact: Available from Shugar Publishing, Inc. 99B Main Street, Westhampton Beach, NY 11978. (631) 288-4404. Fax (631) 288-4435. E-Mail:
[email protected]. Summary: This article, the fourth in a series on pancreatic disease, presents principles of management for the care of patients with acute pancreatitis. The authors note that the treatment of these patients depends primarily on the etiology and severity of the disease. The goals of therapy are to control the inflammatory process and manage any
Studies
11
complications that arise. The finding of complications such as respiratory impairment, sepsis, and renal failure importantly influences treatment planning. Intravascular volume repletion and maintenance is vital in acute pancreatitis because it prevents further extension of the inflammatory process. A new treatment modality that involves the use of dextran seems to provide additional benefits in this regard. Patients with acute pancreatitis should be kept fasting until the inflammatory process is deemed to be controlled. Nutritional support with parenteral feeding is indicated for patients with severe pancreatitis and those expected to fast for a prolonged period. Pain, a cardinal symptom in acute pancreatitis, can be treated with parenteral meperidine. Octreotide seems to decrease the exocrine secretory activity of the pancreas. Prophylaxis with antibiotics may be considered for patients with severe forms of the disease. A new specific cytokine antagonist, lexipafant, has been shown to be effective in decreasing complications in severe acute pancreatitis. Endoscopic treatment of severe gallstone pancreatitis in its early stages decreases the frequency of biliary sepsis. Surgical treatment is indicated in cases of infected necrotizing pancreatitis. The optimal treatment for noninfected necrotizing pancreatitis remains to be defined. Intensive medical treatment should be provided initially, with failure to respond requiring a surgical approach. 1 figure. 57 references. (AA-M). •
Acute Pancreatitis: Clinical Classification and Terminology Source: Practical Gastroenterology. 20(5): 8, 9-10, 12, 14, 16, 21-22, 24. May 1996. Contact: Available from Shugar Publishing, Inc. 99B Main Street, Westhampton Beach, NY 11978. (631) 288-4404. Fax (631) 288-4435. E-Mail:
[email protected]. Summary: This article, the second in a series on pancreatic disease, considers the clinical classification and terminology of acute pancreatitis. The author contends that the management of acute pancreatitis and its complications has been hampered by imprecise terminology and idiosyncratic definitions. Since optimal therapy requires accuracy in diagnosis, and since accurate diagnosis depends in turn on precise terminology, the need for an international consensus was apparent. Accordingly, a multidisciplinary group of 40 internationally recognized experts in acute pancreatitis was assembled in Atlanta, GA, in 1992 for the stated purposes of constructing a clinically based classification system for acute pancreatitis and creating a plan of management based on the new definitions. This article describes the deliberations and resulting recommendations of this symposium. The author concludes that the Atlanta Symposium's suggested classification and resulting therapeutic approach has been in prospective use for the past 5 years by authorities on acute pancreatitis all over the world and may now be recommended without reservation. One chart outlines the flow diagram for the initial management of patients with acute pancreatitis. 3 figures. 7 references. (AA-M).
•
Acute Pancreatitis: Diagnosis and Evaluation Source: Practical Gastroenterology. 20(6): 8, 13-14, 16, 18, 20, 25. June 1996. Contact: Available from Shugar Publishing, Inc. 99B Main Street, Westhampton Beach, NY 11978. (631) 288-4404. Fax (631) 288-4435. E-Mail:
[email protected]. Summary: This article, the third in a series on pancreatic disease, considers the diagnosis and evaluation of acute pancreatitis. The authors note that acute pancreatitis can be diagnosed in the vast majority of patients on the basis of the history and the finding of hyperamylasemia (raised amylase level in the blood). In about 5 to 30 percent of patients, the hyperamylasemia arises from causes other than pancreatitis, thus
12
Acute Pancreatitis
necessitating additional investigations. If differentiation from other catastrophic surgically correctable disease is problematic, an immediate computed tomography (CT) scan or, if CT is not available, laparotomy should be performed. Once the diagnosis of pancreatitis is established, the severity of the attack should be assessed in accord with some grading schema. Severity grading derives importance because it governs prognosis, mortality, and the intensity of therapy. The scoring systems currently in use correctly predict a severe or fulminating attack with an accuracy of about 80 to 90 percent in the 20 percent of patients who present with such attacks. A CT scan should not be used for the sole purpose of assessing severity, as the effect of the contrast material on renal and pancreatic microcirculation is still uncertain. However, CT is essential to uncover and delineate intra abdominal complications if the attack persists. Early etiologic assessment is also important because the detection of potential causes for acute pancreatitis will influence the treatment approach, both immediately and after subsidence of the acute process. 4 tables. 6 references. (AA-M). •
Acute Pancreatitis: Another Piece of the Puzzle? Source: New England Journal of Medicine. 325(6): 423-424. August 8, 1991. Summary: This brief article describes two forms of experimental pancreatitis and hypothesizes a connection between the occurrence of pancreatic cellular injury and calcium levels. The author briefly reviews the history of research work searching for the mechanisms that trigger acute pancreatitis. The author concludes that the observation of a relation between pancreatitis and calcium administration may provide yet another clue to the still puzzling story of the pathogenesis of pancreatitis. Reference is made to another article in the same journal issue that presents research in this area. 10 references.
•
Acute Pancreatitis-A Historical Update Source: Practical Gastroenterology. 16(1): 18-19. January 1992. Summary: This brief article, serving as an introduction to a series of articles on pancreatitis, presents an historical update of the condition. Topics include early references to chronic pancreatitis secondary to alcoholism, the Marseille symposium of 1963, and the non-alcohol-related forms of chronic pancreatitis (senile, hereditary, and idiopathic). 2 figures. 1 table. 14 references.
•
Practice Guidelines in Acute Pancreatitis Source: American Journal of Gastroenterology. 92(3): 377-386. March 1997. Summary: This practice guideline reviews the basis of decisions in the management of patients with acute pancreatitis. The author notes that there are a number of important issues pertaining to these decisions, including the need for a consensus on terminology, the most appropriate criteria for determining severity of acute pancreatitis, choices of medical versus surgical therapy, and options for treating complications, including pancreatic pseudocysts. After a section of definitions, the author provides goals and recommendations for each category. The goals of medical therapy include supportive care, limitation of systemic complications, prevention of pancreatic necrosis, and prevention of pancreatic infection once necrosis takes place. In mild pancreatitis, fluid resuscitation and careful monitoring are the two most important components of treatment. Dynamic contrast-enhanced CT scan is recommended at some point beyond the first 3 days in severe acute pancreatitis to distinguish interstitial from necrotizing disease. In the absence of clinical improvement, guided percutaneous aspiration should be performed to distinguish infected necrosis from severe sterile necrosis. Infected
Studies
13
necrosis requires surgical debridement; severe sterile necrosis can usually be treated medically. Asymptomatic pseudocysts require no specific treatment. Symptomatic pseudocysts can be decompressed by surgical, radiologic, or endoscopic methods. 1 figure. 6 tables. 38 references. (AA-M). •
Management of Acute Pancreatitis: A Critical Assessment as Dr. Bockus Would Have Wished Source: American Journal of Gastroenterology. 90(5): 696-703. May 1995. Summary: This presentation, from the 1994 World Congress of Gastroenterology, reviews the management of acute pancreatitis. Topics covered include etiology and pathogenesis; terminology; severity grading; initial management of acute pancreatitis; peritoneal lavage; necrosis and infection; and biliary pancreatitis. The author focuses on some selected features and certain collateral factors that subtly or overtly influence the nature, breadth, and intensity of the therapeutic measures. 6 figures. 67 references. (AAM).
•
Clinical Update: Management of Acute Pancreatitis Source: Journal of Gastroenterology and Hepatology. 12(3): 189-197. March 1997. Contact: Available from Blackwell Science Pty Ltd. P.O. Box 378, Carlton, Victoria 3053, Australia. Phone: 61 3 9347 0300; Fax: 61 3 9347 5001; E-mail:
[email protected]. Web site: http://www.blacksci.co.uk. Summary: This review article considers the management of acute pancreatitis. The authors follow the clinically based classification system adapted at an international symposium in Atlanta in 1992. Acute pancreatitis refers to an acute inflammatory process of the pancreas, with variable involvement of other regional tissues or remote organ systems. The authors emphasize the importance of confirming the diagnosis and establishing the etiology. Improved methods of assessing the biliary tree may reduce the number of patients regarded as having idiopathic pancreatitis. Detailed clinical and laboratory protocols, designed to assess severity, have no major advantage over clinical assessment. The contrast-enhanced computed tomography (CT) scan is important to assess the degree of pancreatic necrosis and to detect local complications. The treatment of pancreatitis continues to be largely supportive. However, controlled studies support the use of antibiotics in severe acute pancreatitis and indicate a possible role for the use of octreotide and antioxidants. The place of endoscopic and surgical intervention is becoming better defined. Once an attack has passed, further investigation is often required in an attempt to prevent further episodes of inflammation. 1 figure. 2 tables. 99 references. (AA-M).
Federally Funded Research on Acute Pancreatitis The U.S. Government supports a variety of research studies relating to acute pancreatitis. These studies are tracked by the Office of Extramural Research at the National Institutes of Health.2 CRISP (Computerized Retrieval of Information on Scientific Projects) is a searchable
2
Healthcare projects are funded by the National Institutes of Health (NIH), Substance Abuse and Mental Health Services (SAMHSA), Health Resources and Services Administration (HRSA), Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDCP), Agency for Healthcare Research and Quality (AHRQ), and Office of Assistant Secretary of Health (OASH).
14
Acute Pancreatitis
database of federally funded biomedical research projects conducted at universities, hospitals, and other institutions. Search the CRISP Web site at http://crisp.cit.nih.gov/crisp/crisp_query.generate_screen. You will have the option to perform targeted searches by various criteria, including geography, date, and topics related to acute pancreatitis. For most of the studies, the agencies reporting into CRISP provide summaries or abstracts. As opposed to clinical trial research using patients, many federally funded studies use animals or simulated models to explore acute pancreatitis. The following is typical of the type of information found when searching the CRISP database for acute pancreatitis: •
Project Title: ACUTE PANCREATITIS Principal Investigator & Institution: Steer, Michael L.; Professor of Surgery; Beth Israel Deaconess Medical Center St 1005 Boston, Ma 02215 Timing: Fiscal Year 2002; Project Start 01-JUL-1982; Project End 31-JUL-2003 Summary: (Adapted from investigator's abstract) Currently available evidence indicates that digestive enzyme zymogens such as trypsinogen become prematurely activated within acinar cells of the pancreas during the early stages of acute pancreatitis. Activated digestive enzymes are believed to cause cell injury leading to acinar cell death and pancreatitis. The proposed project will pursue the following specific aims: 1) to define the mechanisms responsible for premature activation of zymogens within the pancreas and the role of those activated digestive enzymes in the evolution of acute pancreatitis; and 2) to determine if the type of acinar cell death (ie, necrosis or apoptosis) during acute pancreatitis regulates the severity of that acute pancreatitis. The specific aim #1 studies will build on the observation that infusion of a supramaximally stimulating dose of the CCK analog caerulein causes intrapancreatic activation of trypsinogen as well as pancreatitis in rats. Furthermore, cathepsin B mediated activation of trypsinogen occurs when isolated acini are incubated in vitro with supramaximally stimulating concentrations of caerulein. In the proposed studies, the intracellular location of trypsinogen activation, the cellular events involved in trypsinogen activation, and the mechanism by which trypsinogen activation leads to cell injury will be determined. In the specific aim #2 studies, several models of experimental pancreatitis in laboratory animals (mice, rats, opossums) will be utilized to evaluate the possibility that apoptosis minimizes the severity of pancreatitis. The mechanisms underlying this phenomenon will be examined and the potential value of treating established pancreatitis by inducing apoptosis will be evaluated. Successful completion of these proposed studies will provide important new insights into the cellular basis for acute pancreatitis and identify methods of either preventing or minimizing the severity of this frequently lethal disease. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: APOPTOSIS AND NECROSIS IN PANCREATITIS Principal Investigator & Institution: Gukovskaya, Anna S.; Medicine; University of California Los Angeles 10920 Wilshire Blvd., Suite 1200 Los Angeles, Ca 90024 Timing: Fiscal Year 2003; Project Start 01-APR-2003; Project End 31-MAR-2007 Summary: (provided by applicant): Inflammation and parenchymal tissue damage are hallmarks of pancreatitis. In particular, severe necrosis is a major complication of the disease. Over the past decade, significant progress has been achieved in understanding
Studies
15
the mechanisms of the inflammatory response of pancreatitis. In contrast, very little is known about the mechanisms of pancreatic acinar cell death. Mechanisms of necrosis are largely unknown. Key signals mediating apoptosis have been established; however, their roles in disease processes remain obscure, and they have not been investigated in pancreatitis. The role of cell death pathways in pathologic trypsin activation, an important marker of tissue damage in pancreatitis, has not been explored. Our preliminary data indicate that key necrotic and apoptotic mechanisms: poly (ADPribose) polymerase (PARP), mitochondrial dysfunction, caspases (specific cysteine proteases), and the transcription factor NFkappaB are activated in experimental models of pancreatitis and in pancreatic acinar cells stimulated with cholecystokinin (CCK). For the present application, we hypothesize that in pancreatitis, necrotic and apoptotic signaling pathways are interrelated. Activation of PARP and mitochondrial deenergization leads to ATP depletion and necrosis. On the other hand, effector caspases mediate apoptosis and limit necrosis by inactivating PARP and trypsin. NFkappaB negatively regulates effector caspases and, thus plays an anti-apoptotic role in pancreatitis. Thus PARP, mitochondrial dysfunction, caspases, and NFkappaB play central roles in determining the balance between apoptotic versus necrotic type of acinar cell death and the severity of pancreatitis. We propose the following specific objectives for the present application: 1). Determine the role of PARP in necrosis and apoptosis in experimental pancreatitis and in vitro, in pancreatic acini stimulated with CCK. 2). Determine the role of mitochondrial dysfunction in necrosis and apoptosis in experimental pancreatitis and in vitro, in pancreatic acini stimulated with CCK. 3) Determine the role of caspases in necrosis, apoptosis, and trypsin activation in experimental pancreatitis and in vitro, in pancreatic acini stimulated with CCK. 4). Determine the role of NFkappaB in necrosis and apoptosis in experimental pancreatitis and in vitro, in pancreatic acini stimulated with CCK. Measurements to achieve these goals will include measures of pancreatitis, morphologic characterization of apoptosis and necrosis, intrapancreatic activation of caspases and trypsin, cytochrome c release, mitochondrial membrane potential, ATP levels, and NFkappaB activation by using Western blot and gel shift analyses, enzymatic and fluorimetric assays. The result of the experiments in the proposed specific objectives will be delineation of key molecular mechanisms regulating necrosis and apoptosis in acute pancreatitis, which will lead to novel therapeutic strategies to treat the disease. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: CYSTEINE STRING PROTEIN AND ACUTE PANCREATITIS Principal Investigator & Institution: Groblewski, Guy E.; Nutritional Sciences; University of Wisconsin Madison 750 University Ave Madison, Wi 53706 Timing: Fiscal Year 2003; Project Start 01-MAR-2003; Project End 28-FEB-2005 Summary: (provided by applicant): Acute pancreatitis is an inflammatory disease that is triggered by the premature activation of proteolytic zymogens in acinar cells. As a protective mechanism, zymogens are synthesized as inactive pro-enzymes and packaged in specialized secretory granules destined for exocytosis into the pancreatic duct. During pancreatitis, proteolytic zymogens are prematurely activated in acinar cells by aberrantly mixing with hydrolases present in lysosomes. The mixing of lysosomal hydrolases with zymogens occurs in large cytoplasmic vacuoles as a result of pathogenic alterations in acinar cell membrane trafficking. It is well established that the stress-induced expression of heat shock protein-70 (HSP70) in acini provides a natural protective effect against the pathogenic mixing of lysosomal and secretory granule membrane compartments. This proposal is designed to elucidate the mechanism by
16
Acute Pancreatitis
which HSP70 inhibits the intra-acinar cell activation of zymogens in preventing the onset of acute pancreatitis. HSP70 is a molecular chaperone in the cytosol that requires a co-chaperone protein to stimulate ATPase activation and substrate binding. We have 1) identified an HSP70 co-chaperone protein called cysteine string protein (CSP) in acinar cells, 2) localized this membrane associated molecule throughout the secretory pathway and 3) developed the TAT-fusion protein system to manipulate CSP expression in acinar cells and thereby study its function. We hypothesize that CSP mediates the protective effects of HSP70 against pancreatitis by targeting HSPT0 chaperone activity from the cytosol to the secretory pathway. In Specific Aim 1, mutant forms of CSP that no longer anchor to secretory granule membranes will be overexpressed acinar cells to determine the importance of CSP in targeting HSP70 to these organelles during pancreatitis. In Specific Aim II, short interference RNAs will be used to inhibit CSP expression in pancreatic Iobules and the protective effects of HSP70 on secretagogue-induced acinar cell damage will be evaluated. These studies will allow us to directly evaluate the role of CSP in the secretory pathway of acini under physiological and pathophysiological conditions. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: DIET, DISEASE, AND PANCREATIC ENZYME SYNTHESIS IN HUMANS Principal Investigator & Institution: O'keefe, Stephen J.; Internal Medicine; Virginia Commonwealth University Richmond, Va 232980568 Timing: Fiscal Year 2002; Project Start 01-JUN-2000; Project End 31-MAY-2004 Summary: Acute pancreatitis is a disease of high mortality, induced by premature activation of digestive enzymes in the pancreas, and accompanied by a severe systemic immunoinflammatory response and protein catabolism. Meeting nutritional needs is difficult because food-induced pancreatic stimulation may exacerbate the disease process, and intravenous nutrition (TPN), while "resting the pancreas," increases the risk of septicemia and mucosal atrophy. Recent controlled clinical trials suggest that tubefeeding with elemental diets has advantages over TPN with regard to cost, safety (less infective complications), and efficacy (more anticatabolic). However, it is unknown in humans whether elemental diets stimulate the pancreas, and the beneficial effects may simply reflect better metabolic control and fewer serious complications. Consequently, Dr. O'Keefe and colleagues plan to measure the effects of duodenal infusions of elemental diets on pancreatic enzyme synthesis and secretion in normal volunteers and patients with acute pancreatitis using a unique method that they have developed, based on the 6-hr intravenous and enteral infusion of two isotope-labeled amino acids and measurement of their uptake into trypsin and amylase proteins extracted from duodenal secretions. The method also allows them to obtain simultaneous measurements of the rates of protein catabolism and utilization of dietary amino acids for the synthesis of mucosal proteins (obtained by endoscopic biopsy). Studies will be conducted in groups of 8 normal volunteers to compare the relative effects of complex and elemental diets given as duodenal infusions, versus TPN, on the normal response to a complex oral diet. The results will then be used to evaluate the responses in 20 patients with acute pancreatitis randomized to receive enteral elemental or TPN. The results of these investigations are expected to provide valuable new information on both the stimulatory effects of food on the human digestive system and the nutritional value of modern nutritional support techniques, and help determine why elemental diets are more effective than TPN in the management of patients with acute pancreatitis. The
Studies
17
results are also expected to form a scientific basis for the design of disease-specific diets for patients with acute pancreatic disease. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: ENOS IS PROTECTIVE IN THE INITIATION OF PANCREATITIS Principal Investigator & Institution: Dimagno, Matthew J.; Internal Medicine; University of Michigan at Ann Arbor 3003 South State, Room 1040 Ann Arbor, Mi 481091274 Timing: Fiscal Year 2002; Project Start 01-JAN-2003; Project End 31-DEC-2004 Summary: (provided by applicant): Pharmacological inhibition of nitric oxide synthase (NOS) or enhancement of nitric oxide (NO) in experimental acute pancreatitis (AP) has yielded mixed results, in part because three NOS isoforms exist: neuronal- (nNOS), endothelial- (eNOS) and inducible- (iNOS). Our preliminary data clarifies the role of NO during the initiation of AP and shows that pharmacologic NOS blockade and eNOS deletion, but not nNOS or iNOS deletion, enhance the initiation of an in vivo caerulein hyperstimulation model of AP. By contrast pharmacologic NOS blockade during in vitro caerulein AP has no effect on conversion of intraacinar trypsinogen to trypsin, a hallmark of AP, suggesting that eNOS-derived NO arises from a non-acinar source and/or acts on a non-acinar target. Our data also suggests that upregulation of endothelial eNOS by Simvastatin and Cytochalasin D may attenuate in vivo caerulein AP. We hypothesize that eNOS-derived NO indirectly inhibits initiation of AP by enhancing pancreatic microvascular perfusion. We plan to confirm whether eNOSderived NO acts on a non-acinar target by using an in vitro caerulein model of AP in isolated eNOS KO acini vs. WT acini. Secondly we plan to assess differences in pancreatic perfusion between eNOS KO mice and WT mice during AP using dyelabeled microspheres. Third we plan to determine whether the enhanced initiation of in vivo AP in eNOS KO mice (compared with WT mice) may be normalized by augmenting pancreatic perfusion with NO donors. Fourth we plan to upregulate eNOS pharmacologically in WT and eNOS KO mice to assess for protection against in vivo caerulein AP. We hope that this study may further clarify the role of NO in the pathogenesis of AP. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: EXOCRINE PANCREATIC ZYMOGEN ACTIVATION Principal Investigator & Institution: Gorelick, Fred S.; Professor of Medicine; Internal Medicine; Yale University 47 College Street, Suite 203 New Haven, Ct 065208047 Timing: Fiscal Year 2003; Project Start 15-JUL-1998; Project End 31-MAR-2007 Summary: (provided by applicant): The pathologic proteolytic activation of digestive zymogens within pancreatic acinar cells is a key step in the initiation of pancreatitis. The extracellular and intracellular mechanisms responsible for this activation remain unclear. Supraphysiologic concentrations (>10 fold than required for maximal secretion) of the physiologic ligand, cholecystokinin (CCK), given in vivo cause zymogen activation and pancreatitis. Similarly treated isolated acinar cells respond with zymogen activation and are injured. Factors that can sensitize the acinar cell to the pathologic effects of CCK might be relevant to the pathogenesis of acute pancreatitis. Several experimental studies suggest that CCK-activated pathways contribute to disease. These include pancreatitis induced by ischemia, bile salts, the CDE diet, and ethanol. We hypothesize that: 1) clinically relevant agents or conditions can either act alone or sensitize the acinar cell to the effects of CCK on zymogen activation, and 2) such activation will depend on Ca2+-dependent and independent mechanisms. We find that
18
Acute Pancreatitis
the following relevant factors sensitize the acinar cell to zymogen activation caused by physiologic concentrations of CCK: secretin, VLDL, and short chain fatty acids. With respect to alcohols, sensitization increased with chain length and deceased with branching. At sensitizing concentrations, alcohols caused no detectable changes in either cytosolic Ca2+ signaling or secretion. However, the sensitizing effects of secretin corresponded to effects on CCK induced Ca2+ signaling. Previous studies suggested that a low pH compartment mediated zymogen activation. We find that inhibitors of vacuolar (v) ATPase (bafinomycin and concanomycin) block CCK-induced zymogen activation. Using antibodies to subunits of vATPase, we observed translocation during CCK treatments. Thus, vATPase appears to be activated and contribute to zymogen activation. We plan to examine the cellular signaling pathways stimulated by these sensitizing agents with particular emphasis on Ca2+, cAMP, PKC, and vATPase. Further, we will examine the effects of the sensitizing agents on cell injury and the trafficking of active enzymes. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: LIVER-LUNG INTERACTION DURING ACUTE PANCREATITIS Principal Investigator & Institution: Gray, Keith D.; Surgery; Vanderbilt University 3319 West End Ave. Nashville, Tn 372036917 Timing: Fiscal Year 2002; Project Start 05-FEB-2002 Summary: A prominent feature of severe acute systemic inflammatory response syndrome (SIRS) including acute respiratory distress syndrome (ARDS). The physiology of these responses appears remarkably similar to responses to direct liver injury in other settings. Cytokines produced in the liver and lungs, including tumor necrosis factoralpha (TNF-alpha) and interleukin (IL-1), are implicated in the pathogenesis of SIRS and animal experiments have demonstrated them capable of precipitating acute lung injury. During acute pancreatitis, proteases are released into the portal system, exposing the liver to high levels of activated enzymes. Nuclear factor kappa-B (NF-kappaB), a transcriptional regulator of TNF- alpha, IL-1 and other cytokines, is activated in the pancreas within 30 minutes of inducing experimental acute pancreatitis and subsequently within the liver and lung within 24 hours of acute liver injury. Our central hypothesis is that NF-kappaB activation in the pancreas and liver mediates acute lung injury associated with pancreatitis. Using the biliary cerulein/glycodeoxycholic acid model of acute pancreatitis will address two specific aims: 1) to determine whether altering NF-kappaB activation in the liver affects the pulmonary response to severe acute pancreatitis; 2) to determine the role of Kupffer cells in mediating the multisystem effects of pancreatitis by depleting Kupffer cells prior to induction of pancreatitis. These studies may allow the development of strategies to ameliorate multisystem to ameliorate multi-system injury including pulmonary failure, which can be devastating during this illness. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: MODELS OF TYPE 1 AND TYPE II HEREDITARY PANCREATITIS Principal Investigator & Institution: Ulrich, Charles D.; Internal Medicine; University of Cincinnati 2624 Clifton Ave Cincinnati, Oh 45221 Timing: Fiscal Year 2002; Project Start 01-MAY-2001; Project End 31-MAR-2003 Summary: (Applicant's Abstract): Acute and chronic pancreatitis remain major healthcare problems. The lack of effective preventive and therapeutic strategies in these disease states stems from a lack of understanding regarding disease pathogenesis. The
Studies
19
investigator's group has identified mutations responsible for two delayed-onset, autosomal dominant inherited forms of acute and chronic pancreatitis. An RI 17H mutation in the human cationic trypsinogen gene links with type I hereditary pancreatitis (HP I). An N211 mutation in the same gene links with type II hereditary pancreatitis (HP II). Biochemical data from other groups when combined with the results of there preliminary studies support the hypothesis that the HP I mutation in cationic trypsin renders the molecule resistant to proteolytic digestion, the persistence of mutant trypsin activity resulting in the creation of a "milieu" sufficient for clinicallyapparent acute pancreatitis. The alterations in protein biochemistry responsible for the HP II phenotype remain unclear. In an initial attempt to develop an animal model of HP I, the investigator generated transgenic mice containing a diet-inducible pancreatic acinar cell-specific promoter coupled to either wild-type or HP I mutant human cationic trypsinogen. Unfortunately, these mice fail to develop pancreatitis spontaneously, and all available antibodies to human cationic trypsin cross-react with an identically sized mouse trypsin. The investigator believes that enhanced expression of antibody epitopetagged human cationic trypsinogens will provide him with the best opportunity to develop a successful animal model of hereditary pancreatitis. Toward this end, the investigator proposes (1) studies comparing the biochemical properties of affinitypurified recombinant wild-type, R117H, and N21I human cationic trypsinogen/trypsin (+ I- epitope tag) utilizing a validated in vitro assay system. By design, these studies will also further test the investigator's hypothesis with regard to HP I mutant trypsin, and discern the biochemical alterations induced by the HP II mutation. The investigator will then (2) characterize murine pancreata and acinar cells expressing varying levels of epitope-tagged wild-type, R117H, and N2 11 human cationic trypsinogen/trypsin. The development of these animal models, in combination with the experimental design, should provide him with important insights into the events underlying the delayedonset and pathophysiology of HP I, HP II and non-hereditary forms of acute and chronic pancreatitis. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: MOLECULAR GENETICS OF HEREDITARY PANCREATITIS Principal Investigator & Institution: Whitcomb, David C.; Chief, Div of Gastroenterology, Hepatolo; Medicine; University of Pittsburgh at Pittsburgh 350 Thackeray Hall Pittsburgh, Pa 15260 Timing: Fiscal Year 2002; Project Start 01-APR-1999; Project End 30-NOV-2003 Summary: Acute and chronic pancreatitis are major health-care problems in the United States causing years of pain and disability. Despite the impact of these diseases, mystery surrounds many of the predisposing causes and early molecular events. Furthermore, the devastating effects of acute pancreatitis and chronic pancreatitis, once established, cannot be reversed. We believe that in the future, advances in the treatment of pancreatic disease rest in the early identification of at-risk individuals as well as in the prevention of limitation of pancreatic injury. Thus, the goal of our program is to determine the molecular mechanisms that predispose to acute and chronic pancreatitis and to identify targets for disrupting pathophysiological processes. We believe that effective preemptive actions will prevent or limit pancreatic injury and thus, result in the reduction of he incidence and severity of acute and chronic pancreatitis. To understand the mechanisms of pancreatitis we will identify previously uncharacterized hereditary pancreatitis families and investigate several striking features of this disease including incomplete penetrance and the mechanisms causing pancreatitis with trypsinogen RR117H and N21I mutations. Answering this question may provide insight
20
Acute Pancreatitis
into the pathophysiology of acute and chronic pancreatitis and identify targets for new therapies, and help identify individuals at risk through genetic testing. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: MOLECULAR MECHANISMS OF ACUTE PANCREATITIS Principal Investigator & Institution: Logsdon, Craig D.; Professor; Molecular and Integrative Physiology; University of Michigan at Ann Arbor 3003 South State, Room 1040 Ann Arbor, Mi 481091274 Timing: Fiscal Year 2002; Project Start 10-MAY-1998; Project End 31-AUG-2005 Summary: (provided by applicant): Pancreatitis is an important clinical problem for which treatment is still largely supportive. We have identified the transcription factor NF-KappaB as a molecule that is activated early in the disease contributing to the initiation of an inflammatory cascade. Specific aim #1 is to determine the mechanisms and role of NF-KappaB activation in acute pancreatitis. We will extend our understanding of the significance of NF-KappaB activation by directly activating and inhibiting NF-KappaB within the pancreas using adenoviral expression of active and dominant negative subunits. We hypothesize that NF-KappaB plays a pro-inflammatory role and specifically drives expression of mob-1 and gro-alpha, two important chemokines. We will identify other genes activated by NF-KappaB within pancreatic acinar cells using a combination of adenovirus mediated delivery of an active subunit and oligonucleotide-directed microarray analysis. We will also test the hypothesis that trypsin activation is able to activate NF-KappaB within acinar cells using an adenoviral approach to directly active trypsin within acinar cells. Specific aim #2 is to identify the genes that are induced early in the course of acute pancreatitis. To further identify new molecules that are important in acute pancreatitis, we will utilize oligonucleotide directed microarrays to profile gene expression in rapid onset models of acute pancreatitis. We will specifically focus our search on genes for transcription factors and inflammatory mediators, as these may become targets of therapy for the disease. Specific aim #3 is to determine the mechanisms and role of the transcription factor EGR-1 in acute pancreatitis. Preliminary experiments have shown that the transcription factor EGR-1 is highly induced early in the course of caerulein induced acute pancreatitis. EGR-1 plays an important role in other inflammatory diseases and is a know regulator of tissue factor (TF). We will determine if this transcription factor is also induced in other models of acute pancreatitis, investigate the cellular mechanisms involved in its regulation, and determine the relationship between its activation and the severity of acute pancreatitis. We will also test the hypothesis that EGR-1 drives expression of TF in the pancreas, and identify other targets of this important transcription factor. Specific aim #4 is to determine the roles of pro-inflammatory effectors, mob-1, gro-alpha, TF and CGRP in acute pancreatitis. Of the pro-inflammatory molecules identified as upregulated after treatment of animals with high concentrations of caerulein, we have selected these four as being especially likely to contribute to the severity of acute pancreatitis based upon their known functions in other diseases. Specifically, we will test the hypothesis that mob-1 and gro-alpha are important for chemoattraction of Tcells and neutrophils respectively, that TF is important for initiating blood coagulation in the pancreas, and that CGRP expression in acinar cells contributes to alterations in pancreatic and systemic blood flow. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
Studies
•
Project Title: PANCREATITIS
MOLECULAR
PATHOMECHANISM
OF
21
HEREDITARY
Principal Investigator & Institution: Sahin-Toth, Miklos; Associate Professor; Physiology; University of California Los Angeles 10920 Wilshire Blvd., Suite 1200 Los Angeles, Ca 90024 Timing: Fiscal Year 2002; Project Start 01-MAY-2001; Project End 31-JUL-2002 Summary: (Applicant's abstract): The broad, long-term objectives of this application are to understand the mechanism by which mutations in the human cationic trypsinogen gene (PRSS1) lead to hereditary pancreatitis (HP). HP is an autosomal dominant genetic disorder characterized by early-onset recurrent attacks of acute pancreatitis with frequent progression to chronic pancreatitis and occasionally to pancreatic cancer. HP belongs to the inherited forms of idiopathic chronic pancreatitis, a genetically heterogeneous disease group, where mutations have been found not only in PRSS1, but also in the cystic fibrosis transmembrane conductance regulator (CFTR) gene and in the pancreatic secretory trypsin inhibitor gene (SPINK1). HP has been widely recognized as a highly relevant model system for all forms of human pancreatitis. In the majority of cases, three mutations, Arg117-His, Asn2l-,lle, and Ala8-Val, have been identified in PRSSI. The molecular defects caused by the HP mutations will be studied within the context of a current pathogenesis model, which suggests that HP is caused by excessive intrapancreatic trypsin activity via one of 3 mechanisms: (i) increased trypsinogen activation, (ii) decreased trypsin degradation; or (iii) impaired inhibition by pancreatic secretory trypsin inhibitor (PSTI). The principal objective of the experimental design is to study the effects of the HP-mutations in vitro, using recombinant human trypsinogens. Wild-type and mutant trypsinogens will be expressed in Escherichia coli, and purified to homogeneity with ecotin affinity chromatography. Catalytic properties and autocatalytic degradation (autolysis) of trypsins and autoactivation and autocatalytic degradation (zymogenolysis) of trypsinogens will be characterized. In addition, interactions between wild-type and mutant forms of cationic trypsin(ogen) with anionic trypsin(ogen) and mesotrypsin(ogen) will be examined. Finally, inhibition of human trypsin isoforms and HP mutant trypsins by wild-type and mutant PSTI proteins will be studied. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: NADPH PANCREATITIS
OXIDASE
INHIBITOR
THERAPY
IN
ACUTE
Principal Investigator & Institution: Weinstein, David; Triage Pharmaceuticals, Llc 1 University Pl, Rm A215 Rensselaer, Ny 12144 Timing: Fiscal Year 2002; Project Start 30-SEP-2002; Project End 30-JUN-2003 Summary: (provided by applicant): Triage Pharmaceuticals LLC ("Triage") was chartered in the summer of 1999 to exploit new treatments for vascular leakage related illnesses using NADPH oxidase inhibitors patented by Dr. James Holland, a Triage cofounder. The invention is protected by two issued U.S. patents, granted European and Japanese patents, and a pending Canadian patent application. These cases claim a method of prevention and treatment of diseases related to endothelial hyperpermeability and vascular leakage by therapeutic administration of an NADPH oxidase inhibitor. The scientific rationale for the involvement of NADPH oxidase in mechanisms leading to vascular leakage has been well-documented by Triage in its work on the inhibitory effect of apocynin, a naturally occurring plant extract. In order to further this work, Triage is seeking funding to perform accelerated pharmaceutical development
22
Acute Pancreatitis
and preclinical testing for drug candidates in a vascular leakage disease indication that has a clear, simple, non-costly end-point and treatment duration that should allow determination of clinical efficacy in very short trial periods. Using its current library of potent NADPH oxidase inhibitors, "proof of concept" will be established in the vascular leakage of acute pancreatitis using an established rat model of the disease. PROPOSED COMMERCIAL APPLICATION: There are no currently available drugs for the treatment of the endothelial hyper-permeability and vascular leakage component of vascular diseases, such as acute pancreatitis, diabetes mellitus, atherosclerosis and hypertension. Despite the effectiveness of currently available medical treatments for these vascular diseases, the risks of morbidity and mortality remain high. A combination approach with currently available medical treatment and an orally administered NADPH oxidase inhibitor would significantly improve the treatment of individuals with a high risk for the diseases. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: NEURAL REGULATION OF PANCREATIC FUNCTION Principal Investigator & Institution: Kirkwood, Kimberly S.; Surgery; University of California San Francisco 500 Parnassus Ave San Francisco, Ca 941222747 Timing: Fiscal Year 2002; Project Start 15-MAY-1994; Project End 31-JUL-2004 Summary: (Adapted from Applicant's Abstract): Approximately 10% of patients with acute pancreatitis die from uncontrolled pancreatic inflammation that results in massive fluid losses and shock. The regulation of pancreatic inflammation is poorly understood. In the trachea, sensory nerves regulate inflammation by releasing tachykinins that bind to endothelial cells and induce arteriolar vasodilatation, plasma extravasation and neutrophil infiltration. This well-characterized phenomenon is called neurogenic inflammation. The general hypothesis of this proposal is that neurogenic mechanisms are essential to the pathogenesis of acute pancreatitis. Specifically, we hypothesize that a) tachykinins induce plasma extravasation and neutrophil infiltration in the pancreas by interacting with neurokinin receptors, b) the pro-inflammatory effects of tachykinins are terminated by cell surface peptidases, and c) tachykinins and their receptors regulate inflammation in a widely-used model of acute pancreatitis. Due to the recent availability of "knockout" mice in which the genes encoding neurokinin receptors or cell surface peptidases have been deleted by homologous recombination, these experiments will be performed in mice. Pancreatic inflammation will be assessed by 1) quantifying and localizing plasma extravasation using Evans blue and Monastral blue, respectively, 2) identifying and measuring endothelial cell gaps through which plasma extravasates using a silver stain and light microscopy, 3) quantifying and localizing neutrophil infiltration using myeloperoxidase, and 4) defining the extent of edema, and cytoplasmic vacuolization using histological criteria. Specific Aim 1 will define the contribution of exogenous and endogenous tachykinins to the initiation of acute pancreatic inflammation. The time-course and dose-response will be determined, and the neurokinin receptors that mediate these effects will be identified using antagonists and knockout mice, and localized using receptor-specific antisera. Specific Aim 2 will examine the role of peptidases in the termination of tachykinin-induced pancreatic inflammation. The peptidases neutral endopeptidase and angiotensin converting enzyme will be localized in the pancreas using specific antisera, and their importance in tachykinin-induced inflammation will be determined using inhibitors and knockout mice. Specific Aim 3 will define the importance of sensory nerves, and specifically tachykinins, in the pathogenesis of acute pancreatitis. Using neurokinin receptor
Studies
23
antagonists, peptidase inhibitors, and knockout mice, we will delineate the neurogenic mechanisms that regulate inflammation in acute pancreatitis. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: PANCREAS TRANSCRIPTION FACTORS AND CANCER MODEL SYSTEMS Principal Investigator & Institution: Konieczny, Stephen F.; Associate Professor; Biological Sciences; Purdue University West Lafayette West Lafayette, in 479072040 Timing: Fiscal Year 2002; Project Start 01-MAR-2000; Project End 28-FEB-2005 Summary: (adapted from investigator's abstract): The development of the mammalian pancreas represents an attractive model system to study the molecular signals that direct the commitment and differentiation of epithelial cells along different cell lineages. The pancreas consists of two distinct tissue types which carry out different essential functions. The endocrine pancreas regulates blood sugar levels by secreting glucagon or insulin whereas the exocrine pancreas secretes digestive enzymes into the duodenal part of the small intestine. Although many of the transcription factors responsible for endocrine pancreas formation have been identified and extensively studied, the molecular regulatory circuits that control the establishment and maintenance of the exocrine pancreas are just beginning to be elucidated. Towards a goal of identifying key transcriptional regulators of pancreatic development and function, a novel basic helixloop-helix (bHLH) transcription factor (Mistl) recently was identified that accumulates to high levels in pancreatic exocrine cells. Mistl gene expression is initially detected at mouse embryonic day E10.5 in the developing pancreas and remains expressed to high levels in the acinar cells of the adult. Although the Mistl nuclear protein is capable of binding to specific DNA targets as a homodimer or as a heterodimer with other bHLH transcription factors, it lacks a typical transcription activation domain and instead can serve as a transcriptional repressor in some experimental systems. At this time, a true role for Mistl activity in pancreatic function has not been established, although its expression pattern and DNA binding capabilities suggest that Mistl likely serves as a key regulator of exocrine pancreas gene activity. In order to characterize further the biochemical properties of the Mistl protein and the role of Mistl in pancreatic development, studies are proposed to (1) examine the activity of Mistl using a pancreatic cell line model system, (2) identify pancreas-specific Mistl protein binding partners and (3) utilize mouse genetic approaches to create Mistl homozygous null mice and to identify Mistl target genes. In addition, targeted replacement of the Mistl gene with an activated K-ras allele will be performed to generate novel pancreatic cancer models. A complete characterization of Mistl activity in exocrine pancreatic cells will add critical new information regarding normal pancreatic development and function and may provide future strategies for combating several key human diseases, including acute pancreatitis and pancreatic cancer. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: ROLE PATHOGENESIS
OF
CCK
RECEPTOR
IN
ACUTE
PANCREATITIS
Principal Investigator & Institution: Samuel, Isaac; Surgery; University of Iowa Iowa City, Ia 52242 Timing: Fiscal Year 2003; Project Start 15-JAN-2003; Project End 30-NOV-2007 Summary: (provided by applicant): Acute pancreatitis is a common disease with significant morbidity and mortality but no specific treatment is available as the
24
Acute Pancreatitis
pathogenic mechanisms are not known. The purpose of this research proposal is to elucidate early events in pathogenesis of gallstone-induced acute pancreatitis. We use the rat model of bile-pancreatic duct ligation-induced acute pancreatitis as an experimental corollary. Bile-pancreatic juice exclusion from gut causes feedback exocrine pancreatic stimulation via cholecystokinin-A receptor (CCK-AR) mechanisms. The role of the CCK-AR in disease pathogenesis is not known. Our preliminary studies provide the first evidence that CCK-AR mediated pancreatic acinar cell hyperstimulation plays a contributory role in disease pathogenesis and that induction of CCK-AR occurs within one hour of duct ligation. We hypothesize that pathological amplification of CCK-AR mediated signal transduction exacerbates disease pathogenesis. We propose experiments to test this hypothesis and pursue these specific aims: 1) Characterize the role of the CCK-AR in duct occlusion-induced acute pancreatitis pathogenesis. 2) Characterize the expression and regulation of the CCK-AR in duct occlusion-induced acute pancreatitis. 3) Characterize the CCK-AR mediated signal transduction pathway in duct occlusion-induced acute pancreatitis. Competitive binding assays with radiolabeled ligand will be done to study receptor number, specificity, and affinity. Receptor sensitivity and activity will be determined by measuring downstream signals (cyclic AMP, inositol phosphate). Differences between the induced and native receptor will be determined both in terms of altered functional characteristics and perturbations in intracellular signal transduction pathways. The possibility that promiscuous G-protein coupling in acute pancreatitis could drastically increase CCK-AR affinity and also perpetuate a grossly amplified intracellular signal may have profound implications in mechanisms of disease pathogenesis. An innovative feature of this proposal is the use of an original surgical model, "The Donor Rat Model", that provides a unique opportunity to investigate disease pathogenesis. The significance and health-relatedness of this research endeavor is its ultimate goal to elucidate mechanisms of disease pathogenesis that provide the rationale to base new treatment protocols intended to reduce the morbidity and mortality of acute pancreatitis. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: SURGICAL STUDIES ON METABOLISM OF GI HORMONES Principal Investigator & Institution: Gomez, Guillermo; Surgery; University of Texas Medical Br Galveston 301 University Blvd Galveston, Tx 77555 Timing: Fiscal Year 2002; Project Start 01-MAY-1976; Project End 30-APR-2004 Summary: A major challenge in gastrointestinal research today is to gain a better understanding of the underlying molecular mechanisms for maintenance of the exocrine pancreas and small bowel mucosa. Acute pancreatitis (AP) is a complex and poorly understood disease. Severe acute hemorrhagic or necrotizing pancreatitis in humans results in an exceptionally high morbidity and mortality. Despite the abundance of pancreatitis patients, underlying molecular mechanisms that control the severity of an AP are not known. Likewise, a deficiency in appropriate intestinal regeneration or adaptation following mucosal disease or injury can be clinically relevant. The specialized epithelial cells of the small bowel mucosa constitute an essential organ for nutrient absorption, immune function and regulation of fluid and electrolyte balance. Disruption of the integrity of the intestinal mucosa either through inflammation, infiltration, surgical resection or ischemia results in severe malabsorption and ultimately in clinical malnutrition requiring total parenteral nutritional support. The long term objectives of the proposed work are to understand the roles gastrointestinal (GI) hormones play in the homeostasis of the pancreas, and in controlling GI epithelial restitution and regrowth. The Specific Aims of this research proposal are: 1) to
Studies
25
determine the role of gastrointestinal hormones in the regulation of pancreatic apoptosis and regeneration in experimental models of acute pancreatitis; and, 2) to determine the role of gastrointestinal hormones in the regulation of adaptive hyperplasia of the gut. The proposed studies are designed to precisely define, in a systematic fashion, the components of GI hormone-linked intracellular transduction pathways involved in the regulation of pancreatic apoptosis and regeneration in experimental models of AP; and, the proliferation of GI mucosa associated with adaptive hyperplasia of the gut. In order to accomplish these aims, we will investigate molecular pathways of acinar cell proliferation and apoptosis in three different models of experimental AP, and the intracellular signal transduction pathways mediating the regulation of neurotensin gene expression by insulin-like growth factor-I (IGF-I) and the enhancement of glucagon-like peptide-2 (GLP-2)- stimulated mucosal proliferation by neurotensin. These studies will provide a foundation for the development of innovative therapeutic strategies designed to exploit the unique biological activities of GI hormones on the exocrine pancreas and intestinal mucosa. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: THE CALCIUM-SENSING RECEPTOR IN ACUTE PANCREATITIS Principal Investigator & Institution: Saunders, Christine; Biochemistry; University of Texas Hlth Sci Ctr San Ant 7703 Floyd Curl Dr San Antonio, Tx 78229 Timing: Fiscal Year 2002; Project Start 01-APR-2001; Project End 31-JUL-2002 Summary: (adapted from the application) Acute pancreatitis is an inflammatory disease with significant mortality, affecting about 80,000 Americans a year. The pathophysiologic mechanisms are not thoroughly elucidated, and to date there are few if any effective treatments. Calcium and lipid mediators are integral components of the signaling cascade involved in pancreatic inflammation. Changes in blood calcium levels have been associated with acute pancreatitis, both in humans and in laboratory animals. The recently cloned calcium-sensing receptor (CaSR), a G protein-coupled receptor (GPCR), by virtue of its ability to stimulate inflammatory lipid mediator synthesis, provides a possible mechanism for how calcium, lipid mediators and acute pancreatitis are linked. In fact, recent findings suggest that the CaSR in the pancreas is upregulated during acute pancreatitis in the rat. The hypothesis for the proposed studies is that the pancreatic CaSR is involved in initiating and/or propagating acute pancreatitis by activating PLA2, which stimulates lipid mediators involved in the inflammatory cascade. In this proposal, molecular biologic, biochemical and physiologic approaches will be combined to investigate the role of the pancreatic CaSR in experimental acute pancreatitis. The secretagogue (eg. cerulein) hyperstimulation model in rats is a well established model in which hourly administration of high doses of cerulein for 6 hours induces an edematous acute pancreatitis. Multiple techniques will be used to test the hypothesis by addressing the following specific aims: (1) to identify the pancreatic cells which express the functional CaSR; (2) to determine whether the CaSR is directly involved in acute pancreatitis in the rat; (3) to examine whether cytoskeletal depolymerization during acute pancreatitis provides a mechanism for how the CaSR is upregulated in cerulein-induced pancreatitis; (4) to examine whether there is "cross-talk" between the cholecystokinin A (CCK-A) receptor and the CaSR which might lead to activation of the CaSR in cerulein-treated rats. While the role of the CaSR in inherited diseases is emerging, its function in inflammatory conditions remains unknown. Since the CaSR activates lipid mediator synthesis, its potential role in inflammation seems logical and represents an exciting and novel possibility. Also, this study might serve as a
26
Acute Pancreatitis
paradigm for inflammatory conditions other than pancreatitis, the treatments for which have remained elusive. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: TRANSGENIC MOUSE MODELS OF PANCREATIC EXOCRINE FUNCTION Principal Investigator & Institution: Delisle, Robert C.; Associate Professor; Anatomy and Cell Biology; University of Kansas Medical Center Msn 1039 Kansas City, Ks 66160 Timing: Fiscal Year 2002; Project Start 01-JUN-2002; Project End 31-MAY-2004 Summary: (provided by applicant): This grant application proposes to develop genetically engineered mouse models for acute pancreatitis and cystic fibrosis-related pancreatitis. We will focus on a recently discovered gene, which preliminary data suggest may play a role in development of pancreatitis, and also in the pathogenesis of cystic fibrosis (CF). The gene is called crpd in the mouse and dmbt1 in humans and it encodes the protein Muclin, a high molecular weight, and sulfated glycoprotein. This gene is most highly expressed in the exocrine pancreas, but also as different transcripts in other organs including the intestine, gallbladder, and kidney. The hypothesis is that Muclin is required for normal zymogen granule formation and subsequent solubilization of digestive enzymes upon exocytosis of the granules. We predict that if this gene is a disrupted zymogen granule will fail to mature creating a situation in the acinar cell where the zymogens will be prone to become activated, resulting in pancreatitis. The Muclin-deficient mouse model is intended to explore this hypothesis and, if this is borne out, it will make looking for mutations in this gene in human idiopathic pancreatitis a reasonable endeavor. We also predict that mice over expressing Muclin will exhibit poor release of zymogens after exocytosis and will be prone to CFlike plugging of the acinar lumen, which may predispose to pancreatitis. In CFTR-/mice, a model for CF, the pancreas exhibits over expression of Muclin, which is associated with protein, plugs in the acinar lumen. Mice with a Muclin transgene targeted to the pancreas will allow testing of this hypothesis. The specific aims are to produce genetically engineered mice: 1). Globally deficient in Muclin by targeting the first exon, which is present in all transcripts of this gene. 2). An exocrine cell-specific defective Muclin by targeting the last exon which is translated only in exocrine cell transcripts of the gene and codes for a transmembrane domain that may be important for Muclin' s exocrine function; 3). That over expresses Muclin in the pancreatic acinar cell using the rat elastase promoter to direct cell specific expression. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: VIDEOSCOPIC COLLECTIONS
DRAINAGE
OF
INFECTED
PANCREATIC
Principal Investigator & Institution: Horvath, Karen D.; Surgery; University of Washington Grant & Contract Services Seattle, Wa 98105 Timing: Fiscal Year 2002; Project Start 01-SEP-2002; Project End 31-AUG-2005 Summary: (provided by applicant): External drainage and antibiotics are the fundamental principles of treatment for infected pancreatic fluid collections following necrotizing pancreatitis. Without proper therapy, nearly all patients will die. Open surgical necrosectomy, or the process of removing necrotic tissue, is currently the standard of care. While highly effective, the large abdominal incision is associated with significant morbidity. Percutaneous catheter drainage is another type of external drainage with variable success rates. Although minimally invasive, the necrosectum
Studies
27
often contains particulate debris, 10-30mm in size, which are poorly drained via the 410mm catheters. When percutaneous drainage fails, all patients crossover to open surgical necrosectomy. Preliminary data suggest that videoscopic-assisted retroperitoneal debridement (VARD) is a promising new method that combines the benefits of open surgical necrosectomy and percutaneous catheter drainage. Debridement occurs under direct vision through a small flank incision with videoscopic assistance. This project is a multicenter, single-arm, Phase II safety and efficacy study of patients undergoing VARD of infected pancreatic fluid collections. Patients enrolled will be limited to hemodynamically stable patients with documented infected pancreatic necrosis or pancreatic abscess as defined by the Atlanta Symposium. Patients will be strictly classified based on: CT classification, time from onset of pancreatitis to external drainage, and patient disease severity. Five major teaching hospitals will enroll 40 patients over 18 months. All patients will be followed for 6 months from the onset of pancreatitis. Safety issues will be monitored by an External Review Board. The hypothesis is: In patients with infected pancreatic fluid collections following acute pancreatitis, VARD provides a safe and efficacious procedure for draining infected pancreatic fluid collections adequately without need for crossover to open surgical necrosectomy. The specific aims are to assess: 1) safety and efficacy of VARD of infected pancreatic fluid collections; and 2) the clinical and functional outcomes of patients treated with VARD. The long-term goal is to use data obtained from this study as the basis for a multicenter, Phase III, randomized study comparing the VARD to the current standard of care, open surgical necrosectomy. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
E-Journals: PubMed Central3 PubMed Central (PMC) is a digital archive of life sciences journal literature developed and managed by the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).4 Access to this growing archive of e-journals is free and unrestricted.5 To search, go to http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Pmc, and type “acute pancreatitis” (or synonyms) into the search box. This search gives you access to full-text articles. The following is a sample of items found for acute pancreatitis in the PubMed Central database: •
Activation of polyamine catabolism in transgenic rats induces acute pancreatitis. by Alhonen L, Parkkinen JJ, Keinanen T, Sinervirta R, Herzig KH, Janne J.; 2000 Jul 18; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=26940
•
Acute pancreatitis following medical abortion: Case report. by Hallberg P, Hallberg E, Amini H.; 2004; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=406515
•
Calcium signaling and acute pancreatitis: Specific response to a promiscuous messenger. by Parekh AB.; 2000 Nov 21; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=34065
3 4
Adapted from the National Library of Medicine: http://www.pubmedcentral.nih.gov/about/intro.html.
With PubMed Central, NCBI is taking the lead in preservation and maintenance of open access to electronic literature, just as NLM has done for decades with printed biomedical literature. PubMed Central aims to become a world-class library of the digital age. 5 The value of PubMed Central, in addition to its role as an archive, lies in the availability of data from diverse sources stored in a common format in a single repository. Many journals already have online publishing operations, and there is a growing tendency to publish material online only, to the exclusion of print.
28
Acute Pancreatitis
•
Excretion of cephalothin and cefamandole by the normal pancreas and in acute pancreatitis in dogs. by Studley JG, Schentag JJ, Schenk WG Jr.; 1982 Aug; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=183722
•
Immunoglobulin M antibody response against Mycoplasma pneumoniae lipid antigen in patients with acute pancreatitis. by Leinikki PO, Panzar P, Tykka H.; 1978 Aug; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=275159
•
Mobilization of xanthine oxidase from the gastrointestinal tract in acute pancreatitis. by Granell S, Bulbena O, Genesca M, Sabater L, Sastre J, Gelpi E, Closa D.; 2004; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=331409
•
Phosphatidylinositol 3-kinase-dependent activation of trypsinogen modulates the severity of acute pancreatitis. by Singh VP, Saluja AK, Bhagat L, van Acker GJ, Song AM, Soltoff SP, Cantley LC, Steer ML.; 2001 Nov 1; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=209439
•
Protective action of luminal bile salts in necrotizing acute pancreatitis in mice. by Gomez G, Townsend CM Jr, Green DW, Rajaraman S, Uchida T, Greeley GH Jr, Soloway RD, Thompson JC.; 1990 Jul; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=296724
•
Role of substance P and the neurokinin 1 receptor in acute pancreatitis and pancreatitis-associated lung injury. by Bhatia M, Saluja AK, Hofbauer B, Frossard JL, Lee HS, Castagliuolo I, Wang CC, Gerard N, Pothoulakis C, Steer ML.; 1998 Apr 14; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=22564
The National Library of Medicine: PubMed One of the quickest and most comprehensive ways to find academic studies in both English and other languages is to use PubMed, maintained by the National Library of Medicine.6 The advantage of PubMed over previously mentioned sources is that it covers a greater number of domestic and foreign references. It is also free to use. If the publisher has a Web site that offers full text of its journals, PubMed will provide links to that site, as well as to sites offering other related data. User registration, a subscription fee, or some other type of fee may be required to access the full text of articles in some journals. To generate your own bibliography of studies dealing with acute pancreatitis, simply go to the PubMed Web site at http://www.ncbi.nlm.nih.gov/pubmed. Type “acute pancreatitis” (or synonyms) into the search box, and click “Go.” The following is the type of output you can expect from PubMed for acute pancreatitis (hyperlinks lead to article summaries):
6 PubMed was developed by the National Center for Biotechnology Information (NCBI) at the National Library of Medicine (NLM) at the National Institutes of Health (NIH). The PubMed database was developed in conjunction with publishers of biomedical literature as a search tool for accessing literature citations and linking to full-text journal articles at Web sites of participating publishers. Publishers that participate in PubMed supply NLM with their citations electronically prior to or at the time of publication.
Studies
29
•
A rare initial manifestation of systemic lupus erythematosus--acute pancreatitis: case report and review of the literature. Author(s): Duncan HV, Achara G. Source: The Journal of the American Board of Family Practice / American Board of Family Practice. 2003 July-August; 16(4): 334-8. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12949035
•
Acute pancreatitis after a course of clarithromycin. Author(s): Schouwenberg BJ, Deinum J. Source: The Netherlands Journal of Medicine. 2003 July; 61(7): 266-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14567525
•
Acute pancreatitis and exacerbation of hepatitis B following reduced dose of prednisolone. Author(s): Ohshiro Y, Tawata M, Takasu N. Source: Qjm : Monthly Journal of the Association of Physicians. 2003 November; 96(11): 868-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14566043
•
Acute pancreatitis and modified-release clarithromycin. Author(s): Gonzalez Carro P, Perez Roldan F, Legaz Huidobro ML, Moraleda de Acuna M, Nieto Garcia JC. Source: The Annals of Pharmacotherapy. 2004 March; 38(3): 508-9. Epub 2004 January 30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14755067
•
Acute pancreatitis caused by meglumine antimoniate given for the treatment of visceral leishmaniasis. Author(s): Lambertucci JR, Franca BM, Queiroz Ede M. Source: Revista Da Sociedade Brasileira De Medicina Tropical. 2004 January-February; 37(1): 74-5. Epub 2004 March 19. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15042193
•
Acute pancreatitis complicating 50% full-thickness burns in a 5-year-old child. Author(s): Wilson MD, Sugden P, Durrani A, Dziewulski P. Source: Burns : Journal of the International Society for Burn Injuries. 2003 September; 29(6): 619-21. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12927993
•
Acute pancreatitis due to hydrocortisone in a patient with ulcerative colitis. Author(s): Khanna S, Kumar A. Source: Journal of Gastroenterology and Hepatology. 2003 September; 18(9): 1110-1. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12911675
30
Acute Pancreatitis
•
Acute pancreatitis induced by diffuse pancreatic invasion of adult T-cell leukemia/lymphoma cells. Author(s): Mori A, Kikuchi Y, Motoori S, Watanabe J, Shinozaki M, Eguchi M. Source: Digestive Diseases and Sciences. 2003 October; 48(10): 1979-83. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14627344
•
Acute pancreatitis occurring in the early postpartum period: a case report. Author(s): Fukami T, Chaen H, Imura H, Sudou K, Eguchi F. Source: Journal of Perinatal Medicine. 2003; 31(4): 345-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12951894
•
Acute pancreatitis. Author(s): Parker M. Source: Emergency Nurse : the Journal of the Rcn Accident and Emergency Nursing Association. 2004 March; 11(10): 28-35. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15045929
•
Acute pancreatitis: molecular biology update. Author(s): Whitcomb DC. Source: Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract. 2003 December; 7(8): 940-2. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14675701
•
Acute pancreatitis: symptoms, diagnosis and management. Author(s): Turner B. Source: Nurs Times. 2003 November 18-24; 99(46): 38-40. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14666821
•
Adrenal insufficiency in severe acute pancreatitis. Author(s): De Waele JJ, Hoste E, Decruyenaere J, Colardyn F. Source: Pancreas. 2003 October; 27(3): 244-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14508130
•
Alstrom syndrome with acute pancreatitis: a case report. Author(s): Wu WC, Chen SC, Dia CY, Yu ML, Hsieh MY, Lin ZY, Wang LY, Tsai JF, Chang WY, Chuang WL. Source: Kaohsiung J Med Sci. 2003 July; 19(7): 358-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12926522
Studies
31
•
Ampullary carcinoid tumor presenting as acute pancreatitis in a patient with von Recklinghausen's disease: case report and review of the literature. Author(s): Mayoral W, Salcedo J, Al-Kawas F. Source: Endoscopy. 2003 October; 35(10): 854-7. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14551865
•
Analysis and prevention of factors predisposing to infections associated with severe acute pancreatitis. Author(s): Sun B, Li HL, Gao Y, Xu J, Jiang HC. Source: Hepatobiliary Pancreat Dis Int. 2003 May; 2(2): 303-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14599990
•
Angiographic features in acute pancreatitis: the severity of abdominal vessel ischemic change reflects the severity of acute pancreatitis. Author(s): Inoue K, Hirota M, Beppu T, Ishiko T, Kimura Y, Maeda K, Ogawa M. Source: Jop [electronic Resource] : Journal of the Pancreas. 2003 November; 4(6): 207-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14614201
•
Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Author(s): Bassi C, Larvin M, Villatoro E. Source: Cochrane Database Syst Rev. 2003; (4): Cd002941. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14583957
•
Apoptosis versus necrosis in acute pancreatitis. Author(s): Bhatia M. Source: American Journal of Physiology. Gastrointestinal and Liver Physiology. 2004 February; 286(2): G189-96. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14715516
•
Are cytokines the cause of distant organ injury in acute pancreatitis? Author(s): Fernandez-del Castillo C, Alsfasser G. Source: Surgery. 2003 November; 134(5): 846-7; Author Reply 847. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14674420
•
Bacteremia in acute pancreatitis of different etiologies. Author(s): Chang KK, Lin XZ, Chen CY, Shin JS, Yang CC, Chen CY. Source: J Formos Med Assoc. 1995 December; 94(12): 713-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8541731
32
Acute Pancreatitis
•
Bacterial translocation and its prevention in acute pancreatitis. Author(s): Dervenis C, Smailis D, Hatzitheoklitos E. Source: Journal of Hepato-Biliary-Pancreatic Surgery. 2003; 10(6): 415-8. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14714160
•
Bacterial translocation in acute pancreatitis. Author(s): Thomson A. Source: Journal of Gastroenterology and Hepatology. 2003 October; 18(10): 1214. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12974914
•
Bactericidal/permeability-increasing protein and group I and II phospholipase A2 during the induction phase of human acute pancreatitis. Author(s): Kemppainen E, Hietaranta A, Puolakkainen P, Sainio V, Halttunen J, Haapiainen R, Kivilaakso E, Nevalainen T. Source: Pancreas. 1999 January; 18(1): 21-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9888656
•
Balthazar computed tomography severity index is superior to Ranson criteria and APACHE II and III scoring systems in predicting acute pancreatitis outcome. Author(s): Chatzicostas C, Roussomoustakaki M, Vardas E, Romanos J, Kouroumalis EA. Source: Journal of Clinical Gastroenterology. 2003 March; 36(3): 253-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12590238
•
Baseline hypoxemia as a prognostic marker for pulmonary complications and outcome in patients with acute pancreatitis. Author(s): Polyzogopoulou E, Bikas C, Danikas D, Koutras A, Kalfarentzos F, Gogos CA. Source: Digestive Diseases and Sciences. 2004 January; 49(1): 150-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14992450
•
Behavior of serum interleukin 12 in human acute pancreatitis. Author(s): Pezzilli R, Miniero R, Cappelletti O, Barakat B. Source: Pancreas. 1999 April; 18(3): 247-51. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10206482
•
Bifid pancreas. An unusual anomaly associated with acute pancreatitis. Author(s): Krishnamurty VS, Rajendran S, Korsten MA. Source: International Journal of Pancreatology : Official Journal of the International Association of Pancreatology. 1994 October-December; 16(2-3): 179-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7868944
Studies
33
•
Biliary sludge and acute pancreatitis. Author(s): Lee SP. Source: Hosp Pract (Off Ed). 1994 May 15; 29(5): 45-52. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8175937
•
Bilirubinate granules: main pathologic bile component in patients with idiopathic acute pancreatitis. Author(s): Perez-Martin G, Gomez-Cerezo J, Codoceo R, Olveira A, Conde P, Garces MC, Barbado FJ, Vazquez JJ. Source: The American Journal of Gastroenterology. 1998 March; 93(3): 360-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9517640
•
Biochemical evaluation of patients with acute pancreatitis. Author(s): Ignjatovic S, Majkic-Singh N, Mitrovic M, Gvozdenovic M. Source: Clinical Chemistry and Laboratory Medicine : Cclm / Fescc. 2000 November; 38(11): 1141-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11156345
•
Biochemical model of logistic regression for early prediction of the etiology of acute pancreatitis. Author(s): Tourne I, Viedma JA, Perez-Mateo M. Source: Rev Esp Enferm Dig. 1997 December; 89(12): 885-96. English, Spanish. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9494376
•
Biochemical parameters in the early differentiation of the etiology of acute pancreatitis. Author(s): Stimac D, Rubinic M, Lenac T, Kovac D, Vcev A, Miletic D. Source: The American Journal of Gastroenterology. 1996 November; 91(11): 2355-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8931417
•
Blood concentrations of polymorphonuclear leucocyte elastase and interleukin-6 are indicators for the occurrence of multiple organ failures at the early stage of acute pancreatitis. Author(s): Ikei S, Ogawa M, Yamaguchi Y. Source: Journal of Gastroenterology and Hepatology. 1998 December; 13(12): 1274-83. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9918438
•
Blood tests for detection of alcoholic cause of acute pancreatitis. Author(s): Jaakkola M, Sillanaukee P, Lof K, Koivula T, Nordback I. Source: Lancet. 1994 May 28; 343(8909): 1328-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7910327
34
Acute Pancreatitis
•
Blue toe syndrome: a rare complication of acute pancreatitis. Author(s): Bhalla A, Gupta S, Jain AP, Jajoo UN, Gupta OP, Kalantri SP. Source: Jop [electronic Resource] : Journal of the Pancreas. 2003 January; 4(1): 17-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12555011
•
Bockus Lecture: World Congress of Gastroenterology, Los Angeles, CA--October 3, 1994. The management of acute pancreatitis: a critical assessment as Dr. Bockus would have wished. Author(s): Berk JE. Source: The American Journal of Gastroenterology. 1995 May; 90(5): 696-703. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7733071
•
Body composition, physiological function and psychological changes in patients with predicted severe acute pancreatitis. Author(s): Gupta R, Rajani R, Primrose JN, Johnson CD. Source: Pancreatology : Official Journal of the International Association of Pancreatology (Iap). [et Al.]. 2001; 1(1): 58-62. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12120269
•
Bouveret's syndrome complicated by acute pancreatitis. Author(s): Fenchel RF, Krige JE, Bornman PC. Source: Digestive Surgery. 1999; 16(6): 525-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10805556
•
Buprenorphine or procaine for pain relief in acute pancreatitis. A prospective randomized study. Author(s): Jakobs R, Adamek MU, von Bubnoff AC, Riemann JF. Source: Scandinavian Journal of Gastroenterology. 2000 December; 35(12): 1319-23. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11199374
•
Calcitonin precursors: early markers of gut barrier dysfunction in patients with acute pancreatitis. Author(s): Ammori BJ, Becker KL, Kite P, Snider RH, Nylen ES, White JC, Barclay GR, Larvin M, McMahon MJ. Source: Pancreas. 2003 October; 27(3): 239-43. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14508129
•
Can roxithromycin and betamethasone induce acute pancreatitis? A case report. Author(s): Renkes P, Petitpain N, Cosserat F, Bangratz S, Trechot P. Source: Jop [electronic Resource] : Journal of the Pancreas. 2003 September; 4(5): 184-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14526130
Studies
35
•
Carbofuran-induced acute pancreatitis. Author(s): Rizos E, Liberopoulos E, Kosta P, Efremidis S, Elisaf M. Source: Jop [electronic Resource] : Journal of the Pancreas. 2004 January; 5(1): 44-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14730122
•
Carcinoid of the ampulla of Vater presenting as acute pancreatitis. Author(s): Mergener K, Gottfried MR, Feldman JM, Branch MS. Source: The American Journal of Gastroenterology. 1996 November; 91(11): 2426-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8931432
•
Childhood acute pancreatitis in a children's hospital. Author(s): Goh SK, Chui CH, Jacobsen AS. Source: Singapore Med J. 2003 September; 44(9): 453-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14740774
•
Chylous cardiac tamponade in acute pancreatitis. Author(s): Arendt T, Bastian A, Lins M, Klause N, Schmidt WE, Folsch UR. Source: Digestive Diseases and Sciences. 1996 October; 41(10): 1972-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8888709
•
Circulating intact parathyroid hormone levels in acute pancreatitis. Author(s): McKay C, Beastall GH, Imrie CW, Baxter JN. Source: The British Journal of Surgery. 1994 March; 81(3): 357-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8173897
•
Clinical effects of continuous high volume hemofiltration on severe acute pancreatitis complicated with multiple organ dysfunction syndrome. Author(s): Wang H, Li WQ, Zhou W, Li N, Li JS. Source: World Journal of Gastroenterology : Wjg. 2003 September; 9(9): 2096-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12970914
•
Clinical evaluation of serum interleukin 10 in patients with acute pancreatitis. Author(s): Han XC, Zhang YC, Wang Y, Jia MK. Source: Hepatobiliary Pancreat Dis Int. 2003 February; 2(1): 135-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14607666
•
Clinical study on nutrition support in patients with severe acute pancreatitis. Author(s): Zhao G, Wang CY, Wang F, Xiong JX. Source: World Journal of Gastroenterology : Wjg. 2003 September; 9(9): 2105-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12970916
36
Acute Pancreatitis
•
Clinical value of lipopolysaccharide-binding protein (LBP) determinations in acute pancreatitis. Author(s): Rau B, Steinbach G, Kruger CM, Baumgart K, Schilling M, Beger HG. Source: Langenbeck's Archives of Surgery / Deutsche Gesellschaft Fur Chirurgie. 2003 July; 388(3): 181-8. Epub 2003 July 11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12856185
•
Colon involvement in acute pancreatitis. Author(s): Chen CY, Lin XZ, Lin CY, Chang TT, Shin JS, Yang CC, Lin PW, Tsai HM. Source: Journal of Clinical Gastroenterology. 1994 April; 18(3): 243-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8034928
•
Compartmentalization of the inflammatory response during acute pancreatitis: correlation with local and systemic complications. Author(s): Dugernier TL, Laterre PF, Wittebole X, Roeseler J, Latinne D, Reynaert MS, Pugin J. Source: American Journal of Respiratory and Critical Care Medicine. 2003 July 15; 168(2): 148-57. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12851244
•
Compartments that cause the real damage in severe acute pancreatitis. Author(s): Raraty MG, Neoptolemos JP. Source: American Journal of Respiratory and Critical Care Medicine. 2003 July 15; 168(2): 141-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12851239
•
Computed tomography and magnetic resonance imaging in the assessment of acute pancreatitis. Author(s): Arvanitakis M, Delhaye M, De Maertelaere V, Bali M, Winant C, Coppens E, Jeanmart J, Zalcman M, Van Gansbeke D, Deviere J, Matos C. Source: Gastroenterology. 2004 March; 126(3): 715-23. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14988825
•
Controversies in clinical pancreatology. Recurrent "idiopathic" acute pancreatitis: should a laparoscopic cholecystectomy be the first procedure of choice? Author(s): Steinberg WM, Geenen JE, Bradley EL 3rd, Barkin JS. Source: Pancreas. 1996 November; 13(4): 329-34. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8899791
Studies
37
•
Controversies in clinical pancreatology: should the sphincter of Oddi be measured in patients with idiopathic recurrent acute pancreatitis, and should sphincterotomy be performed if the pressure is high? Author(s): Steinberg WM. Source: Pancreas. 2003 August; 27(2): 118-21. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12883258
•
Current aspects of the pathophysiology of acute pancreatitis and therapeutic effects of an inflammatory cell infiltration inhibitor. Author(s): Manabe T. Source: Journal of Gastroenterology. 2003; 38(3): 305-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12693385
•
Cytokine release, pancreatic injury, and risk of acute pancreatitis after spinal fusion surgery. Author(s): He Z, Tonb DJ, Dabney KW, Miller F, Shah SA, Brenn BR, Theroux MC, Mehta DI. Source: Digestive Diseases and Sciences. 2004 January; 49(1): 143-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14992449
•
Cytokines (IL-6, IL-8, TNF): early and reliable predictors of severe acute pancreatitis. Author(s): Pooran N, Indaram A, Singh P, Bank S. Source: Journal of Clinical Gastroenterology. 2003 September; 37(3): 263-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12960727
•
Dapsone-induced acute pancreatitis. Author(s): Jha SH, Reddy JA, Dave JK. Source: The Annals of Pharmacotherapy. 2003 October; 37(10): 1438-40. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14519046
•
Decreased HLA (human leucocyte antigen)-DR expression on peripheral blood monocytes predicts the development of organ failure in patients with acute pancreatitis. Author(s): Mentula P, Kylanpaa-Back ML, Kemppainen E, Takala A, Jansson SE, Kautiainen H, Puolakkainen P, Haapiainen R, Repo H. Source: Clinical Science (London, England : 1979). 2003 October; 105(4): 409-17. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12780344
•
Depletion of serum L-arginine in patients with acute pancreatitis. Author(s): Sandstrom P, Gasslander T, Sundqvist T, Franke J, Svanvik J. Source: Pancreas. 2003 October; 27(3): 261-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14508133
38
Acute Pancreatitis
•
Detection of abnormal union of pancreaticobiliary junction by magnetic resonance cholangiopancreatography in a girl with acute pancreatitis. Author(s): Suzuki R, Shimizu T, Suzuki M, Yamashiro Y. Source: Pediatrics International : Official Journal of the Japan Pediatric Society. 2002 April; 44(2): 183-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11896881
•
Detection of choledocholithiasis by EUS in acute pancreatitis: a prospective evaluation in 100 consecutive patients. Author(s): Liu CL, Lo CM, Chan JK, Poon RT, Lam CM, Fan ST, Wong J. Source: Gastrointestinal Endoscopy. 2001 September; 54(3): 325-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11522972
•
Development and use of a new staging system for severe acute pancreatitis based on a nationwide survey in Japan. Author(s): Ogawa M, Hirota M, Hayakawa T, Matsuno S, Watanabe S, Atomi Y, Otsuki M, Kashima K, Koizumi M, Harada H, Yamamoto M, Nishimori I. Source: Pancreas. 2002 November; 25(4): 325-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12409824
•
Diabetic hypertriglyceridemia-induced acute pancreatitis masquerading as biliary pancreatitis. Author(s): Huang DB, Raskin P. Source: Journal of Diabetes and Its Complications. 2002 March-April; 16(2): 180-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12039403
•
Diagnosis and early management of acute pancreatitis. Author(s): Powell JJ, Parks RW. Source: Hosp Med. 2003 March; 64(3): 150-5. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12669481
•
Diagnostic value of pancreatic elastase-1 in human acute pancreatitis. Author(s): Wereszczynska-Siemiatkowska U, Jedynak M, Mroczko B, Siemiatkowski A. Source: Arch Immunol Ther Exp (Warsz). 2003; 51(3): 195-200. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12894874
•
Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Author(s): Oiofinlade O. Source: Gastroenterology. 2004 February; 126(2): 632; Author Reply 632. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14765402
Studies
39
•
Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Author(s): Murray B, Carter R, Imrie C, Evans S, O'Suilleabhain C. Source: Gastroenterology. 2003 June; 124(7): 1786-91. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12806612
•
Discrepancies between population-based data and adverse reaction reports in assessing drugs as causes of acute pancreatitis. Author(s): Lancashire RJ, Cheng K, Langman MJ. Source: Alimentary Pharmacology & Therapeutics. 2003 April 1; 17(7): 887-93. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12656691
•
Do we need a computed tomography examination in all patients with acute pancreatitis within 72 h after admission to hospital for the detection of pancreatic necrosis? Author(s): Lankisch PG, Struckmann K, Assmus C, Lehnick D, Maisonneuve P, Lowenfels AB. Source: Scandinavian Journal of Gastroenterology. 2001 April; 36(4): 432-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11336171
•
Does anion gap predict severity in acute pancreatitis? Author(s): Escofet X, Kang SP, Woods WG, Khan AZ. Source: Journal of Clinical Gastroenterology. 2001 October; 33(4): 343-4. Erratum In: J Clin Gastroenterol 2001 November-December; 33(5): 427. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11588556
•
Does mortality occur early or late in acute pancreatitis? Author(s): Mutinga M, Rosenbluth A, Tenner SM, Odze RR, Sica GT, Banks PA. Source: International Journal of Pancreatology : Official Journal of the International Association of Pancreatology. 2000 October; 28(2): 91-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11128978
•
Drainage for acute pancreatitis. Author(s): Kimura W, Fuse A, Usuba O, Mizutani M, Matsukura A, Makuuchi M. Source: Hepatogastroenterology. 2001 March-April; 48(38): 434-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11379326
•
Duodenal duplication cysts: A rare cause of acute pancreatitis in children. Author(s): Keller MS, Weber TR, Sotelo-Avila C, Brink DS, Luisiri A. Source: Surgery. 2001 July; 130(1): 112-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11436024
40
Acute Pancreatitis
•
Duodenal lesions following severe acute pancreatitis: review of 10 years' clinical experience. Author(s): Chen CY, Lu CL, Chang FY, Lee SD. Source: Hepatogastroenterology. 2001 May-June; 48(39): 869-71. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11462944
•
Duodenal necrosis associated with acute pancreatitis. Author(s): Takeyama Y, Ueda T, Hori Y, Shinkai M, Ajiki T, Kuroda Y. Source: Pancreas. 2001 March; 22(2): 217-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11249081
•
Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis. Author(s): Buter A, Imrie CW, Carter CR, Evans S, McKay CJ. Source: The British Journal of Surgery. 2002 March; 89(3): 298-302. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11872053
•
Early activation of peripheral lymphocytes in human acute pancreatitis. Author(s): Pezzilli R, Maldini M, Morselli-Labate AM, Barakat B, Romboli E, Beltrandi E, Migliori M, Tomassetti P, Corinaldesi R. Source: Journal of Clinical Gastroenterology. 2003 April; 36(4): 360-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12642746
•
Early assessment of severity in acute pancreatitis. Author(s): Taxonera Samso C. Source: Rev Esp Enferm Dig. 2002 September; 94(9): 515-22. English, Spanish. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12587231
•
Early measurement of procalcitonin does not predict severity in patients with acute pancreatitis. Author(s): Frasquet J, Saez J, Trigo C, Martinez J, Such J, Perez-Mateo M. Source: The British Journal of Surgery. 2003 September; 90(9): 1129-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12945081
•
Early multi-system organ failure associated with acute pancreatitis: a plea for a conservative therapeutic strategy. Author(s): Dugernier T, Reynaert M, Laterre PF. Source: Acta Gastroenterol Belg. 2003 April-June; 66(2): 177-83. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12891929
Studies
41
•
Early physiological response to intensive care as a clinically relevant approach to predicting the outcome in severe acute pancreatitis. Author(s): Flint R, Windsor JA. Source: Archives of Surgery (Chicago, Ill. : 1960). 2004 April; 139(4): 438-43. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15078714
•
Early prediction of severe acute pancreatitis by urinary trypsinogen activation peptide. Author(s): Liu ZS, Jiang CQ, Qian Q, Sun Q, Fan LF, Ai ZL. Source: Hepatobiliary Pancreat Dis Int. 2002 May; 1(2): 285-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14612286
•
Early severity indexes in acute pancreatitis. Author(s): Johnson CD. Source: Acta Gastroenterol Belg. 2003 April-June; 66(2): 174-6. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12891928
•
Enalapril-associated acute pancreatitis: recurrence after rechallenge. Author(s): Maringhini A, Termini A, Patti R, Ciambra M, Biffarella P, Pagliaro L. Source: The American Journal of Gastroenterology. 1997 January; 92(1): 166-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8995963
•
Endoscopic pancreaticoduodenostomy for treatment of pancreatic duct disconnection because of severe acute pancreatitis. Author(s): Zein CO, Baron TH, Morgan DE. Source: Gastrointestinal Endoscopy. 2003 July; 58(1): 130-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12838241
•
Endoscopic sphincterotomy and recurrence of acute pancreatitis in gallstone patients considered unfit for surgery. Author(s): Uomo G, Manes G, Laccetti M, Cavallera A, Rabitti PG. Source: Pancreas. 1997 January; 14(1): 28-31. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8981504
•
Endotoxin, cellular immune dysfunction and acute pancreatitis. Author(s): Curley PJ. Source: Annals of the Royal College of Surgeons of England. 1996 November; 78(6): 5315. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8943639
42
Acute Pancreatitis
•
Enteral nutrition during acute pancreatitis: feasibility study of a self-propeeling spiral distal end jejunal tube. Author(s): Karsenti D, Viguier J, Bourlier P, d'alteroche L, Barbieux JP, Metman EH, Dorval E. Source: Gastroenterologie Clinique Et Biologique. 2003 June; 27(6-7): 614-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12910227
•
Enteral nutrition in severe acute pancreatitis: future development. Author(s): Dervenis C. Source: Jop [electronic Resource] : Journal of the Pancreas. 2004 March; 5(2): 60-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15007186
•
Enteral nutrition in treatment of severe acute pancreatitis. Author(s): Shi D, Zhang CW, Jiang JS, Xie ZJ, Zou SC. Source: Hepatobiliary Pancreat Dis Int. 2002 February; 1(1): 146-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14607646
•
Enterolith ileus complicating afferent loop syndrome simulating acute pancreatitis. Author(s): Sarli L, Iusco D, Violi V, Roncoroni L. Source: Int Surg. 2003 July-September; 88(3): 129-32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14584766
•
ERCP and acute pancreatitis. Author(s): Fiocca F, Santagati A, Ceci V, Donatelli G, Pasqualini MJ, Moretti MG, Speranza V, Di Giuli M, Minervini S, Sportelli G, Giri S. Source: Eur Rev Med Pharmacol Sci. 2002 January-February; 6(1): 13-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12608652
•
Etiology and age have only a limited influence on the course of acute pancreatitis. Author(s): Lankisch PG, Burchard-Reckert S, Petersen M, Lehnick D, Schirren CA, Stockmann F, Kohler H. Source: Pancreas. 1996 November; 13(4): 344-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8899794
•
Etiology of acute pancreatitis--a multi-center study in Taiwan. Author(s): Chang MC, Su CH, Sun MS, Huang SC, Chiu CT, Chen MC, Lee KT, Lin CC, Lin JT. Source: Hepatogastroenterology. 2003 September-October; 50(53): 1655-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14571809
Studies
43
•
Evaluation of Pankrin, a new serum test for diagnosis of acute pancreatitis. Author(s): Keim V, Teich N, Bodeker H, Mossner J. Source: Clinica Chimica Acta; International Journal of Clinical Chemistry. 2003 June; 332(1-2): 45-50. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12763279
•
Evolving concepts in the pathophysiology of acute pancreatitis. Author(s): Zyromski N, Murr MM. Source: Surgery. 2003 March; 133(3): 235-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12660632
•
Factors influencing morbidity and mortality in acute pancreatitis; an analysis of 279 cases. Author(s): de Beaux AC, Palmer KR, Carter DC. Source: Gut. 1995 July; 37(1): 121-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7672660
•
Factors predicting mortality in severe acute pancreatitis. Author(s): Company L, Saez J, Martinez J, Aparicio JR, Laveda R, Grino P, Perez-Mateo M. Source: Pancreatology : Official Journal of the International Association of Pancreatology (Iap). [et Al.]. 2003; 3(2): 144-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12748423
•
Factors predisposing to severe acute pancreatitis: evaluation and prevention. Author(s): Sun B, Li HL, Gao Y, Xu J, Jiang HC. Source: World Journal of Gastroenterology : Wjg. 2003 May; 9(5): 1102-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12717866
•
Failure of the Hong Kong criteria to predict the severity of acute pancreatitis. Author(s): Heath DI, Meng WC, Anderson JH, Leung KL, Lau WY, Li AK. Source: International Journal of Pancreatology : Official Journal of the International Association of Pancreatology. 1997 December; 22(3): 201-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9444551
•
Fatal acute pancreatitis caused by valproic acid. Author(s): Evans RJ, Miranda RN, Jordan J, Krolikowski FJ. Source: The American Journal of Forensic Medicine and Pathology : Official Publication of the National Association of Medical Examiners. 1995 March; 16(1): 62-5. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7771387
44
Acute Pancreatitis
•
Fatal acute pancreatitis with cystic formation in reactive systemic AA amyloidosis secondary to rheumatoid arthritis. Author(s): Matsuda M, Sakurai S, Suzuki A, Kadoya M, Ikeda S. Source: Intern Med. 2003 September; 42(9): 888-92. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14518683
•
Fatal acute pancreatitis. Characteristics of patients never reaching hospital. Author(s): Andersson R, Andren-Sandberg A. Source: Pancreatology : Official Journal of the International Association of Pancreatology (Iap). [et Al.]. 2003; 3(1): 64-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12649566
•
Fatal outcome in acute pancreatitis: its occurrence and early prediction. Author(s): Blum T, Maisonneuve P, Lowenfels AB, Lankisch PG. Source: Pancreatology : Official Journal of the International Association of Pancreatology (Iap). [et Al.]. 2001; 1(3): 237-41. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12120201
•
Fatal sepsis associated with acute pancreatitis caused by Moraxella catarrhalis in a child. Author(s): Ohkusu K, Nakamura A, Horie H, Udagawa A. Source: The Pediatric Infectious Disease Journal. 2001 September; 20(9): 914-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11734777
•
Fibrotic stricture of the extrapancreatic biliary tract: a new complication of acute pancreatitis. Two cases. Author(s): Delcenserie R, Joly JP, Lenne C, Kannoun MM, Sevestre H, Capron JP, Dupas JL. Source: Pancreas. 1995 January; 10(1): 100-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7899453
•
Flexible approach to nutritional support in severe acute pancreatitis. Author(s): De Beaux AC, Plester C, Fearon KC. Source: Nutrition (Burbank, Los Angeles County, Calif.). 1994 May-June; 10(3): 246-8; Discussion 249. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7919677
•
Formalized therapeutic guideline for hyperlipidemic severe acute pancreatitis. Author(s): Mao EQ, Tang YQ, Zhang SD. Source: World Journal of Gastroenterology : Wjg. 2003 November; 9(11): 2622-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14606112
Studies
45
•
Frank Brooks memorial Lecture: The early intraacinar cell events which occur during acute pancreatitis. Author(s): Steer ML. Source: Pancreas. 1998 July; 17(1): 31-7. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9667517
•
Frequency and risk factors of recurrent pain during refeeding in patients with acute pancreatitis: a multivariate multicentre prospective study of 116 patients. Author(s): Levy P, Heresbach D, Pariente EA, Boruchowicz A, Delcenserie R, Millat B, Moreau J, Le Bodic L, de Calan L, Barthet M, Sauvanet A, Bernades P. Source: Gut. 1997 February; 40(2): 262-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9071942
•
Fulminant acute pancreatitis and infected necrosis: results of open management of the abdomen and "planned" reoperations. Author(s): Bosscha K, Hulstaert PF, Hennipman A, Visser MR, Gooszen HG, van Vroonhoven TJ, v d Werken C. Source: Journal of the American College of Surgeons. 1998 September; 187(3): 255-62. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9740182
•
Fungaemia due to Candida pelliculosa in a case of acute pancreatitis. Author(s): Neumeister B, Rockemann M, Marre R. Source: Mycoses. 1992 November-December; 35(11-12): 309-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1302804
•
Fungal infections in patients with severe acute pancreatitis and the use of prophylactic therapy. Author(s): De Waele JJ, Vogelaers D, Blot S, Colardyn F. Source: Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America. 2003 July 15; 37(2): 208-13. Epub 2003 Jul 09. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12856213
•
Further evidence for endothelin as an important mediator of pancreatic and intestinal ischemia in severe acute pancreatitis. Author(s): Inoue K, Hirota M, Kimura Y, Kuwata K, Ohmuraya M, Ogawa M. Source: Pancreas. 2003 April; 26(3): 218-23. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12657945
•
Gabexate mesilate in acute pancreatitis: miracle or mirage? Author(s): Bradley EL 3rd. Source: Dig Liver Dis. 2001 January-February; 33(1): 12-3. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11303968
46
Acute Pancreatitis
•
Gabexate mesilate in acute pancreatitis: neither a miracle nor a mirage, merely the search of optimal dosage. Author(s): Pezzilli R. Source: Dig Liver Dis. 2001 August-September; 33(6): 502. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11572579
•
Gadolinium arteriography complicated by acute pancreatitis and acute renal failure. Author(s): Schenker MP, Solomon JA, Roberts DA. Source: Journal of Vascular and Interventional Radiology : Jvir. 2001 March; 12(3): 393. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11287523
•
Gallstones, the choledochoduodenal junction and initiation of acute pancreatitis: are two stones the culprits rather than one stone? Author(s): Arendt T, Monig H, Stuber E, Katsoulis S, Folsch UR. Source: Medical Hypotheses. 2000 April; 54(4): 570-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10859640
•
Gastric colonisation, intestinal permeability and septic morbidity in acute pancreatitis. Author(s): McNaught CE, Woodcock NP, Mitchell CJ, Rowley G, Johnstone D, MacFie J. Source: Pancreatology : Official Journal of the International Association of Pancreatology (Iap). [et Al.]. 2002; 2(5): 463-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12378114
•
Gastric intramucosal pH predicts death in severe acute pancreatitis. Author(s): Bonham MJ, Abu-Zidan FM, Simovic MO, Windsor JA. Source: The British Journal of Surgery. 1997 December; 84(12): 1670-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9448612
•
Gastric tonometry in assessing splanchnic tissue perfusion in acute pancreatitis. Author(s): Juvonen PO, Alhava EM, Takala JA. Source: Scandinavian Journal of Gastroenterology. 2000 March; 35(3): 318-21. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10766328
•
Gastrointestinal bleeding due to acute pancreatitis. Author(s): Verger P, Gruau M, Dhunnoo K, Blais J. Source: Endoscopy. 1998 September; 30(7): S87. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9826163
Studies
47
•
Gastrointestinal case of the day. Pseudoaneurysm of the left gastric artery as a complication of acute pancreatitis. Author(s): Smith RE, Fontanez-Garcia D, Plavsic BM. Source: Radiographics : a Review Publication of the Radiological Society of North America, Inc. 1999 September-October; 19(5): 1390-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10489192
•
Gastrointestinal disorders of the critically ill. Shock and acute pancreatitis. Author(s): Isenmann R, Henne-Bruns D, Adler G. Source: Best Practice & Research. Clinical Gastroenterology. 2003 June; 17(3): 345-55. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12763500
•
Gastrointestinal dysmotility in patients with acute pancreatitis. Author(s): Wang X, Gong Z, Wu K, Wang B, Yuang Y. Source: Journal of Gastroenterology and Hepatology. 2003 January; 18(1): 57-62. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12519225
•
Gastrointestinal mucosal lesions in patients with acute pancreatitis. Author(s): Lin CK, Wang ZS, Lai KH, Lo GH, Hsu PI. Source: Zhonghua Yi Xue Za Zhi (Taipei). 2002 June; 65(6): 275-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12201568
•
Gatifloxacin-induced hepatotoxicity and acute pancreatitis. Author(s): Cheung O, Chopra K, Yu T, Nalesnik MA, Amin S, Shakil AO. Source: Annals of Internal Medicine. 2004 January 6; 140(1): 73-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14706991
•
Glutamine-supplemented total parenteral nutrition reduces blood mononuclear cell interleukin-8 release in severe acute pancreatitis. Author(s): de Beaux AC, O'Riordain MG, Ross JA, Jodozi L, Carter DC, Fearon KC. Source: Nutrition (Burbank, Los Angeles County, Calif.). 1998 March; 14(3): 261-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9583368
•
Guidelines for the management of acute pancreatitis. Author(s): Toouli J, Brooke-Smith M, Bassi C, Carr-Locke D, Telford J, Freeny P, Imrie C, Tandon R; Working Party of the Program Commitee of the Bangkok World Congress of Gastroenterology 2002. Source: Journal of Gastroenterology and Hepatology. 2002 February; 17 Suppl: S15-39. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12000591
48
Acute Pancreatitis
•
Guidelines for treatment of acute pancreatitis. Author(s): Andrulli A, Perri F, Annese V. Source: Gut. 1999 April; 44(4): 579-80. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10366292
•
Guidelines for treatment of severe acute pancreatitis. Author(s): Wu XN. Source: Hepatobiliary Pancreat Dis Int. 2002 August; 1(3): 446-51. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14607725
•
Gut barrier dysfunction in experimental acute pancreatitis. Author(s): Andersson R, Wang XD. Source: Ann Acad Med Singapore. 1999 January; 28(1): 141-6. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10374040
•
Gut barrier dysfunction in patients with acute pancreatitis. Author(s): Ammori BJ. Source: Journal of Hepato-Biliary-Pancreatic Surgery. 2002; 9(4): 411-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12483261
•
Gut permeability in patients with acute pancreatitis. Author(s): Juvonen PO, Alhava EM, Takala JA. Source: Scandinavian Journal of Gastroenterology. 2000 December; 35(12): 1314-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11199373
•
Haemobilia causing acute pancreatitis after percutaneous liver biopsy: diagnosis by magnetic resonance cholangiopancreatography. Author(s): Asselah T, Condat B, Sibert A, Rivet P, Lebray P, Bernuau J, Benhamou JP, Erlinger S, Marcellin P, Valla D. Source: European Journal of Gastroenterology & Hepatology. 2001 July; 13(7): 877-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11474321
•
Has blood glucose level measured on admission to hospital in a patient with acute pancreatitis any prognostic value? Author(s): Lankisch PG, Blum T, Bruns A, Droge M, Brinkmann G, Struckmann K, Nauck M, Maisonneuve P, Lowenfels AB. Source: Pancreatology : Official Journal of the International Association of Pancreatology (Iap). [et Al.]. 2001; 1(3): 224-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12120199
Studies
49
•
Hepatitis A and acute pancreatitis. Author(s): Sood A, Midha V. Source: J Assoc Physicians India. 1999 July; 47(7): 736-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10778600
•
Hepatobiliary and pancreatic: a woman with recurrent idiopathic acute pancreatitis. Intraductal papillary mucinous tumor of the pancreas. Author(s): Mosca S, Bottino V, Molino C. Source: Journal of Gastroenterology and Hepatology. 2001 September; 16(9): 1070, 1075. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11595076
•
Hereditary pancreatitis--a rare differential diagnosis in patients with menstruationassociated recurrent acute pancreatitis: a case report. Author(s): Heinig J, Greb RR, Kiesel L, Bass S, Simon P. Source: Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology. 2004 January; 18(1): 47-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15106365
•
Hiatal hernia with pancreatic volvulus: a rare cause of acute pancreatitis. Author(s): Chevallier P, Peten E, Pellegrino C, Souci J, Motamedi JP, Padovani B. Source: Ajr. American Journal of Roentgenology. 2001 August; 177(2): 373-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11461866
•
High dose octreotide in the management of acute pancreatitis. Author(s): Karakoyunlar O, Sivrel E, Tanir N, Denecli AG. Source: Hepatogastroenterology. 1999 May-June; 46(27): 1968-72. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10430379
•
High early mortality rate from acute pancreatitis in Scotland, 1984-95. Author(s): Woodcock S, Siriwardena A. Source: The British Journal of Surgery. 2000 March; 87(3): 379-80. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10718974
•
High signal peripancreatic fat on fat-suppressed spoiled gradient echo imaging in acute pancreatitis: preliminary evaluation of the prognostic significance. Author(s): Martin DR, Karabulut N, Yang M, McFadden DW. Source: Journal of Magnetic Resonance Imaging : Jmri. 2003 July; 18(1): 49-58. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12815639
50
Acute Pancreatitis
•
High, not low, amylase and lipase levels indicate severe acute pancreatitis! Author(s): Lankisch PG, Petersen M, Gottesleben F. Source: Zeitschrift Fur Gastroenterologie. 1994 April; 32(4): 213-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7517087
•
HLA-DR expression in acute pancreatitis. Author(s): Richter A, Nebe T, Wendl K, Schuster K, Klaebisch G, Quintel M, Lorenz D, Post S, Trede M. Source: The European Journal of Surgery = Acta Chirurgica. 1999 October; 165(10): 94751. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10574102
•
How hemolysis causes acute pancreatitis. Author(s): Saruc M, Ozden N, Yuceyar H. Source: Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 2002 December; 8(12): Le51-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12546022
•
How we do it: Acute pancreatitis. Author(s): Horton KM. Source: Critical Reviews in Computed Tomography. 2003; 44(2): 63-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12757312
•
Human leukocyte antigen-DR expression on peripheral monocytes as a predictive marker of sepsis during acute pancreatitis. Author(s): Satoh A, Miura T, Satoh K, Masamune A, Yamagiwa T, Sakai Y, Shibuya K, Takeda K, Kaku M, Shimosegawa T. Source: Pancreas. 2002 October; 25(3): 245-50. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12370535
•
Hydronephrosis associated with acute pancreatitis. Author(s): Takeyama Y, Ueda T, Hori Y, Takase K, Fukumoto S, Kuroda Y. Source: Pancreas. 2001 August; 23(2): 218-20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11484926
•
Hypertriglyceridemia, acute pancreatitis, and diabetic ketoacidosis possibly associated with mirtazapine therapy: a case report. Author(s): Chen JL, Spinowitz N, Karwa M. Source: Pharmacotherapy. 2003 July; 23(7): 940-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12885107
Studies
51
•
Hypertriglyceridemia-induced acute pancreatitis--treatment with heparin and insulin. Author(s): Monga A, Arora A, Makkar RP, Gupta AK. Source: Indian J Gastroenterol. 2003 May-June; 22(3): 102-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12839385
•
Hypocalcemia in patients with acute pancreatitis: a putative role for systemic endotoxin exposure. Author(s): Ammori BJ, Barclay GR, Larvin M, McMahon MJ. Source: Pancreas. 2003 April; 26(3): 213-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12657944
•
Hypocaloric jejunal feeding is better than total parenteral nutrition in acute pancreatitis: results of a randomized comparative study. Author(s): Abou-Assi S, Craig K, O'Keefe SJ. Source: The American Journal of Gastroenterology. 2002 September; 97(9): 2255-62. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12358242
•
Hypothermia and acute pancreatitis: myth or reality? Author(s): Stiff RE, Morris-Stiff GJ, Torkington J. Source: Journal of the Royal Society of Medicine. 2003 May; 96(5): 228-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12724432
•
IAP guidelines in acute pancreatitis. Author(s): Sarr MG. Source: Digestive Surgery. 2003; 20(1): 1-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12846213
•
Idiopathic acute pancreatitis. Author(s): Kim HJ, Kim MH, Bae JS, Lee SS, Seo DW, Lee SK. Source: Journal of Clinical Gastroenterology. 2003 September; 37(3): 238-50. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12960724
•
Imaging changes of the pancreas and the occasion of refeeding in patients with acute pancreatitis. Author(s): Qin RY, Qiu FZ. Source: Hepatobiliary Pancreat Dis Int. 2002 May; 1(2): 290-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14612287
•
Immune function early in acute pancreatitis. Author(s): Wyllie JH, Myint F. Source: The British Journal of Surgery. 1996 October; 83(10): 1480-1. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8944482
52
Acute Pancreatitis
•
Immune function in patients with acute pancreatitis. Author(s): Uehara S, Gothoh K, Handa H, Tomita H, Tomita Y. Source: Journal of Gastroenterology and Hepatology. 2003 April; 18(4): 363-70. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12653883
•
Incidence, etiology, and impact of Fever in patients with acute pancreatitis. Author(s): Bohidar NP, Garg PK, Khanna S, Tandon RK. Source: Pancreatology : Official Journal of the International Association of Pancreatology (Iap). [et Al.]. 2003; 3(1): 9-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12649559
•
Increased nitric oxide excretion in patients with severe acute pancreatitis: evidence of an endotoxin mediated inflammatory response? Author(s): Rahman SH, Ammori BJ, Larvin M, McMahon MJ. Source: Gut. 2003 February; 52(2): 270-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12524412
•
Indications for surgery in severe acute pancreatitis. Author(s): McFadden DW, Reber HA. Source: International Journal of Pancreatology : Official Journal of the International Association of Pancreatology. 1994 April; 15(2): 83-90. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8071574
•
Infected necrosis complicating acute pancreatitis: experience with 131 cases. Author(s): Bhansali SK, Shah SC, Desai SB, Sunawala JD. Source: Indian J Gastroenterol. 2003 January-February; 22(1): 7-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12617444
•
Infectious causes of acute pancreatitis. Author(s): Parenti DM, Steinberg W, Kang P. Source: Pancreas. 1996 November; 13(4): 356-71. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8899796
•
Influence of etiology on the course and outcome of acute pancreatitis. Author(s): Uhl W, Isenmann R, Curti G, Vogel R, Beger HG, Buchler MW. Source: Pancreas. 1996 November; 13(4): 335-43. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8899793
Studies
53
•
Influence of severe underlying pathology and hypovolemic shock on the development of acute pancreatitis in children. Author(s): Berney T, Belli D, Bugmann P, Beghetti M, Morel P, LeCoultre C. Source: Journal of Pediatric Surgery. 1996 September; 31(9): 1256-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8887096
•
Influence of somatostatin in the evolution of acute pancreatitis. A prospective randomized study. Author(s): Luengo L, Vicente V, Gris F, Coronas JM, Escuder J, Ramon Gomez J, Castellote JM. Source: International Journal of Pancreatology : Official Journal of the International Association of Pancreatology. 1994 April; 15(2): 139-44. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7915294
•
Interleukin 18 levels reflect the severity of acute pancreatitis. Author(s): Endo S, Inoue Y, Fujino Y, Wakabayashi G, Inada K, Sato S. Source: Res Commun Mol Pathol Pharmacol. 2001; 110(5-6): 285-91. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12889520
•
Interleukin-6 is a useful marker for early prediction of the severity of acute pancreatitis. Author(s): Inagaki T, Hoshino M, Hayakawa T, Ohara H, Yamada T, Yamada H, Iida M, Nakazawa T, Ogasawara T, Uchida A, Hasegawa C, Miyaji M, Takeuchi T. Source: Pancreas. 1997 January; 14(1): 1-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8981500
•
Intestinal hypoperfusion contributes to gut barrier failure in severe acute pancreatitis. Author(s): Rahman SH, Ammori BJ, Holmfield J, Larvin M, McMahon MJ. Source: Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract. 2003 January; 7(1): 26-35; Discussion 35-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12559182
•
Intrahepatic hemorrhage and subcapsular hematoma developing in acute pancreatitis. Author(s): Lin CK, Chen CH, Yeh CH, Lin SL, Tsang YM, Sheu JC. Source: Hepatogastroenterology. 2003 March-April; 50(50): 571-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12749275
•
Intramural duodenal hematoma and acute pancreatitis. Author(s): Bodnar Z, Varvolgyi C. Source: Endoscopy. 2003 August; 35(8): 708; Author Reply 708. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12929071
54
Acute Pancreatitis
•
Intravenous n-acetylcysteine, ascorbic acid and selenium-based anti-oxidant therapy in severe acute pancreatitis. Author(s): Virlos IT, Mason J, Schofield D, McCloy RF, Eddleston JM, Siriwardena AK. Source: Scandinavian Journal of Gastroenterology. 2003 December; 38(12): 1262-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14750647
•
Is site of necrosis in acute pancreatitis a predictor of outcome? Author(s): Blazeby JM, Cooper MJ. Source: Lancet. 1996 October 19; 348(9034): 1044. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8874449
•
Jejunal feeding in necrotising acute pancreatitis--a retrospective study. Author(s): Hamvas J, Schwab R, Pap A. Source: Acta Chir Hung. 1999; 38(2): 177-85. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10596325
•
Jejunal perforation mimicking acute pancreatitis in a patient with systemic lupus erythematosus: case report. Author(s): Doyle GJ, Pugash RA, Clark JA, Mustard R. Source: Canadian Association of Radiologists Journal = Journal L'association Canadienne Des Radiologistes. 1999 June; 50(3): 159-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10405646
•
Kallikrein-kinin system in acute pancreatitis: potential of B(2)-bradykinin antagonists and kallikrein inhibitors. Author(s): Griesbacher T. Source: Pharmacology. 2000 April; 60(3): 113-20. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10754447
•
Ketorolac tromethamine-induced acute pancreatitis. Author(s): Goyal SB, Goyal RS. Source: Archives of Internal Medicine. 1998 February 23; 158(4): 411. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9487239
•
Laboratory diagnostic tests in acute pancreatitis. Author(s): Smotkin J, Tenner S. Source: Journal of Clinical Gastroenterology. 2002 April; 34(4): 459-62. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11907364
Studies
55
•
Lamivudine-induced acute pancreatitis in a patient with decompensated Hbv-related chronic liver disease. Author(s): Soylu AR, Dokmeci G, Tezel A, Cakir B, Umit H, Karahan N, Amuca H. Source: Journal of Clinical Gastroenterology. 2004 February; 38(2): 134. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14745288
•
Laparoscopic management of severe acute pancreatitis. Author(s): Zhou ZG, Zheng YC, Shu Y, Hu WM, Tian BL, Li QS, Zhang ZD. Source: Pancreas. 2003 October; 27(3): E46-50. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14508140
•
Laparoscopic treatment of secondary infected pancreatic collections after an acute pancreatitis: two cases. Author(s): el Yassini AE, Hoebeke Y, Keuleneer RD. Source: Acta Chir Belg. 1996 September-October; 96(5): 226-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8950385
•
Laparoscopic treatment of severe acute pancreatitis. Author(s): Kjossev KT, Losanoff JE. Source: Surgical Endoscopy. 2001 October; 15(10): 1239-41. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11727121
•
Late mortality in patients with severe acute pancreatitis. Author(s): Senapati PS, Ammori BJ. Source: The British Journal of Surgery. 2002 April; 89(4): 491; Author Reply 491. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11952601
•
Late mortality in patients with severe acute pancreatitis. Author(s): Gloor B, Muller CA, Worni M, Martignoni ME, Uhl W, Buchler MW. Source: The British Journal of Surgery. 2001 July; 88(7): 975-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11442530
•
Leptin modulates the inflammatory response in acute pancreatitis. Author(s): Konturek PC, Jaworek J, Maniatoglou A, Bonior J, Meixner H, Konturek SJ, Hahn EG. Source: Digestion. 2002; 65(3): 149-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12138320
56
Acute Pancreatitis
•
Letter 1: Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis (Br J Surg 2002; 89: 11031107). Author(s): Weale R, Edwards A. Source: The British Journal of Surgery. 2003 January; 90(1): 122-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12520591
•
Letter 2: Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis (Br J Surg 2002; 89: 11031107). Author(s): Rahman SH, Catton JA, McMahon MJ. Source: The British Journal of Surgery. 2003 January; 90(1): 123. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12520593
•
Levels of leukocyte proteases in plasma and peritoneal exudate in severe, acute pancreatitis. Author(s): Bergenfeldt M, Berling R, Ohlsson K. Source: Scandinavian Journal of Gastroenterology. 1994 April; 29(4): 371-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8047815
•
Levels of the chemokines growth-related oncogene alpha and epithelial neutrophilactivating protein 78 are raised in patients with severe acute pancreatitis (Br J Surg 2002; 89: 566-72). Author(s): Makhija R, Kingsnorth AN. Source: The British Journal of Surgery. 2002 September; 89(9): 1194. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12190691
•
Levels of the chemokines growth-related oncogene alpha and epithelial neutrophilactivating protein 78 are raised in patients with severe acute pancreatitis. Author(s): Shokuhi S, Bhatia M, Christmas S, Sutton R, Neoptolemos JP, Slavin J. Source: The British Journal of Surgery. 2002 May; 89(5): 566-72. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11972545
•
Lexipafant and acute pancreatitis: a critical appraisal of the clinical trials. Author(s): Abu-Zidan FM, Windsor JA. Source: The European Journal of Surgery = Acta Chirurgica. 2002; 168(4): 215-9. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12440758
•
Liver damages during experimental acute pancreatitis. Author(s): Mozzhelin ME, Vengerovskii AI, Sukhodolo IV, Saratikov AS. Source: Bulletin of Experimental Biology and Medicine. 2001 July; 132(1): 647-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11687843
Studies
57
•
Local renin-angiotensin system in the pancreas: the significance in acute pancreatitis. Author(s): Lai PB. Source: Jop [electronic Resource] : Journal of the Pancreas. 2001 January; 2(1): 13-5. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11862017
•
Local renin-angiotensin system in the pancreas: the significance of changes by chronic hypoxia and acute pancreatitis. Author(s): Leung PS. Source: Jop [electronic Resource] : Journal of the Pancreas. 2001 January; 2(1): 3-8. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11862015
•
Long-term health-related quality of life in survivors of severe acute pancreatitis. Author(s): Halonen KI, Pettila V, Leppaniemi AK, Kemppainen EA, Puolakkainen PA, Haapiainen RK. Source: Intensive Care Medicine. 2003 May; 29(5): 782-6. Epub 2003 April 09. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12684744
•
Long-term results of endoscopic management of pancreas divisum with recurrent acute pancreatitis. Author(s): Heyries L, Barthet M, Delvasto C, Zamora C, Bernard JP, Sahel J. Source: Gastrointestinal Endoscopy. 2002 March; 55(3): 376-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11868012
•
Lung injury in acute pancreatitis: mechanisms, prevention, and therapy. Author(s): Shields CJ, Winter DC, Redmond HP. Source: Current Opinion in Critical Care. 2002 April; 8(2): 158-63. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12386518
•
Macrophage migration inhibitory factor is a critical mediator of severe acute pancreatitis. Author(s): Sakai Y, Masamune A, Satoh A, Nishihira J, Yamagiwa T, Shimosegawa T. Source: Gastroenterology. 2003 March; 124(3): 725-36. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12612911
•
Magnetic resonance imaging of acute pancreatitis: the pancreatogram. Author(s): Gosset J, Deviere J, Matos C. Source: Jop [electronic Resource] : Journal of the Pancreas. 2004 January; 5(1): 48-50. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14730123
58
Acute Pancreatitis
•
Malignant pheochromocytoma masquerading as acute pancreatitis--a rare but potentially lethal occurrence. Author(s): Perrier NA, van Heerden JA, Wilson DJ, Warner MA. Source: Mayo Clinic Proceedings. 1994 April; 69(4): 366-70. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7513373
•
Management of acute pancreatitis. Author(s): O'Reilly DA, Kingsnorth AN. Source: Bmj (Clinical Research Ed.). 2004 April 24; 328(7446): 968-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15105303
•
Management of infected necrosis secondary to acute pancreatitis: a balanced role for minimal access techniques. Author(s): Carter R. Source: Pancreatology : Official Journal of the International Association of Pancreatology (Iap). [et Al.]. 2003; 3(2): 133-8. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12774803
•
Management of infection in acute pancreatitis. Author(s): Hartwig W, Werner J, Uhl W, Buchler MW. Source: Journal of Hepato-Biliary-Pancreatic Surgery. 2002; 9(4): 423-8. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12483263
•
Management of severe acute pancreatitis. Author(s): Yousaf M, McCallion K, Diamond T. Source: The British Journal of Surgery. 2003 April; 90(4): 407-20. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12673741
•
Management of sterile necrosis in acute pancreatitis: is surgery a necessity? Author(s): Collawn C, Barkin JS. Source: The American Journal of Gastroenterology. 1996 November; 91(11): 2443-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8931442
•
Matrix metalloproteinase-1 and cytokines in patients with acute pancreatitis. Author(s): Nakae H, Endo S, Inoue Y, Fujino Y, Wakabayashi G, Inada K, Sato S. Source: Pancreas. 2003 March; 26(2): 134-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12604910
Studies
59
•
Microcirculatory dysfunction in acute pancreatitis. A new concept of pathogenesis involving vasomotion-associated arteriolar constriction and dilation. Author(s): Vollmar B, Menger MD. Source: Pancreatology : Official Journal of the International Association of Pancreatology (Iap). [et Al.]. 2003; 3(3): 181-90. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12817573
•
Minimal-access approaches to complications of acute pancreatitis and benign neoplasms of the pancreas. Author(s): Kellogg TA, Horvath KD. Source: Surgical Endoscopy. 2003 November; 17(11): 1692-704. Epub 2003 September 10. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12958685
•
Minute pancreatic carcinoma with initial symptom of acute pancreatitis. Author(s): Imamura M, Asahi S, Yamauchi H, Tadokoro K, Suzuki H. Source: Journal of Hepato-Biliary-Pancreatic Surgery. 2002; 9(5): 632-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12541052
•
Mirtazapine: another drug responsible for drug-induced acute pancreatitis? A letter of warning. Author(s): Lankisch PG, Werner HM. Source: Pancreas. 2003 March; 26(2): 211. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12604923
•
Modern phase-specific management of acute pancreatitis. Author(s): Werner J, Uhl W, Hartwig W, Hackert T, Muller C, Strobel O, Buchler MW. Source: Digestive Diseases (Basel, Switzerland). 2003; 21(1): 38-45. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12837999
•
Natural history of organ failure in acute pancreatitis. Author(s): McKay CJ, Buter A. Source: Pancreatology : Official Journal of the International Association of Pancreatology (Iap). [et Al.]. 2003; 3(2): 111-4. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12748419
•
Necrotic stenosis of the right colon secondary to acute pancreatitis. Author(s): Chartrand-Lefebvre C, Clermont RJ, Heppell J, Bernard EJ, Prosmanne O. Source: Canadian Journal of Surgery. Journal Canadien De Chirurgie. 1994 April; 37(2): 140-2. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8156467
60
Acute Pancreatitis
•
Necrotizing acute pancreatitis induced by Salmonella typhimurium. Author(s): Blank A, Maybody M, Isom-Batz G, Roslin M, Dillon EH. Source: Digestive Diseases and Sciences. 2003 August; 48(8): 1472-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12924638
•
Neopterin in acute pancreatitis. Author(s): Uomo G, Spada OA, Manes G, Feola B, Misso S, Cavallera A, Rabitti PG. Source: Scandinavian Journal of Gastroenterology. 1996 October; 31(10): 1032-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8898426
•
New-onset QT prolongation and torsades de pointes accompanied by left ventricular dysfunction secondary to acute pancreatitis. Author(s): Mofrad PS, Rashid H, Tracy CM. Source: Pacing and Clinical Electrophysiology : Pace. 2003 August; 26(8): 1765-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12877713
•
No parallel between the biochemical course of acute pancreatitis and morphologic findings. Author(s): Lankisch PG, Haseloff M, Becher R. Source: Pancreas. 1994 March; 9(2): 240-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8190726
•
Non-occlusive mesenteric ischemia and its associated intestinal gangrene in acute pancreatitis. Author(s): Hirota M, Inoue K, Kimura Y, Mizumoto T, Kuwata K, Ohmuraya M, Ishiko T, Beppu T, Ogawa M. Source: Pancreatology : Official Journal of the International Association of Pancreatology (Iap). [et Al.]. 2003; 3(4): 316-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12890994
•
Novel therapeutic targets for acute pancreatitis and associated multiple organ dysfunction syndrome. Author(s): Bhatia M. Source: Current Drug Targets. Inflammation and Allergy. 2002 December; 1(4): 343-51. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14561181
•
Nutritional support in acute pancreatitis. Author(s): Avgerinos C, Delis S, Rizos S, Dervenis C. Source: Digestive Diseases (Basel, Switzerland). 2003; 21(3): 214-9. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14571094
Studies
61
•
Nutritional support in acute pancreatitis. Author(s): McClave SA. Source: Nestle Nutr Workshop Ser Clin Perform Programme. 2003; (8): 207-15; Discussion 215-21. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12968456
•
Obesity and treatment of diabetes with glyburide may both be risk factors for acute pancreatitis. Author(s): Blomgren KB, Sundstrom A, Steineck G, Wiholm BE. Source: Diabetes Care. 2002 February; 25(2): 298-302. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11815499
•
Olanzapine-induced acute pancreatitis. Author(s): Doucette DE, Grenier JP, Robertson PS. Source: The Annals of Pharmacotherapy. 2000 October; 34(10): 1128-31. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11054978
•
Onset time of complications in patients with severe acute pancreatitis receiving nonoperative therapy. Author(s): Gong ZY, Tang YQ. Source: Hepatobiliary Pancreat Dis Int. 2002 February; 1(1): 143-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14607645
•
Operative timing and indications for patients with severe acute pancreatitis: report of 172 cases. Author(s): Sun B, Jiang HC, Xun J. Source: Hepatobiliary Pancreat Dis Int. 2002 February; 1(1): 129-32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14607641
•
Optimising outcomes in acute pancreatitis. Author(s): Norton ID, Clain JE. Source: Drugs. 2001; 61(11): 1581-91. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11577795
•
Organ failure associated with severe acute pancreatitis. Author(s): Zhu AJ, Shi JS, Sun XJ. Source: World Journal of Gastroenterology : Wjg. 2003 November; 9(11): 2570-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14606099
62
Acute Pancreatitis
•
Outcome analysis of patients with acute pancreatitis by using an artificial neural network. Author(s): Keogan MT, Lo JY, Freed KS, Raptopoulos V, Blake S, Kamel IR, Weisinger K, Rosen MP, Nelson RC. Source: Academic Radiology. 2002 April; 9(4): 410-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11942655
•
Outcome and quality of life of patients with acute pancreatitis requiring intensive care. Author(s): Soran A, Chelluri L, Lee KK, Tisherman SA. Source: The Journal of Surgical Research. 2000 June 1; 91(1): 89-94. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10816356
•
Outcome of necrosectomy in acute pancreatitis: the case for continued vigilance. Author(s): Beattie GC, Mason J, Swan D, Madhavan KK, Siriwardena AK. Source: Scandinavian Journal of Gastroenterology. 2002 December; 37(12): 1449-53. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12523596
•
Outcome of open necrosectomy in acute pancreatitis. Author(s): Bassi C, Butturini G, Falconi M, Salvia R, Frigerio I, Pederzoli P. Source: Pancreatology : Official Journal of the International Association of Pancreatology (Iap). [et Al.]. 2003; 3(2): 128-32. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12748421
•
Patent accessory pancreatic duct prevents acute pancreatitis. Author(s): Kamisawa T, Yoshiike M, Egawa N, Nakajima H. Source: The American Journal of Gastroenterology. 2003 December; 98(12): 2807-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14687842
•
Perforation of a gastrojejunal anastomosis due to acute pancreatitis revealed by helical computed tomography. Author(s): Pinto A, Scaglione M, Romano L. Source: Acta Radiologica (Stockholm, Sweden : 1987). 2003 November; 44(6): 572-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14616199
•
Plasma endothelin and nitric oxide levels in patients with acute pancreatitis. Author(s): Zeng XH, Zhu SQ, Zhang XM, Luo WJ, Li SW. Source: Hepatobiliary Pancreat Dis Int. 2002 February; 1(1): 140-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14607644
Studies
63
•
Portal vein erosion and acute abdominal hemorrhage as a complication of acute pancreatitis. Author(s): Ko HS, Anders M, Diehl S, Dominguez E, Lohr M, Duber C. Source: Abdominal Imaging. 2003 September-October; 28(5): 700-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14628880
•
Predictive value of complement activation fragments C3a and sC5b-9 for development of severe disease in patients with acute pancreatitis. Author(s): Gloor B, Stahel PF, Muller CA, Schmidt OI, Buchler MW, Uhl W. Source: Scandinavian Journal of Gastroenterology. 2003 October; 38(10): 1078-82. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14621284
•
Primary human immunodeficiency virus infection presenting as acute pancreatitis. Author(s): Tyner R, Turett G. Source: Southern Medical Journal. 2004 April; 97(4): 393-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15108835
•
Prognostic value of CT in the early assessment of patients with acute pancreatitis. Author(s): Casas JD, Diaz R, Valderas G, Mariscal A, Cuadras P. Source: Ajr. American Journal of Roentgenology. 2004 March; 182(3): 569-74. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14975947
•
Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Author(s): Isenmann R, Runzi M, Kron M, Kahl S, Kraus D, Jung N, Maier L, Malfertheiner P, Goebell H, Beger HG; German Antibiotics in Severe Acute Pancreatitis Study Group. Source: Gastroenterology. 2004 April; 126(4): 997-1004. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15057739
•
Prophylactic antibiotic use in severe acute pancreatitis: hemlock, help, or hype? Author(s): Brown A. Source: Gastroenterology. 2004 April; 126(4): 1195-8. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15057759
•
Prospective multicentre survey on acute pancreatitis in Italy (ProInf-AISP): results on 1005 patients. Author(s): Cavallini G, Frulloni L, Bassi C, Gabbrielli A, Castoldi L, Costamagna G, De Rai P, Di Carlo V, Falconi M, Pezzilli R, Uomo G; ProInf-AISP Study Group. Source: Dig Liver Dis. 2004 March; 36(3): 205-11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15046191
64
Acute Pancreatitis
•
Red blood cells deformability and oxidative stress in acute pancreatitis. Author(s): Chmiel B, Grabowska Bochenek R, Piskorska D, Skorupa A, Cierpka L, Kusmierski S. Source: Clinical Hemorheology and Microcirculation. 2002; 27(3-4): 155-62. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12454371
•
Redifferentiation and apoptosis of pancreatic cells during acute pancreatitis. Author(s): Iovanna JL. Source: International Journal of Pancreatology : Official Journal of the International Association of Pancreatology. 1996 October; 20(2): 77-84. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8968862
•
Relapses of biliary acute pancreatitis in patients with previous attack of biliary pancreatitis and gallbladder in situ. Author(s): Billi P, Barakat B, D'Imperio N, Pezzilli R. Source: Dig Liver Dis. 2003 September; 35(9): 653-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14563188
•
Results of treating severe acute pancreatitis with gabexate is associated with neutrophil apoptosis activity. Author(s): Chiu DF, Chen JC, Chen HM, Ng CJ, Shyr MH, Chen MF. Source: Hepatogastroenterology. 2003 March-April; 50(50): 553-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12749271
•
Risk factors influencing mortality of patients with severe acute pancreatitis within 24 hours after admission. Author(s): Zhu AJ, Shi JS, Sun XJ. Source: Hepatobiliary Pancreat Dis Int. 2003 August; 2(3): 453-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14599959
•
Risk of acute pancreatitis in users of azathioprine: a population-based case-control study. Author(s): Floyd A, Pedersen L, Nielsen GL, Thorlacius-Ussing O, Sorensen HT. Source: The American Journal of Gastroenterology. 2003 June; 98(6): 1305-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12818274
•
Risk of acute pancreatitis in users of finasteride: a population-based case-control study. Author(s): Floyd A, Pedersen L, Nielsen GL, Thorlacius-Ussing O, Sorensen HT. Source: Journal of Clinical Gastroenterology. 2004 March; 38(3): 276-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15128076
Studies
65
•
Role of cytokines and oxidative stress in the pathophysiology of acute pancreatitis: therapeutical implications. Author(s): Gomez-Cambronero LG, Sabater L, Pereda J, Cassinello N, Camps B, Vina J, Sastre J. Source: Current Drug Targets. Inflammation and Allergy. 2002 December; 1(4): 393-403. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14561185
•
Role of oxygen free radicals in patients with acute pancreatitis. Author(s): Park BK, Chung JB, Lee JH, Suh JH, Park SW, Song SY, Kim H, Kim KH, Kang JK. Source: World Journal of Gastroenterology : Wjg. 2003 October; 9(10): 2266-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14562390
•
Role of the gut in the course of severe acute pancreatitis. Author(s): Ammori BJ. Source: Pancreas. 2003 March; 26(2): 122-9. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12604908
•
Serum alpha 2-macroglobulin-trypsin complex and early recognition of severe acute pancreatitis after endoscopic retrograde pancreatography. Author(s): Nakae Y, Hayakawa T, Kondo T, Shibata T, Kitagawa M, Sakai Y, Sobajima H, Ishiguro H, Tanikawa M. Source: Journal of Gastroenterology and Hepatology. 1994 May-June; 9(3): 272-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7519897
•
Serum complex of trypsin 2 and alpha 1 antitrypsin as diagnostic and prognostic marker of acute pancreatitis: clinical study in consecutive patients. Author(s): Hedstrom J, Sainio V, Kemppainen E, Haapiainen R, Kivilaakso E, Schroder T, Leinonen J, Stenman UH. Source: Bmj (Clinical Research Ed.). 1996 August 10; 313(7053): 333-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8760740
•
Severe acute pancreatitis associated with acute hepatitis A: a case report. Author(s): Batra Y, Chakravarty S, Bhatt G. Source: Trop Gastroenterol. 2003 January-March; 24(1): 27-8. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12974212
•
Severe acute pancreatitis due to hepatitis A virus infection in a patient of acute viral hepatitis. Author(s): Khanna S, Vij JC. Source: Trop Gastroenterol. 2003 January-March; 24(1): 25-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12974211
66
Acute Pancreatitis
•
Should enteral feeding be the standard of care for acute pancreatitis? Author(s): Alsolaiman MM, Green JA, Barkin JS. Source: The American Journal of Gastroenterology. 2003 November; 98(11): 2565-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14638366
•
Spontaneous resolution of a pancreatic-colonic fistula after acute pancreatitis. Author(s): Green BT, Mitchell RM, Branch MS. Source: The American Journal of Gastroenterology. 2003 December; 98(12): 2809-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14687844
•
State-of-the-art imaging of acute pancreatitis. Author(s): Mortele KJ, Banks PA, Silverman SG. Source: Jbr-Btr. 2003 July-August; 86(4): 193-208. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14527059
•
Surgical treatment of severe acute pancreatitis: timing of operation is crucial for survival. Author(s): Gotzinger P, Wamser P, Exner R, Schwanzer E, Jakesz R, Fugger R, Sautner T. Source: Surgical Infections. 2003 Summer; 4(2): 205-11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12906721
•
Systemic lupus erythematosus as a cause and prognostic factor of acute pancreatitis. Author(s): Pascual-Ramos V, Duarte-Rojo A, Villa AR, Hernandez-Cruz B, AlarconSegovia D, Alcocer-Varela J, Robles-Diaz G. Source: The Journal of Rheumatology. 2004 April; 31(4): 707-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15088295
•
Systemic lupus erythematosus-related acute pancreatitis: a case report. Author(s): Fan HC, Cheng SN, Hua YM, Chu CH, Juan CJ, Lee MY, Hung CH. Source: J Microbiol Immunol Infect. 2003 September; 36(3): 212-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14582568
•
Technetium-99m hexamethylpropylene amine oxime leucocyte scintigraphy in the early course of mild acute pancreatitis following endoscopic retrograde cholangiopancreatography. Author(s): Mortensen JC, Jensen JJ, Thorsgaard N. Source: European Journal of Nuclear Medicine. 1996 November; 23(11): 1460-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8854842
Studies
67
•
The ascites to serum amylase ratio identifies two distinct populations in acute pancreatitis with ascites. Author(s): Haas LS, Gates LK Jr. Source: Pancreatology : Official Journal of the International Association of Pancreatology (Iap). [et Al.]. 2002; 2(2): 100-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12123088
•
The biochemical detection of biliary etiology of acute pancreatitis on admission: a revisit in the modern era of biliary imaging. Author(s): Ammori BJ, Boreham B, Lewis P, Roberts SA. Source: Pancreas. 2003 March; 26(2): E32-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12604925
•
The early increase in intestinal permeability and systemic endotoxin exposure in patients with severe acute pancreatitis is not associated with systemic bacterial translocation: molecular investigation of microbial DNA in the blood. Author(s): Ammori BJ, Fitzgerald P, Hawkey P, McMahon MJ. Source: Pancreas. 2003 January; 26(1): 18-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12499912
•
The soluble interleukin-2 receptor, peripheral blood, and reticulocyte fractions in acute pancreatitis. Author(s): Salomone T, Boni P, Serra C, Morselli-Labate AM, Di Gioia AL, Romboli M, Guariento A. Source: International Journal of Pancreatology : Official Journal of the International Association of Pancreatology. 1996 December; 20(3): 197-203. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9013281
•
The usefulness of laboratory tests in the early assessment of severity of acute pancreatitis. Author(s): Rettally CA, Skarda S, Garza MA, Schenker S. Source: Critical Reviews in Clinical Laboratory Sciences. 2003 April; 40(2): 117-49. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12755453
•
The William Nelson ECG quiz: acute pancreatitis. Author(s): Nelson W. Source: Cardiovasc J S Afr. 2002 March-April; 13(2): 77, 84. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12166358
68
Acute Pancreatitis
•
Therapeutic efficacy of high-dose vitamin C on acute pancreatitis and its potential mechanisms. Author(s): Du WD, Yuan ZR, Sun J, Tang JX, Cheng AQ, Shen DM, Huang CJ, Song XH, Yu XF, Zheng SB. Source: World Journal of Gastroenterology : Wjg. 2003 November; 9(11): 2565-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14606098
•
Thrombotic microangiopathy in acute pancreatitis. Author(s): Bong JJ, Ammori BJ, McMahon MJ, Kumar A, Turney JH, Norfolk DR. Source: Pancreas. 2002 July; 25(1): 107-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12131780
•
Trypsinogen-2 and trypsinogen activation peptide (TAP) in urine of patients with acute pancreatitis. Author(s): Lempinen M, Stenman UH, Finne P, Puolakkainen P, Haapiainen R, Kemppainen E. Source: The Journal of Surgical Research. 2003 May 15; 111(2): 267-73. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12850473
•
Ultrasonographic splanchnic arterial flow measurement in severe acute pancreatitis. Author(s): Sakagami J, Kataoka K, Sogame Y, Usui N, Mitsuyoshi M. Source: Pancreas. 2002 May; 24(4): 357-64. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11961488
•
Ultrathin cutting needle biopsy histology in the tissue diagnosis of acute pancreatitis-experimental study and application in a human case. Author(s): He ZJ, Alho H, Harmoinen A, Sand J, Nordback I. Source: International Journal of Surgical Investigation. 2000; 1(5): 441-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11341600
•
Understanding the care of patients with acute pancreatitis. Author(s): Hughes E. Source: Nursing Standard : Official Newspaper of the Royal College of Nursing. 2004 January 14-20; 18(18): 45-52; Quiz 54-5. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14768233
•
Unraveling the mystery of acute pancreatitis. Author(s): Cole L. Source: Dimensions of Critical Care Nursing : Dccn. 2002 May-June; 21(3): 86-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12042691
Studies
69
•
Unraveling the mystery of acute pancreatitis. Author(s): Cole L. Source: Nursing. 2001 December; 31(12): 58-63; Quiz 64. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11921720
•
Urinary trypsinogen activation peptide is more accurate than hematocrit in determining severity in patients with acute pancreatitis: a prospective study. Author(s): Khan Z, Vlodov J, Horovitz J, Jose RM, Iswara K, Smotkin J, Brown A, Tenner S. Source: The American Journal of Gastroenterology. 2002 August; 97(8): 1973-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12190163
•
Use of antioxidants to treat pain in patients with acute pancreatitis. Author(s): Ladero JM. Source: Rev Esp Enferm Dig. 2000 June; 92(6): 371-4. English, Spanish. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10985096
•
Use of endoscopic naso-pancreatic drainage in the treatment of severe acute pancreatitis. Author(s): Quan ZF, Wang ZM, Li WQ, Li JS. Source: World Journal of Gastroenterology : Wjg. 2003 April; 9(4): 868-70. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12679951
•
Useful markers for predicting severity and monitoring progression of acute pancreatitis. Author(s): Werner J, Hartwig W, Uhl W, Muller C, Buchler MW. Source: Pancreatology : Official Journal of the International Association of Pancreatology (Iap). [et Al.]. 2003; 3(2): 115-27. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12748420
•
Usefulness of endoscopic ultrasonography in patients with "idiopathic" acute pancreatitis. Author(s): Frossard JL, Sosa-Valencia L, Amouyal G, Marty O, Hadengue A, Amouyal P. Source: The American Journal of Medicine. 2000 August 15; 109(3): 196-200. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10974181
•
Valproate-associated acute pancreatitis in a child with neuronal ceroid lipofuscinosis. Author(s): Talwar D. Source: Journal of Child Neurology. 1994 January; 9(1): 36-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8151078
70
Acute Pancreatitis
•
Value of early blood Th-1 cytokine determination in predicting severity of acute pancreatitis. Author(s): Heresbach D, Letourneur JP, Bahon I, Pagenault M, Guillou YM, Dyard F, Fauchet R, Malledant Y, Bretagne JF, Gosselin M. Source: Scandinavian Journal of Gastroenterology. 1998 May; 33(5): 554-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9648999
•
Variations in implementation of current national guidelines for the treatment of acute pancreatitis: implications for acute surgical service provision. Author(s): Barnard J, Siriwardena AK. Source: Annals of the Royal College of Surgeons of England. 2002 March; 84(2): 79-81. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11995768
•
Varicella infection as a cause of acute pancreatitis in an immunocompetent child. Author(s): Torre JA, Martin JJ, Garcia CB, Polo ER. Source: The Pediatric Infectious Disease Journal. 2000 December; 19(12): 1218-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11144392
•
Vascular complications in acute pancreatitis assessed by color duplex ultrasonography. Author(s): Dorffel T, Wruck T, Ruckert RI, Romaniuk P, Dorffel Q, Wermke W. Source: Pancreas. 2000 August; 21(2): 126-33. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10975705
•
Vitamin C status in patients with acute pancreatitis. Author(s): Scott P, Bruce C, Schofield D, Shiel N, Braganza JM, McCloy RF. Source: The British Journal of Surgery. 1993 June; 80(6): 750-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8330166
•
Von Hippel-Lindau disease complicated by acute pancreatitis and Evan's syndrome. Author(s): Tenner S, Roston A, Lichtenstein D, Sica G, Carr-Locke D, Banks PA. Source: International Journal of Pancreatology : Official Journal of the International Association of Pancreatology. 1995 December; 18(3): 271-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8708400
•
Wandering spleen presenting as acute pancreatitis in pregnancy. Author(s): Gilman RS, Thomas RL. Source: Obstetrics and Gynecology. 2003 May; 101(5 Pt 2): 1100-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12738115
Studies
71
•
Wegener's granulomatosis with onset of acute pancreatitis and rapid progress. A case report. Author(s): Matsubayashi H, Seki T, Niki S, Mizumura Y, Taguchi Y, Moriyasu F, Go K. Source: Pancreatology : Official Journal of the International Association of Pancreatology (Iap). [et Al.]. 2001; 1(3): 263-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12120205
•
Wernicke's encephalopathy: a complication of acute pancreatitis? Author(s): Lee YD, Lee SO, Lee ST. Source: Hosp Med. 2003 June; 64(6): 372-3. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12833836
•
What is the best biochemical test to diagnose acute pancreatitis? A prospective clinical study. Author(s): Sternby B, O'Brien JF, Zinsmeister AR, DiMagno EP. Source: Mayo Clinic Proceedings. 1996 December; 71(12): 1138-44. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8945483
•
When should radiologists intervene in management of pancreatic pseudocysts and other complications of acute pancreatitis? Author(s): Wittich GR, vanSonnenberg E. Source: Ajr. American Journal of Roentgenology. 1996 January; 166(1): 211. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8571881
•
Which etiology causes the most severe acute pancreatitis? Author(s): Lankisch PG, Assmus C, Pflichthofer D, Struckmann K, Lehnick D. Source: International Journal of Pancreatology : Official Journal of the International Association of Pancreatology. 1999 October; 26(2): 55-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10597400
•
Why clinical trials might succeed in acute pancreatitis when they failed in septic shock. Author(s): Frossard JL, Morel P, Pastor CM. Source: Jop [electronic Resource] : Journal of the Pancreas. 2003 January; 4(1): 11-6. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12555010
73
CHAPTER 2. NUTRITION AND ACUTE PANCREATITIS Overview In this chapter, we will show you how to find studies dedicated specifically to nutrition and acute pancreatitis.
Finding Nutrition Studies on Acute Pancreatitis The National Institutes of Health’s Office of Dietary Supplements (ODS) offers a searchable bibliographic database called the IBIDS (International Bibliographic Information on Dietary Supplements; National Institutes of Health, Building 31, Room 1B29, 31 Center Drive, MSC 2086, Bethesda, Maryland 20892-2086, Tel: 301-435-2920, Fax: 301-480-1845, E-mail:
[email protected]). The IBIDS contains over 460,000 scientific citations and summaries about dietary supplements and nutrition as well as references to published international, scientific literature on dietary supplements such as vitamins, minerals, and botanicals.7 The IBIDS includes references and citations to both human and animal research studies. As a service of the ODS, access to the IBIDS database is available free of charge at the following Web address: http://ods.od.nih.gov/databases/ibids.html. After entering the search area, you have three choices: (1) IBIDS Consumer Database, (2) Full IBIDS Database, or (3) Peer Reviewed Citations Only. Now that you have selected a database, click on the “Advanced” tab. An advanced search allows you to retrieve up to 100 fully explained references in a comprehensive format. Type “acute pancreatitis” (or synonyms) into the search box, and click “Go.” To narrow the search, you can also select the “Title” field.
7
Adapted from http://ods.od.nih.gov. IBIDS is produced by the Office of Dietary Supplements (ODS) at the National Institutes of Health to assist the public, healthcare providers, educators, and researchers in locating credible, scientific information on dietary supplements. IBIDS was developed and will be maintained through an interagency partnership with the Food and Nutrition Information Center of the National Agricultural Library, U.S. Department of Agriculture.
74
Acute Pancreatitis
The following information is typical of that found when using the “Full IBIDS Database” to search for “acute pancreatitis” (or a synonym): •
Animal model of acute pancreatitis induced by synthetic prooxidant. Author(s): Medical University, Gdansk (Poland) I.N.R.C.A. and Biancalana Mazera Foundation, Ancona (Italy) Ancona University, (Italy) Source: Sledzinski, Z. Stanek, A. Wajda, Z. Wozniak, M. Brunelli, A. Scutti, G. Bertoil, E. Lezoche, E. Polish-Journal-of-Environmental-Studies (Poland). (1998). volume 7(6) page 373.
Additional physician-oriented references include: •
Absence of endogenous interleukin-6 enhances the inflammatory response during acute pancreatitis induced by cerulein in mice. Author(s): Institute of Pharmacology, School of Medicine, University of Messina, Italy.
[email protected] Source: Cuzzocrea, S Mazzon, E Dugo, L Centorrino, T Ciccolo, A McDonald, M C de Sarro, A Caputi, A P Thiemermann, C Cytokine. 2002 June 7; 18(5): 274-85 1043-4666
•
Acute pancreatitis after morphine administration. Source: Famularo, G Pozzessere, C Polchi, S De Simone, C Ital-J-Gastroenterol-Hepatol. 1999 Aug-September; 31(6): 522-3 1125-8055
•
Acute pancreatitis in a multi-ethnic population. Author(s): Department of Surgery, Perak College of Medicine, Malaysia.
[email protected] Source: Kandasami, P Harunarashid, H Kaur, H Singapore-Med-J. 2002 June; 43(6): 2848 0037-5675
•
Acute pancreatitis secondary to isotretinoin-induced hyperlipidemia. Author(s): St. Anthony Hospital, 608 NW 9th Street, Suite 4100, Oklahoma City, OK 73102, USA. Source: Jamshidi, Mohammad Obermeyer, Robert J Govindaraj, Satish Garcia, Armand Ghani, Abdul J-Okla-State-Med-Assoc. 2002 February; 95(2): 79-80 0030-1876
•
Acute pancreatitis. Hillbrow Hospital experience. Source: D'Egidio, A S-Afr-J-Surg. 1988 December; 26(4): 163-5 0038-2361
•
Acute pancreatitis-induced hypomagnesemia. Author(s): Department of Internal Medicine, Medical School, University of Ioannina, GR-451 10 Ioannina, Greece. Source: Liamis, G Gianoutsos, C Elisaf, M Pancreatology. 2001; 1(1): 74-6 1424-3903
•
Caerulein-induced acute pancreatitis in rats: changes in glycoprotein-composition of subcellular membrane systems in acinar cells. Author(s): Department of Internal Medicine, Philipps-University Marburg, Federal Republic of Germany. Source: Willemer, S Bialek, R Kohler, H Adler, G Histochemistry. 1990; 95(1): 87-96 03015564
•
CFTR gene mutations in patients suffering from acute pancreatitis. Author(s): Department of Human Genetics, Medical University, Lublin, Poland. Source: Kostuch, M Rudzki, S Semczuk, A Kulczycki, L Med-Sci-Monit. 2002 September; 8(9): BR369-72 1234-1010
Nutrition
75
•
Changes of plasma levels of gastrointestinal peptides over the course of acute pancreatitis. Any significance for the pathophysiology and treatment of acute pancreatitis? Author(s): 1st Department of Propedeutic Medicine, University of Athens, Medical School, Athens, Greece. Source: Nikou, G C Giamarellos Bourboulis, E J Toumpanakis, C Arnaoutis, T P Kitsou, E Kyriaki, D Katsilambros, N Hepatogastroenterology. 2002 May-June; 49(45): 706-8 0172-6390
•
Conservative treatment of acute pancreatitis: the use of somatostatin. Author(s): 2nd Department of Internal Medicine-Propaedeutic, Athens University, Evangelismos Hospital, Greece. Source: Ladas, S D Raptis, S A Hepatogastroenterology. 1992 October; 39(5): 466-9 01726390
•
Early acinar cell changes in caerulein-induced interstitial acute pancreatitis in the rat. Author(s): Department of Pathology, University of Turku, Finland. Source: Gronroos, J M Aho, H J Hietaranta, A J Nevalainen, T J Exp-Pathol. 1991; 41(1): 21-30 0232-1513
•
Early jejunal nutrition and changes in the immunological parameters of patients with acute pancreatitis. Author(s): Second Department of Surgery, University of Debrecen, Debrecen, Moricz Zs. str. 22., 4004 Debrecen, Hungary.
[email protected] Source: Hallay, J Kovacs, G Szatmari, K Bako, A Szentkereszty, Z Lakos, G Sipka, S Sapy, P Hepatogastroenterology. 2001 Sep-October; 48(41): 1488-92 0172-6390
•
Effect of different regimens of gut decontamination on bacterial translocation and mortality in experimental acute pancreatitis. Author(s): Department of Surgery, University of Cincinnati, School of Medicine, Ohio, USA. Source: Gianotti, L Munda, R Gennari, R Pyles, R Alexander, J W Eur-J-Surg. 1995 February; 161(2): 85-92 1102-4151
•
Effect of platelet-activating factor antagonists (BN-52021, WEB-2170, and BB-882) on bacterial translocation in acute pancreatitis. Author(s): Department of Gastroenterology, Sao Paulo University Medical School, Rua Maria Jesus de Simoes, 48 Lauzanne Paulista, 02469-010 Sao Paulo SP, Brazil.
[email protected] Source: de Souza, L J Sampietre, S N Assis, R S Knowles, C H Leite, K R Jancar, S Monteiro Cunha, J E Machado, M C J-Gastrointest-Surg. 2001 Jul-August; 5(4): 364-70 1091-255X
•
Effects of short-term administration of the CCK receptor antagonist, KSG-504, on regeneration of pancreatic acinar cells in acute pancreatitis in rats. Author(s): Department of Internal Medicine, Shiga University of Medical Science, Japan. Source: Okumura, Y Inoue, H Fujiyama, Y Bamba, T J-Gastroenterol. 1995 August; 30(4): 493-9 0944-1174
•
Effects of Tetrandrine and QYT on ICAM-1 and SOD gene expression in pancreas and liver of rats with acute pancreatitis. Author(s): Department of Pathophysiology, Medical College of Tongji University, Shanghai 200331, China.
[email protected] Source: Li, Y Y Li, X L Yang, C X Zhong, H Yao, H Zhu, L World-J-Gastroenterol. 2003 January; 9(1): 155-9 1007-9327
76
Acute Pancreatitis
•
Evidence for extraluminal trypsinogen activation in three different models of acute pancreatitis. Author(s): Department of Surgery, Massachusetts General Hospital, Boston 02114. Source: Foitzik, T Lewandrowski, K B Fernandez del Castillo, C Rattner, D W Warshaw, A L Surgery. 1994 June; 115(6): 698-702 0039-6060
•
Exocrine pancreatic disease in the dog and cat. 1. Acute pancreatitis. Source: Pidgeon, G. Companion-Anim-Pract. Santa Barbara, Calif. : Veterinary Practice Publishing Co. March 1987. volume 1 (1) page 67, 70-71. 0894-9794
•
Feeding a cat with acute pancreatitis. Author(s): University of Florida, Gainesville, FL. Source: Hill, R. North-American-Veterinary-Conference (USA). (1996). volume 10 page 320-321. cats animal nutrition pancreatitis
•
Gallium-67 scintigraphy in acute pancreatitis. Author(s): Mubarak Al-Kabeer Hospital, Ministry of Public Health, Kuwait. Source: al Suhaili, A R Wafai, I Bahar, R Nawaz, K Nema, T A Eriksson, S Higazi, E Abdel Dayem, H M Eur-J-Nucl-Med. 1988; 14(1): 8-11 0340-6997
•
Histoprotective effect of antihypoxant olifen during experimental acute pancreatitis. Author(s): I. I. Dzhanelidze St. Petersburg Institute of Ambulance Service. Source: Tolstoi, A D Dzhurko, B I Vashetko, R V Medvedev, Y V Gol'tsov, V R DvoiNovember, V G Zakharova, E V Bull-Exp-Biol-Med. 2001 April; 131(4): 312-4 00074888
•
Induction of heat shock proteins fails to produce protection against trypsin-induced acute pancreatitis in rats. Author(s): First Department of Medicine, University of Szeged, Hungary.
[email protected] Source: Rakonczay, Z Jr Takacs, T Ivanyi, B Mandi, Y Papai, G Boros, I Varga, I Jost, K Lonovics, J Clin-Exp-Med. 2002 July; 2(2): 89-97 1591-8890
•
Influence of somatostatin on acute pancreatitis in rats. Author(s): Department of Surgery, Hopital de la Timone, Marseille, France. Source: Berthet, B Guillou, N Brioche, M I Choux, R Viret, P Ledoray, V Billardon, M Assadourian, R Eur-J-Surg. 1998 October; 164(10): 785-90 1102-4151
•
Nitric oxide, heparin and procaine treatment in experimental ceruleine-induced acute pancreatitis in rats. Author(s): 2nd Department of General, Gastroenterological and Endocrine Surgery, University Medical School, Gdansk, Poland. Source: Dobosz, M Wajda, Z Hac, S Mysliwska, J Bryl, E Mionskowska, L Roszkiewicz, A Mysliwski, A Arch-Immunol-Ther-Exp-(Warsz). 1999; 47(3): 155-60 0004-069X
•
Nutrition in patients with acute pancreatitis. Author(s): Department of Surgery, Academic Hospital Maastricht, NL-6202 Maastricht, The Netherlands.
[email protected] Source: Dejong, C H Greve, J W Soeters, P B Curr-Opin-Crit-Care. 2001 August; 7(4): 251-6 1070-5295
•
Nutritional management of patients with feeding-induced pain: acute pancreatitis. Author(s): Cleveland Clinic Foundation, OH, USA. Source: Seidner, D L Fish, J A Semin-Gastrointest-Dis. 1998 October; 9(4): 200-9 10495118
Nutrition
77
•
Oxidative stress in acute pancreatitis. Author(s): Department of Surgery, Otto-von-Guericke-University of Magdeburg, Germany.
[email protected] Source: Schulz, H U Niederau, C Klonowski Stumpe, H Halangk, W Luthen, R Lippert, H Hepatogastroenterology. 1999 Sep-October; 46(29): 2736-50 0172-6390
•
Pancreatic head mass: how can we treat it? Acute pancreatitis: conservative treatment. Author(s): Internal Medicine Department, 3rd Division, Cardarelli Hospital. Napoli, Italy.
[email protected] Source: Uomo, G JOPage 2000 September; 1(3 Suppl): 130-7 1590-8577
•
Pathogenesis of acute pancreatitis. Author(s): Department of Surgery, Charles A. Dana Research Laboratories, Boston, Massachusetts. Source: Steer, M L Meldolesi, J Annu-Rev-Med. 1988; 3995-105 0066-4219
•
Possible role of cholecystokinin in the development of acute pancreatitis in rats. Source: Shinya, H Fujimura, M Nippon-Geka-Hokan. 1989 January 1; 58(1): 3-17 00039152
•
Protecting effects of intravenous insoluble glycogen treatment on the experimental necrotizing acute pancreatitis of dogs. Author(s): 3rd Department of Internal Medicine, University Medical School of Debrecen. Source: Sipka, S Sapy, P Bot, G Furka, I Miko, I Arkossy, P Dauda, G Szappanos, M Kovacs, J Lakos, G Szegedi, G Hepatogastroenterology. 1997 Jan-February; 44(13): 12732 0172-6390
•
Secondary pancreatic involvement by diffuse large B-cell lymphoma presenting as acute pancreatitis: treatment and outcome. Author(s): Department of Gastroenterology and Hepatology, Henry Mondor University Hospital, Creteil, France. Source: Bernardeau, M Auroux, J Cavicchi, M Haioun, C Tsakiris, L Delchier, J C Pancreatology. 2002; 2(4): 427-30 1424-3903
•
Severe acute pancreatitis: treatment with somatostatin. Author(s): Intensive Care Unit, Hospital General Universitari Vall d'Hebron, Barcelona, Spain. Source: Planas, M Perez, A Iglesia, R Porta, I Masclans, J R Bermejo, B Intensive-CareMed. 1998 January; 24(1): 37-9 0342-4642
•
Somatostatin and octreotide in acute pancreatitis: the never-ending story. Author(s): Department of Surgical and Gastroenterological Sciences, University of Verona, Italy. Source: Cavallini, G Frulloni, L Dig-Liver-Dis. 2001 March; 33(2): 192-201
•
Somatostatin prevents acute pancreatitis after pancreatic duct sphincter hydrostatic balloon dilation in patients with idiopathic recurrent pancreatitis. Author(s): Gastroenterology Department, Hospital General del Oeste, M.S.A.S. Los Magallanes, Catia, Caracas, Venezuela. Source: Guelrud, M Mendoza, S Viera, L Gelrud, D Gastrointest-Endosc. 1991 JanFebruary; 37(1): 44-7 0016-5107
•
The effect of fat-rich diet and chronic ethanol ingestion on ascitic fluid and plasma enzyme activities in acute pancreatitis in rats. Source: Ramo, O J Jalovaara, P Makela, A Schroder, T Acta-Chir-Scand. 1987 March; 153(3): 203-7 0001-5482
78
Acute Pancreatitis
•
The influence of nifedipine (calcium channel blocker) and Bay-K-8644 (calcium channel agonist) on the development of experimental acute pancreatitis. Author(s): Dept. of Gastroenterology, Medical University of Lublin. Source: Slomka, M Celinski, K Wargocki, J Kleinrok, Z Czerny, K Cichoz Lach, H AnnUniv-Mariae-Curie-Sklodowska-[Med]. 2001; 56: 29-34 0066-2240
•
The role of oxygen-derived free radicals in two models of experimental acute pancreatitis: effects of catalase, superoxide dismutase, dimethylsulfoxide, and allopurinol. Author(s): Department of Surgery, Beth Israel Hospital, Boston. Source: Steer, M L Rutledge, P L Powers, R E Saluja, M Saluja, A K Klin-Wochenschr. 1991 December 15; 69(21-23): 1012-7 0023-2173
•
The role of prostaglandins in acute pancreatitis. Source: Glazer, G Gilliland, E L Aldridge, M A Surg-Annu. 1987; 19175-203 0081-9638
•
Thyroid function in acute pancreatitis. Author(s): Department of Digestive Medicine, Costa del Sol Hospital, Marbella, Malaga, Spain. Source: De Sola, C Redondo, M Pallares, F Redondo, E Hortas, M L Morell, M Rev-EspEnferm-Dig. 1998 January; 90(1): 15-22 1130-0108
•
Time course of malonic dialdehyde and alpha-tocopherol in rat pancreas during the first hours of acute pancreatitis. Author(s): Institute of Molecular Biology and Biophysics, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk. Source: Prokop'eva, N V Gulyaeva, L F Kolosova, N G Bull-Exp-Biol-Med. 2000 May; 129(5): 452-4 0007-4888
•
Timing of tumor necrosis factor antagonism is critical in determining outcome in murine lethal acute pancreatitis. Author(s): Department of Surgery, University of South Florida, Tampa 33612, USA. Source: Norman, J G Fink, G W Messina, J Carter, G Franz, M G Surgery. 1996 September; 120(3): 515-21 0039-6060
•
Use of a synthetic protease inhibitor for the treatment of L-asparaginase-induced acute pancreatitis complicated by disseminated intravascular coagulation. Author(s): First Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan. Source: Murakawa, M Okamura, T Shibuya, T Harada, M Otsuka, T Niho, Y AnnHematol. 1992 May; 64(5): 249-52 0939-5555
Federal Resources on Nutrition In addition to the IBIDS, the United States Department of Health and Human Services (HHS) and the United States Department of Agriculture (USDA) provide many sources of information on general nutrition and health. Recommended resources include: •
healthfinder®, HHS’s gateway to health information, including diet and nutrition: http://www.healthfinder.gov/scripts/SearchContext.asp?topic=238&page=0
•
The United States Department of Agriculture’s Web site dedicated to nutrition information: www.nutrition.gov
Nutrition
79
•
The Food and Drug Administration’s Web site for federal food safety information: www.foodsafety.gov
•
The National Action Plan on Overweight and Obesity sponsored by the United States Surgeon General: http://www.surgeongeneral.gov/topics/obesity/
•
The Center for Food Safety and Applied Nutrition has an Internet site sponsored by the Food and Drug Administration and the Department of Health and Human Services: http://vm.cfsan.fda.gov/
•
Center for Nutrition Policy and Promotion sponsored by the United States Department of Agriculture: http://www.usda.gov/cnpp/
•
Food and Nutrition Information Center, National Agricultural Library sponsored by the United States Department of Agriculture: http://www.nal.usda.gov/fnic/
•
Food and Nutrition Service sponsored by the United States Department of Agriculture: http://www.fns.usda.gov/fns/
Additional Web Resources A number of additional Web sites offer encyclopedic information covering food and nutrition. The following is a representative sample: •
AOL: http://search.aol.com/cat.adp?id=174&layer=&from=subcats
•
Family Village: http://www.familyvillage.wisc.edu/med_nutrition.html
•
Google: http://directory.google.com/Top/Health/Nutrition/
•
Healthnotes: http://www.healthnotes.com/
•
Open Directory Project: http://dmoz.org/Health/Nutrition/
•
Yahoo.com: http://dir.yahoo.com/Health/Nutrition/
•
WebMDHealth: http://my.webmd.com/nutrition
•
WholeHealthMD.com: http://www.wholehealthmd.com/reflib/0,1529,00.html
The following is a specific Web list relating to acute pancreatitis; please note that any particular subject below may indicate either a therapeutic use, or a contraindication (potential danger), and does not reflect an official recommendation: •
Food and Diet Beef Source: Healthnotes, Inc.; www.healthnotes.com Kiwi Source: Healthnotes, Inc.; www.healthnotes.com
81
CHAPTER 3. ALTERNATIVE MEDICINE AND ACUTE PANCREATITIS Overview In this chapter, we will begin by introducing you to official information sources on complementary and alternative medicine (CAM) relating to acute pancreatitis. At the conclusion of this chapter, we will provide additional sources.
National Center for Complementary and Alternative Medicine The National Center for Complementary and Alternative Medicine (NCCAM) of the National Institutes of Health (http://nccam.nih.gov/) has created a link to the National Library of Medicine’s databases to facilitate research for articles that specifically relate to acute pancreatitis and complementary medicine. To search the database, go to the following Web site: http://www.nlm.nih.gov/nccam/camonpubmed.html. Select “CAM on PubMed.” Enter “acute pancreatitis” (or synonyms) into the search box. Click “Go.” The following references provide information on particular aspects of complementary and alternative medicine that are related to acute pancreatitis: •
A randomized double-blind study using CaNa2EDTA, a phospholipase A2 inhibitor, in the management of human acute pancreatitis. Author(s): Tykka HT, Vaittinen EJ, Mahlberg KL, Railo JE, Pantzar PJ, Sarna S, Tallberg T. Source: Scandinavian Journal of Gastroenterology. 1985 January; 20(1): 5-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3922048
•
Acute pancreatitis associated with chemotherapy for germ cell tumors in two patients. Author(s): Socinski MA, Garnick MB. Source: Annals of Internal Medicine. 1988 April; 108(4): 567-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2450502
82
Acute Pancreatitis
•
Acute pancreatitis causing death in a child on the ketogenic diet. Author(s): Stewart WA, Gordon K, Camfield P. Source: Journal of Child Neurology. 2001 September; 16(9): 682. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11575609
•
Acute pancreatitis induced by diffuse pancreatic invasion of adult T-cell leukemia/lymphoma cells. Author(s): Mori A, Kikuchi Y, Motoori S, Watanabe J, Shinozaki M, Eguchi M. Source: Digestive Diseases and Sciences. 2003 October; 48(10): 1979-83. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14627344
•
Alterations in intestinal function in acute pancreatitis in an experimental model. Author(s): Wang XD, Wang Q, Andersson R, Ihse I. Source: The British Journal of Surgery. 1996 November; 83(11): 1537-43. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9026331
•
An observational study of severe hypertriglyceridemia, hypertriglyceridemic acute pancreatitis, and failure of triglyceride-lowering therapy when estrogens are given to women with and without familial hypertriglyceridemia. Author(s): Goldenberg NM, Wang P, Glueck CJ. Source: Clinica Chimica Acta; International Journal of Clinical Chemistry. 2003 June; 332(1-2): 11-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12763274
•
Cerulein-induced acute pancreatitis in the rat is significantly ameliorated by treatment with MEK1/2 inhibitors U0126 and PD98059. Author(s): Clemons AP, Holstein DM, Galli A, Saunders C. Source: Pancreas. 2002 October; 25(3): 251-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12370536
•
Cholecystokinin cleavage to cholecystokinin-octapeptide in vivo and in vitro: accelerated cleavage in acute pancreatitis. Author(s): Springer CJ, Calam J. Source: Gastroenterology. 1988 July; 95(1): 143-50. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2453390
•
Controlled trial of high-dose octreotide in treatment of acute pancreatitis. Evidence of improvement in disease severity. Author(s): Beechey-Newman N. Source: Digestive Diseases and Sciences. 1993 April; 38(4): 644-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8462363
Alternative Medicine 83
•
Cytostatics in the treatment of chronic and acute pancreatitis. Author(s): Popiela T, Turczynowski W, Zajac A. Source: Hepatogastroenterology. 1980 October; 27(5): 390-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7009361
•
Effect of Qingyitang on activity of intracellular Ca2+-Mg2+-ATPase in rats with acute pancreatitis. Author(s): Qiu Y, Li YY, Li SG, Song BG, Zhao GF. Source: World Journal of Gastroenterology : Wjg. 2004 January; 10(1): 100-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14695778
•
Effects of green tea catechins (Polyphenon 100) on cerulein-induced acute pancreatitis in rats. Author(s): Takabayashi F, Harada N. Source: Pancreas. 1997 April; 14(3): 276-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9094158
•
Effects of Tetrandrine and QYT on ICAM-1 and SOD gene expression in pancreas and liver of rats with acute pancreatitis. Author(s): Li YY, Li XL, Yang CX, Zhong H, Yao H, Zhu L. Source: World Journal of Gastroenterology : Wjg. 2003 January; 9(1): 155-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12508373
•
Emblica officinalis: a novel therapy for acute pancreatitis--an experimental study. Author(s): Thorat SP, Rege NN, Naik AS, Thatte UM, Joshi A, Panicker KN, Bapat RD, Dahanukar SA. Source: Hpb Surg. 1995; 9(1): 25-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8857450
•
Foreign serum-induced pancreatitis in mice. I. A new model of acute pancreatitis. Author(s): Janigan DT, Nevalainen TJ, MacAulay MA, Vethamany VG. Source: Laboratory Investigation; a Journal of Technical Methods and Pathology. 1975 December; 33(6): 591-607. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1202281
•
Formalized therapeutic guideline for hyperlipidemic severe acute pancreatitis. Author(s): Mao EQ, Tang YQ, Zhang SD. Source: World Journal of Gastroenterology : Wjg. 2003 November; 9(11): 2622-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14606112
•
Guidelines for treatment of severe acute pancreatitis. Author(s): Wu XN.
84
Acute Pancreatitis
Source: Hepatobiliary Pancreat Dis Int. 2002 August; 1(3): 446-51. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14607725 •
High dose octreotide in the management of acute pancreatitis. Author(s): Karakoyunlar O, Sivrel E, Tanir N, Denecli AG. Source: Hepatogastroenterology. 1999 May-June; 46(27): 1968-72. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10430379
•
Hyperbaric oxygen therapy in the treatment of refractory peripancreatic abscess associated with severe acute pancreatitis. Author(s): Izawa K, Tsunoda T, Ura K, Yamaguchi T, Ito T, Kanematsu T, Tsuchiya R. Source: Gastroenterol Jpn. 1993 April; 28(2): 284-91. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8486216
•
Hyperbaric oxygen, allopurinol, and diet-induced acute pancreatitis. Author(s): Degertekin H, Ertan A, Yater RD, Van Meter K, Akdamar K. Source: Annals of Internal Medicine. 1985 September; 103(3): 474-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=4026099
•
Letter 1: Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis (Br J Surg 2002; 89: 11031107). Author(s): Weale R, Edwards A. Source: The British Journal of Surgery. 2003 January; 90(1): 122-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12520591
•
Mechanisms of Chinese herb emodin and somatostatin analogs on pancreatic regeneration in acute pancreatitis in rats. Author(s): Gong Z, Yuan Y, Lou K, Tu S, Zhai Z, Xu J. Source: Pancreas. 2002 August; 25(2): 154-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12142738
•
Pancreatic microvascular permeability in caerulein-induced acute pancreatitis. Author(s): Sweiry JH, Mann GE. Source: The American Journal of Physiology. 1991 October; 261(4 Pt 1): G685-92. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1928354
•
Pathological events in experimental acute pancreatitis prevented by the bradykinin antagonist, Hoe 140. Author(s): Griesbacher T, Tiran B, Lembeck F.
Alternative Medicine 85
Source: British Journal of Pharmacology. 1993 February; 108(2): 405-11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8448591 •
Patient with gemfibrozil-controlled hypertriglyceridemia that developed acute pancreatitis after starting ketogenic diet. Author(s): Buse GJ, Riley KD, Dress CM, Neumaster TD. Source: Current Surgery. 2004 March-April; 61(2): 224-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15051269
•
Phospholipase A2 inhibitors and their possible clinical use in the treatment of acute pancreatitis. Author(s): Tykka H, Mahlberg K, Pantzar P, Tallberg T. Source: Scandinavian Journal of Gastroenterology. 1980; 15(5): 519-28. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6777862
•
Phospholipase activity in pancreatic exudate in experimental acute pancreatitis. Author(s): Gjone E, Ofstad E, Marton PF, Amundsen E. Source: Scandinavian Journal of Gastroenterology. 1967; 2(3): 181-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=4963682
•
Protective effect of a microtubule stabilizer taxol on caerulein-induced acute pancreatitis in rat. Author(s): Ueda T, Takeyama Y, Kaneda K, Adachi M, Ohyanagi H, Saitoh Y. Source: The Journal of Clinical Investigation. 1992 January; 89(1): 234-43. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1370296
•
Protective effects of rhubarb on experimental severe acute pancreatitis. Author(s): Zhao YQ, Liu XH, Ito T, Qian JM. Source: World Journal of Gastroenterology : Wjg. 2004 April 1; 10(7): 1005-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15052683
•
Secondary pancreatic involvement by diffuse large B-cell lymphoma presenting as acute pancreatitis: treatment and outcome. Author(s): Bernardeau M, Auroux J, Cavicchi M, Haioun C, Tsakiris L, Delchier JC. Source: Pancreatology : Official Journal of the International Association of Pancreatology (Iap). [et Al.]. 2002; 2(4): 427-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12138234
•
The effect of combination therapy of hyperbaric oxygen, meropenem, and selective nitric oxide synthase inhibitor in experimental acute pancreatitis. Author(s): Isik AT, Mas MR, Comert B, Yasar M, Korkmaz A, Akay C, Deveci S, Tasci I, Mas N, Ates Y, Kocar IH.
86
Acute Pancreatitis
Source: Pancreas. 2004 January; 28(1): 53-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14707730 •
The effects of free oxygen radical scavenger and platelet-activating factor antagonist agents in experimental acute pancreatitis. Author(s): Soybir G, Koksoy F, Ekiz F, Yalcin O, Fincan K, Haklar G, Yuksel M. Source: Pancreas. 1999 August; 19(2): 143-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10438161
•
The effects of green tea catechins (Polyphenon) on DL-ethionine-induced acute pancreatitis. Author(s): Takabayashi F, Harada N, Hara Y. Source: Pancreas. 1995 August; 11(2): 127-31. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7479668
•
Therapeutic efficacy of high-dose vitamin C on acute pancreatitis and its potential mechanisms. Author(s): Du WD, Yuan ZR, Sun J, Tang JX, Cheng AQ, Shen DM, Huang CJ, Song XH, Yu XF, Zheng SB. Source: World Journal of Gastroenterology : Wjg. 2003 November; 9(11): 2565-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14606098
•
Treatment of acute pancreatitis with liyi tang--a report of 50 cases. Author(s): Chen Q, Lu J. Source: J Tradit Chin Med. 1997 December; 17(4): 250-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10437205
•
Use of a synthetic protease inhibitor for the treatment of L-asparaginase-induced acute pancreatitis complicated by disseminated intravascular coagulation. Author(s): Murakawa M, Okamura T, Shibuya T, Harada M, Otsuka T, Niho Y. Source: Annals of Hematology. 1992 May; 64(5): 249-52. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1623061
Additional Web Resources A number of additional Web sites offer encyclopedic information covering CAM and related topics. The following is a representative sample: •
Alternative Medicine Foundation, Inc.: http://www.herbmed.org/
•
AOL: http://search.aol.com/cat.adp?id=169&layer=&from=subcats
•
Chinese Medicine: http://www.newcenturynutrition.com/
•
drkoop.com: http://www.drkoop.com/InteractiveMedicine/IndexC.html
Alternative Medicine 87
•
Family Village: http://www.familyvillage.wisc.edu/med_altn.htm
•
Google: http://directory.google.com/Top/Health/Alternative/
•
Healthnotes: http://www.healthnotes.com/
•
MedWebPlus: http://medwebplus.com/subject/Alternative_and_Complementary_Medicine
•
Open Directory Project: http://dmoz.org/Health/Alternative/
•
HealthGate: http://www.tnp.com/
•
WebMDHealth: http://my.webmd.com/drugs_and_herbs
•
WholeHealthMD.com: http://www.wholehealthmd.com/reflib/0,1529,00.html
•
Yahoo.com: http://dir.yahoo.com/Health/Alternative_Medicine/
The following is a specific Web list relating to acute pancreatitis; please note that any particular subject below may indicate either a therapeutic use, or a contraindication (potential danger), and does not reflect an official recommendation: •
General Overview Pancreatic Insufficiency Source: Healthnotes, Inc.; www.healthnotes.com Pancreatitis Source: Integrative Medicine Communications; www.drkoop.com
General References A good place to find general background information on CAM is the National Library of Medicine. It has prepared within the MEDLINEplus system an information topic page dedicated to complementary and alternative medicine. To access this page, go to the MEDLINEplus site at http://www.nlm.nih.gov/medlineplus/alternativemedicine.html. This Web site provides a general overview of various topics and can lead to a number of general sources.
89
CHAPTER 4. DISSERTATIONS ON ACUTE PANCREATITIS Overview In this chapter, we will give you a bibliography on recent dissertations relating to acute pancreatitis. We will also provide you with information on how to use the Internet to stay current on dissertations. IMPORTANT NOTE: When following the search strategy described below, you may discover non-medical dissertations that use the generic term “acute pancreatitis” (or a synonym) in their titles. To accurately reflect the results that you might find while conducting research on acute pancreatitis, we have not necessarily excluded non-medical dissertations in this bibliography.
Dissertations on Acute Pancreatitis ProQuest Digital Dissertations, the largest archive of academic dissertations available, is located at the following Web address: http://wwwlib.umi.com/dissertations. From this archive, we have compiled the following list covering dissertations devoted to acute pancreatitis. You will see that the information provided includes the dissertation’s title, its author, and the institution with which the author is associated. The following covers recent dissertations found when using this search procedure: •
The role of cyclooxygenase-2 (COX-2) in acute pancreatitis by Ethridge, Richard Thomas; PhD from The University of Texas Graduate Sch. of Biomedical Sci. at Galveston, 2003, 108 pages http://wwwlib.umi.com/dissertations/fullcit/3083540
Keeping Current Ask the medical librarian at your library if it has full and unlimited access to the ProQuest Digital Dissertations database. From the library, you should be able to do more complete searches via http://wwwlib.umi.com/dissertations.
91
CHAPTER 5. PATENTS ON ACUTE PANCREATITIS Overview Patents can be physical innovations (e.g. chemicals, pharmaceuticals, medical equipment) or processes (e.g. treatments or diagnostic procedures). The United States Patent and Trademark Office defines a patent as a grant of a property right to the inventor, issued by the Patent and Trademark Office.8 Patents, therefore, are intellectual property. For the United States, the term of a new patent is 20 years from the date when the patent application was filed. If the inventor wishes to receive economic benefits, it is likely that the invention will become commercially available within 20 years of the initial filing. It is important to understand, therefore, that an inventor’s patent does not indicate that a product or service is or will be commercially available. The patent implies only that the inventor has “the right to exclude others from making, using, offering for sale, or selling” the invention in the United States. While this relates to U.S. patents, similar rules govern foreign patents. In this chapter, we show you how to locate information on patents and their inventors. If you find a patent that is particularly interesting to you, contact the inventor or the assignee for further information. IMPORTANT NOTE: When following the search strategy described below, you may discover non-medical patents that use the generic term “acute pancreatitis” (or a synonym) in their titles. To accurately reflect the results that you might find while conducting research on acute pancreatitis, we have not necessarily excluded nonmedical patents in this bibliography.
Patents on Acute Pancreatitis By performing a patent search focusing on acute pancreatitis, you can obtain information such as the title of the invention, the names of the inventor(s), the assignee(s) or the company that owns or controls the patent, a short abstract that summarizes the patent, and a few excerpts from the description of the patent. The abstract of a patent tends to be more technical in nature, while the description is often written for the public. Full patent descriptions contain much more information than is presented here (e.g. claims, references, figures, diagrams, etc.). We will tell you how to obtain this information later in the chapter. 8Adapted
from the United States Patent and Trademark Office: http://www.uspto.gov/web/offices/pac/doc/general/whatis.htm.
92
Acute Pancreatitis
The following is an example of the type of information that you can expect to obtain from a patent search on acute pancreatitis: •
Bradykinin-antagonists for the treatment of acute pancreatitis Inventor(s): Griesbacher; Thomas (Hitzendorf, AT), Lembeck; Fred (Graz, AT) Assignee(s): Hoechst Aktiengesellschaft (frankfurt AM Main, De) Patent Number: 5,670,619 Date filed: April 22, 1994 Abstract: The invention relates to the use of bradykinin-antagonists of the formulaR.sup.1 -A-B-C-E-F-G-J-K-R.sup.2wherein R.sup.1 represents hydrogen, C.sub.1 -C.sub.4 -alkanoyl which can be substituted by mercapto, hydroxyphenyl, (4benzoyl)phenoxy or represents (4-benzoyl)benzoyl-Lys; A represents D-Arg or D-Lys or stands for a direct bond; B represents Arg which can be substituted by NO.sub.2 or toluol-4-sulfonyl or represents Lys which can be substituted by toluol-4-sulfonyl or CO-NH--C.sub.6 H.sub.5, or stands for a direct bond; C represents Hyp-Pro-Gly, Pro-HypGly, Pro-Pro-Gly or dehydroPro-Hyp-Gly; E represents Thi, Phe, Leu or Cha; F represents Ser or Cys; G represents D-Tic, D-Phe or D-Hyp substituted by C.sub.1 C.sub.4 -alkoxy; J represents Tic, Aoc or Oic; K represents Arg or Ahx or stands for a direct bond; R.sup.2 is hydroxy or amino; and the physiologically tolerable salts thereof for the treatments of acute pancreatitis, to pharmaceutical agents containing them and to the use thereof for the preparation of appropriate pharmaceutical compositions. Excerpt(s): The invention relates to the use of bradykinin-antagonists or the physiologically tolerated salts thereof for the treatments of acute pancreatitis, to pharmaceutical agents containing them and to the use thereof for the preparation of appropriate pharmaceutical compositions. Bradykinin has long been thought to participate in acute pancreatitis. In 1989 however, Berg et. al. have defeated this hypothesis. Berg et al. have demonstrated (The Journal of Pharmacology and Experimental Therapeutics, Vol. 251, No. 2 (1989) p. 731-734) that hypotension caused by development of acute pancreatitis in rats was not influenced by D-Arg.sup.0 Hyp.sup.3 -Thi.sup.5.8 -D-Phe.sup.7 -BK (D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Phe-ThiArg). and their physiologically tolerable salts. Web site: http://www.delphion.com/details?pn=US05670619__
•
Interleukin-1 receptor antagonist decreases severity of acute pancreatitis Inventor(s): Norman, Jr.; James G. (Tampa, FL) Assignee(s): University of South Florida (tampa, Fl) Patent Number: 5,508,262 Date filed: December 15, 1993 Abstract: A method for treating acute pancreatitis comprising administering an effective amount of Interleukin-1 receptor antagonist (IL-1ra) or a pharmaceutically acceptable salt thereof to a person afflicted with that condition. Excerpt(s): The present invention relates to a method for treating acute pancreatitis. Acute pancreatitis is a common clinical problem which remains evasive of specific therapy.sup.1 Each year more than 15,000 admissions to U.S. hospitals are caused by
Patents 93
acute pancreatitis. It is most often caused by alcoholism or biliary tract disease. Less commonly, it is associated with hyperlipemia, hyperparathyroidism, abdominal trauma, vasculitis or uremia. The average length of hospitalization for the disease is 12.4 days, with a significant number of patients staying much longer because of associated complications. With more recent understanding of the complex mechanisms of tissue and cellular injury associated with inflammatory processes, such as sepsis,.sup.5 it is reasonable to assume that many of these inflammatory processes are not specific to sepsis syndromes alone. Several authors have suggested that much of the intrinsic pancreatic damage seen in acute pancreatitis is due to the release of toxic substances from macrophages and other white blood cells which migrate into the damaged gland.sup.6,7,8,9,10,11,12 These substances are known as cytokines and are now well known as mediators of inflammation and tissue injury. Web site: http://www.delphion.com/details?pn=US05508262__ •
Method of diagnosis and severity-assessment of pancreatic disease Inventor(s): Austen; Brian M. (London, GB2), Hermon-Taylor; John (London, GB2) Assignee(s): Bioscience International, Inc. (boston, Ma) Patent Number: 4,948,723 Date filed: July 28, 1987 Abstract: Pancreatic disease can be diagnosed by assaying a patient's body fluid, e.g. serum or urine, for the activation peptides of pancreatic zymogens specifically cleaved by proteolysis during activation, (PAP) e.g. peptides including the sequence D.sub.4 K having the lysine as the carboxy terminus. When PAP is assayed for, the test provides a means for distinguishing necrotising acute pancreatitis from oedematous acute pancreatitis, provides for diagnosis of chronic pancreatitis in exacerbation, and permits monitoring of the severity progress of the disease. Also described are antibodies having specificity for the pancreatic activation peptides, as well as such peptides and antibodies which are labelled with revealing agents and/or immobilized on solid supports, and their use in diagnostic test kits. Excerpt(s): The present invention relates generally to the diagnosis of pancreatic disease. More particularly, the present invention relates to trypsinogen activation peptides and their use in diagnosing pancreatitis. Acute and chronic pancreatitis are human diseases which have shown a significant increase in frequency in recent years [1]. Acute pancreatitis presents as an abdominal emergency, whereas chronic pancreatitis in general involves the differential diagnosis of chronic or intermittent abdominal pain. The exocrine pancreas produces and stores a range of digestive enzymes, including amylase and lipase, biosynthesised in active form, and others including trypsinogens, chymotrypsinogens, proelastases, procarboxypeptidases, and prophospholipases A2, synthesised as inactive proenzymes or zymogens. Zymogen activation normally occurs following secretion of pancreatic juice into the duodenal lumen, and involves the specific catalytic conversion of trypsinogen to active trypsin by duodenal enteropeptidase (E.C. 3.4.21.9). This removes from trypsinogen an amino-terminal oligopeptide containing the sequence tetra-L-aspartyl-L-lysine, an event followed by tryptic activation of the other proenzymes in a cascade of proteolytic cleavage. Activation peptides of pancreatic zymogens released in the course of this physiological process are thought to be degraded by duodenal oligopeptidases. Web site: http://www.delphion.com/details?pn=US04948723__
94
•
Acute Pancreatitis
Method of treating acute pancreatitis with isometheptene Inventor(s): DeNovellis; Michelangelo (Bologna, IT), Labriola; Ernesto (Bologna, IT), Marlettini; Maria G. (Bologna, IT), Salomone; Teresa (Bologna, IT), Tomassetti; Paola (Bologna, IT) Assignee(s): Knoll AG (de) Patent Number: 4,522,827 Date filed: July 2, 1982 Abstract: A method of relieving the symptoms of acute pancreatitis comprising administering Isometheptene to a person afflicted with that condition. Excerpt(s): This invention relates to a method for relieving symptoms of acute pancreatitis in mammals. More particularly, the invention concerns a method for treating persons afflicted with acute pancreatitis by administering to such a person a sufficient amount of Isometheptene to effectively relieve symptoms of that disease. Acute pancreatitis causes pathologic changes in the pancreas ranging from a mild edematous process to an overwhelming necrotizing lesion which may be lifethreatening. While its symptoms are variable it is principally characterized by epigastric pain radiating to either the upper quadrant or directly through to the back. The typical pain is gnawing, of sudden onset, of exceeding severity, unremitting, and sometimes colicky in character. It is not relieved by vomiting and is little affected by morphine, for example. Patients with this condition are also commonly found to have persistent high amylase in the blood and urine and frequently develop shock due to circulating vasoactive substances or retroperitoneal hemorrhage. A standard rationale in treating this condition is to set the gland to rest, such as by restricting the intake of food, administering fluids, and maintaining electrolyte balance. Treatment involving the use of various drug compositions has also been attempted previously, including the use of specific drugs which are known to inhibit gastric and/or pancreatic secretions such as Aprotinin, but none of these treatments appears to exhibit any proven overall benefit. Web site: http://www.delphion.com/details?pn=US04522827__
•
Method of using IL-11 for inflammation associated with acute pancreatitis Inventor(s): Keith; James (Andover, MA), Schendel; Paul (Wayland, MA) Assignee(s): Genetics Institute, Inc. (cambridge, Ma) Patent Number: 6,274,135 Date filed: June 22, 1999 Abstract: Provided by the present invention are methods of treating a variety of disorders including AIDS, arthritis (rheumatoid arthritis, osteoarthritis, spondyloarthropathies), antibiotic induced diarrheal diseases (Closbidium difficile), multiple sclerosis, osteoporosis, gingivitis, peptic ulcer disease, esophagitis, diabetes, retinitis, uveitis, reperfusion injury after myocardial infarction (MI) or cerebral vascular accident (CVA), aphthous ulcers (oral), atherosclerosis (plaque rupture), prevention of tumor metastases, asthma, preeclampsia, acute pancreatitis, psoriasis, infertility and allergic disorders such as rhinitis, conjunctivitis, and urticaria. Excerpt(s): The present invention relates generally to methods of treating disorders such as AIDS, arthritis (rheumatoid arthritis, osteoarthritis, spondyloarthropathies), antibiotic induced diarrheal diseases (Clostridium difficile), multiple sclerosis, osteoporosis,
Patents 95
gingivitis, peptic ulcer disease, esophagitis, diabetes, retinitis, uveitis, reperfusion injury after myocardial infarction (MI), cerebral vascular accident (CVA), aphthous ulcers (oral), atherosclerosis (plaque rupture), prevention of tumor metastases, asthma, preeclampsia, acute pancreatitis, psoriasis, infertility and allergic disorders such as rhinitis, conjunctivitis, and urticaria. Inflammatory responses include a broad range of host reaction to a variety of insults, such as injury, infection, or rejection. It is the over production of mediators that is believed to be associated with a broad range of disorders, including AIDS, arthritis (rheumatoid arthritis, osteoarthritis, spondyloarthropathies), antibiotic induced diarrheal diseases (Clostridium difficile), multiple sclerosis, osteoporosis, gingivitis, peptic ulcer disease, esophagitis, diabetes, retinitis, uveitis, reperfusion injury after myocardial infarction (MI), cerebral vascular accident (CVA), aphthous ulcers (oral), atherosclerosis (plaque rupture), tumor metastases, asthma, preeclampsia, acute pancreatitis, psoriasis, infertility and allergic disorders such as rhinitis, conjunctivitis, and urticaria. These disorders and their symptoms are briefly summarized below. According to the methods of the present invention, IL-11 is administered to modulate the hosts' over reaction to insult thereby treating the following disorders. Web site: http://www.delphion.com/details?pn=US06274135__ •
Monoclonal antibodies against type I phospholipase A.sub.2 as a diagnostic and antiinflammatory therapeutic agent Inventor(s): Hubner-Parajsz; Christa (Tutzing, DE), Scheuer; Werner (Penzberg, DE), Tibes; Ulrich (Frankfurt, DE) Assignee(s): Boehringer Mannheim Gmbh (mannheim, De) Patent Number: 5,767,249 Date filed: August 8, 1995 Abstract: The invention provides for monoclonal antibodies which specifically bind to type I phospholipase A.sub.2 for use as a diagnostic agent and as an anti-inflammatory therapeutic agent, which is particularly suitable for application in acute pancreatitis. The invention further provides for pharmaceutical compositions including the antibodies of the invention. The invention also provides for a method for treating subjects suffering from inflammatory symptoms and for detecting the activity of type I phospholipase A.sub.2 in a sample. Excerpt(s): The invention concerns the use of monoclonal antibodies against type I phospholipase A.sub.2 for the production of an anti-inflammatory therapeutic agent which is particularly suitable for application in acute pancreatitis. There is neither a causal nor symptomatic therapy for acute pancreatitis (The Merck Manual of Diagnosis and Therapy 15 (1987), pages 763-767). The pathogenetic basis of acute pancreatitis is autolysis of the pancreas. Phospholipase A.sub.2 has been attributed a decisive function in this process. It has a lysing action on the cell membrane and liberates arachidonic acid from the membrane phospholipids in this process. The metabolites of arachidonic acid (prostaglandins and leukotrienes) are an important component of the inflammatory reaction. Phospholipase A.sub.2 occurs in two forms. The phospholipase A.sub.2 designated type I is mainly found in pancreatic tissue and plays an important role in acute pancreatitis. In contrast type II phospholipase A.sub.2 occurs in many different tissues. Web site: http://www.delphion.com/details?pn=US05767249__
96
•
Acute Pancreatitis
Pancreas elastase 1-specific antibody, a process for obtaining it, and a test kit containing such antibody Inventor(s): Scheefers; Hans (Wettenberg, DE), Scheefers-Borchel; Ursula (Wettenberg, DE), Sziegoleit; Andreas (Langgons, DE) Assignee(s): Schebo Tech Medizinisch-biologische Forschungsgesellschaft Mbh (wettenberg, De) Patent Number: 5,622,837 Date filed: June 1, 1995 Abstract: A process is described for obtaining highly specific pancreas elastase 1 antibodies which react both with bodily fluids and with stools. Such an antibody is obtainable by immunizing with an antigen having the amino acid sequence Thr-MetVal-Ala-Gly-Gly-Asp-Ile-Arg (SEQ ID NO:1) or immunologically active partial peptides thereof. A test kit containing such antibodies is suitable for the diagnosis and course monitoring of chronic and acute pancreatitis as well as mucoviscidosis in bodily fluids and/or in stools. Excerpt(s): This invention relates to a highly sensitive and selective anti-elastase 1 antibody, a process for its manufacture, and a highly sensitive diagnostic test kit containing said antibody. Instances of inflammatory diseases of the pancreas are constantly increasing in industrial countries (W. Rosch, Deutsches Arzteblatt 84: C-397398, 1987). These diseases usually have an intermittent course and can finally lead to complete loss of the gland. Acute episodes are recognizable by severe abdominal pain and nausea, but intermediate phases are usually experienced by the patient as free from pain. They evolve only with uncharacteristic digestive complaints, so that they are hard to recognize. Consideration is therefore to be given to a chronic pancreatic disease in all digestive disorders. Determination of the serum amylase level has hitherto usually been made in laboratory diagnoses of pancreatitis. However, an elevation in serum amylase also occurs in other intra-abdominal inflammations, e.g., in intestinal perforation, mumps or renal failure. Moreover, an elevation in the serum amylase level may also be observed following the administration of morphines. Another laboratory diagnostic possibility consists of determining the ratio of amylase to creatinine clearance, which ratio increases in acute pancreatitis. Unfortunately, amylase values elevated in acute pancreatitis normalize very rapidly, so that normal values are already found 48 hours after the onset of the disease in one-third of the patients (J. A. Eckfeldt et al., Arch. Pathol. Lab. Med. 109:316-319, 1985). Web site: http://www.delphion.com/details?pn=US05622837__
•
Protein associated with acute pancreatitis agents for the screening of acute pancreatitis Inventor(s): Dagorn; Jean-Charles (Marseille, FR), Iovanna; Juan-Lucio (Marseille, FR), Volker; Keim (Heddesheim, FR) Assignee(s): Institut National DE LA Sante ET DE LA Recherche Medicale (paris Cedex, Fr) Patent Number: 5,436,169 Date filed: December 19, 1991
Patents 97
Abstract: The invention relates to the family of the protein (PAP) associated with acute pancreatitis in man and in the rat. It also relates to the nucleotide fragments coding for the above proteins.Also included in the framework of the invention are antibodies which recognize the PAP and which are capable of being used for the purpose of diagnosing pancreatitis.The invention also relates to the production of the PAP, in particular by genetic engineering. Excerpt(s): The present invention relates to proteins associated with acute pancreatitis and agents for the diagnosis of this disease. Acute pancreatitis is an inflammatory disease of the pancreas which, pathologically speaking, extends from the simple edematous form to the complete hemorrhagic necrosis of the gland. Necrohemorrhagic hepatitis is a very serious disease since, depending on the authors, its mortality is estimated to vary from 30 to 70%. In certain cases it is very difficult to establish the diagnosis of acute pancreatitis with certainty (Sarner, M. et al, Gastroenterol. (1984), 13: 865-870). This diagnosis is based in particular on clinical examination (acute abdominal pain), on the determination of a certain number of substances in the plasma or in the peritoneal fluid (Bradley, J. et al., Br. J. Surg. (1981), 68: 245-246; and Dubick, M. et al., Dig. Dis. Sci. (1987), 32: 305-312). The analytical determinations employed include those for amylase, lipase, trypsin, elastase, ribonuclease, phospholipase A2,.alpha.-2 macroglobulin, calcium, LDH, protease inhibitors and others. However, none of them has proved to be specific, practical or above all, discriminating. Hence, it is usually considered sufficient to determine amylasemia. Recently, ultrasonography and computerized tomography have appeared to be able to facilitate the diagnosis of pancreatitis without, however, decisive progress being made (Silverstein, W. et al., Am. J. Roentgenol., (1981), 137: 497-502). In 1984, Keim et al. published (Digestion, (1984), 29: 242-249) results of the consequences of cannulation of the pancreatic duct and the induction of pancreatitis on the protein composition of the pancreatic juice in the rat, this animal being used as an experimental model. After the operation of cannulation (1 to 2 days later), the authors observed a fall in the level of amylase in the pancreatic juice followed, 3 to 4 days after the operation, by a return to the normal amylase level. Web site: http://www.delphion.com/details?pn=US05436169__
Patent Applications on Acute Pancreatitis As of December 2000, U.S. patent applications are open to public viewing.9 Applications are patent requests which have yet to be granted. (The process to achieve a patent can take several years.) The following patent applications have been filed since December 2000 relating to acute pancreatitis: •
AGENT FOR PREVENTING AND/OR TREATING MULTIPLE ORGAN FAILURE Inventor(s): ARISAWA, HIROHIKO; (TOCHIGI, JP), HIGASHIO, KANJI; (SAITAMA, JP), MASUNAGA, HIROAKI; (TOCHIGI, JP), OGAWA, HIROMI; (TOCHIGI, JP) Correspondence: Testa Hurwitz & Thbeault; High Street Tower; 125 High Street; Boston; MA; 02110 Patent Application Number: 20010051146 Date filed: August 27, 1999
9
This has been a common practice outside the United States prior to December 2000.
98
Acute Pancreatitis
Abstract: The present invention is to provide an agent for preventing and/or treating multiple organ failure comprising Tumor cytotoxic factor-II (TCF-II) or Hepatocyte growth factor (HGF) as an effective ingredient.The agent of the present invention will be useful for preventing and/or treating the development from burn, disseminated intravascular coagulation (DIC), circulatory failure, hemorrhagic shock, infectious disease, acute pancreatitis, ischemic disorder, hepatorenal syndrome, gastrointestinal hemorrhage, nutritional metabolic failure, terminal cancer, acquired immunodeficiency syndrome (AIDS), deterioration of systemic conditions due to radiation affection and cachexia etc. to multiple organ failure. Excerpt(s): The present invention relates to a novel agent for preventing and/or treating multiple organ failure. Development from burn, disseminated intravascular coagulation (DIC), circulatory failure, hemorrhagic shock, infectious disease, acute pancreatitis, ischemic disorder, hepatorenal syndrome, gastrointestial hemorrhage, nutritional metabolic failure, terminal cancer, acquired immunodeficiency syndrome (AIDS), deterioration of systemic conditions due to radiation affection and cachexia etc. to multiple organ failure can be prevented or treated by the present invention. Onset or exacerbation of multiple organ failure can be classified into the following 3 categories with respect to mechanism: (1) Parallel induction of several organ disorders due to the same factor; (2) Induction of a specific organ dysfunction due to disorder of an organ; and (3) Participation of an iatrogenic factor. Excessive insults due to severe trauma or major surgeries, infectious diseases, shock etc. directly or through various kinds of mediator participate in the onset or deterioration of multiple organ failure by mechanism (1). In the case of multiple organ failure accompanied with organ disorder due to trauma or primary hepatic insufficiency, participation of mechanism (2) through organ correlation mechanism will largely contribute to the onset or deterioration thereof. By mechanism (3), medical care carried out during intensive care or care to correspond with an organ disorder may result in the other organ disorder. In patients, these 3 mechanisms participate to the development or deterioration of disorder in a complexed manner. The prognosis of patients of multiple organ failure is generally very poor and, in fact, the survival rate is low as 20-30% in spite of a wide variety of corresponding treatment. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html •
Method of detecting procarboxypeptidase A and carboxypeptidase A levels in biological fluids Inventor(s): Gilvarg, Charles; (Princeton, NJ) Correspondence: Licata & Tyrrell P.C.; 66 E. Main Street; Marlton; NJ; 08053; US Patent Application Number: 20010055785 Date filed: June 12, 2001 Abstract: Methods of enhancing sensitivity and specificity of an assay measuring enzymatic activity in a sample by measuring enzymatic activity in the sample in the presence and absence of a specific inhibitor of the enzymatic activity are provided. Methods of measuring carboxypeptidase A levels and total carboxypeptidase A levels, wherein procarboxypeptidase A is converted to carboxypeptidase A by addition of clostripain, in a biological fluid with a carboxypeptidase A substrate, specificity of which is enhanced by addition of a carboxypeptidase A specific inhibitor are also provided. In addition, methods of diagnosing acute pancreatitis by measurement of
Patents 99
carboxypeptidase A levels and pancreatic cancer by measurement of total carboxypeptidase A levels are also provided. Excerpt(s): This application is a continuation of U.S. patent application Ser. No. 09/402,405 filed Oct. 4, 1999, which is the U.S. National Phase of PCT Application PCT/US98/06615 filed Apr. 10, 1998, which claims the benefit of priority from U.S. Provisional Application Serial Nos. 60/055,495 filed Aug. 12, 1997 and 60/041,835 filed Apr. 10, 1997. Determination of altered enzyme levels by measurement of enzyme activity in biological samples is used routinely by clinicians to assist in the diagnosis of a multitude of diseases or conditions wherein physical symptoms alone may not be definitive. However, the usefulness of such assays is dependent upon the specificity of the enzyme to the disease or condition and the sensitivity and selectivity of the enzymatic assay. For example, acute pancreatitis is defined clinically as a discrete episode of symptoms caused by intrapancreatic activation of digestive enzymes. The cause of this activation is unknown; however, premature activation of zymogen to active enzymes within the pancreas results in autodigestion and inflammation of the pancreas. Symptoms include a steady, dull or boring pain in the epigastrium or left upper abdominal quadrant which is poorly localized and reaches peak intensity within fifteen minutes to one hour. The incidence of acute pancreatitis is difficult to ascertain as uniform diagnostic criteria and effort have not been applied. However, there is an urgency in accurately diagnosing acute pancreatitis to exclude other acute conditions that require different, usually surgical, management such as perforated peptic ulcer, acute cholangitis, appendicitis and mesenteric infarction. In contrast, pancreatitis is best treated through a "hands off" approach of eliminating food intake and increasing hydration. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html •
METHODS AND COMPOSITIONS FOR THE TREATMENT OF PANCREATITIS Inventor(s): AOKI, KEI ROGER; (COTO DE CAZA, CA), SACHS, GEORGE; (ENCINO, CA) Correspondence: Allergan Inc; 2525 Dupont Drive; Irvine; CA; 92612 Patent Application Number: 20010018049 Date filed: April 8, 1999 Abstract: Methods and compositions for the treatment of acute pancreatitis in a mammal. Particular compositions comprise a binding element, a translocation element, and a therapeutic element able to prevent accumulation of digestive enzymes within the pancreas. Excerpt(s): The present invention includes methods and compositions for the treatment of acute pancreatitis. In a preferred embodiment the invention concerns the use of agents to reduce or prevent the secretion of pancreatic digestive enzymes within the pancreas. Such agents are targeted to pancreatic cells, and serve to prevent the exocytotic fusion of vesicles containing these enzymes with the plasma membrane. The invention is also concerned with methods of treating a mammal suffering from pancreatitis through the administration of such agents. Pancreatitis is a serious medical condition involving an inflammation of the pancreas. In acute or chronic pancreatitis the inflammation manifests itself in the release and activation of pancreatic enzymes within the organ itself, leading to autodigestion. In many cases of acute pancreatitis, the condition can lead to death. In normal mammals, the pancreas, a large gland similar in
100
Acute Pancreatitis
structure to the salivary gland, is responsible for the production and secretion of digestive enzymes, which digest ingested food, and bicarbonate for the neutralization of the acidic chyme produced in the stomach. The pancreas contains acinar cells, responsible for enzyme production, and ductal cells, which secrete large amounts of sodium bicarbonate solution. The combined secretion product is termed "pancreatic juice"; this liquid flows through the pancreatic duct past the sphincter of Oddi into the duodenum. The secretion of pancreatic juice is stimulated by the presence of chyme in the upper portions of the small intestine, and the precise composition of pancreatic juice appears to be influenced by the types of compounds (carbohydrate, lipid, protein, and/or nucleic acid) in the chyme. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html
Keeping Current In order to stay informed about patents and patent applications dealing with acute pancreatitis, you can access the U.S. Patent Office archive via the Internet at the following Web address: http://www.uspto.gov/patft/index.html. You will see two broad options: (1) Issued Patent, and (2) Published Applications. To see a list of issued patents, perform the following steps: Under “Issued Patents,” click “Quick Search.” Then, type “acute pancreatitis” (or synonyms) into the “Term 1” box. After clicking on the search button, scroll down to see the various patents which have been granted to date on acute pancreatitis. You can also use this procedure to view pending patent applications concerning acute pancreatitis. Simply go back to http://www.uspto.gov/patft/index.html. Select “Quick Search” under “Published Applications.” Then proceed with the steps listed above.
101
CHAPTER 6. BOOKS ON ACUTE PANCREATITIS Overview This chapter provides bibliographic book references relating to acute pancreatitis. In addition to online booksellers such as www.amazon.com and www.bn.com, excellent sources for book titles on acute pancreatitis include the Combined Health Information Database and the National Library of Medicine. Your local medical library also may have these titles available for loan.
Book Summaries: Federal Agencies The Combined Health Information Database collects various book abstracts from a variety of healthcare institutions and federal agencies. To access these summaries, go directly to the following hyperlink: http://chid.nih.gov/detail/detail.html. You will need to use the “Detailed Search” option. To find book summaries, use the drop boxes at the bottom of the search page where “You may refine your search by.” Select the dates and language you prefer. For the format option, select “Monograph/Book.” Now type “acute pancreatitis” (or synonyms) into the “For these words:” box. You should check back periodically with this database which is updated every three months. The following is a typical result when searching for books on acute pancreatitis: •
ABC of Liver, Pancreas and Gall Bladder Source: London, UK: BMJ Publishing Group. 2001. 54 p. Contact: Available from BMJ Publishing Group. BMA Books, BMA House, Tavistock Square, London WCIH 9JR. Fax 44 (0)20 7383 6402. E-mail:
[email protected]. Website: www.bmjbooks.com. PRICE: Contact publisher for price. ISBN: 0727915312. Summary: Diseases of the liver, pancreas, and biliary system affect a substantial proportion of the world's population and involve doctors and health care workers across many disciplines. Many of these disease produce great misery and distress and are economically important requiring much time off work. This atlas of the liver, pancreas and gallbladder provides an overview of these diseases and enable the busy clinician to keep abreast of advances in diagnosis and management of not only the common but also the rarer, but none the less important, conditions. The atlas includes
102
Acute Pancreatitis
fourteen chapters: investigation of liver and biliary disease, gallstone disease, acute hepatitis, chronic viral hepatitis, other causes of parenchymal liver disease, portal hypertension and ascites, portal hypertension and encephalopathy, liver tumors, liver abscesses and hydatid disease, acute pancreatitis, chronic pancreatitis, pancreatic tumors, liver and pancreatic trauma, and transplantation of the liver and pancreas. Each chapter covers the symptoms, diagnosis, etiology, natural course, and treatment of the disease under consideration. Each chapter is illustrated with full-color diagrams, charts, and clinical photographs. A subject index concludes the book. •
Hepatobiliary and Pancreatic Disease: The Team Approach to Management Source: Boston, MA: Little, Brown and Company. 1995. 493 p. Contact: Available from Lippincott-Raven Publishers. 12107 Insurance Way, Hagerstown, MD 21740. (800) 777-2295. Fax (301) 824-7390. E-mail:
[email protected]. Website: http://www.lrpub.com. PRICE: $99.95. ISBN: 0316709158. Summary: In this book, the editors identify 42 hepatobiliary and pancreatic problems that require a team approach to management. For each of the 42 chapters, a surgeon, gastroenterologist, or radiologist is the lead author, and physicians from different specialties are coauthors. The authors discuss etiology, pathogenesis, and diagnosis, but focus on patient management and results. The chapters cover hepatitis, hepatic failure, cirrhosis, portal hypertension, primary biliary cirrhosis, Budd-Chiari syndrome, noninflammatory cysts, hepatic abscesses, hydatid disease, hemobilia, hepatic trauma, benign hepatic tumors, hepatocellular carcinoma, hepatic metastases, biliary atresia, biliary cysts, gallbladder stones, choledocholithiasis, hepatolithiasis, acute cholecystitis, acute cholangitis, biliary parasites, sclerosing cholangitis, benign strictures, motility disorders, gallbladder cancer, cholangiocarcinoma, acute pancreatitis, gallstone pancreatitis, pseudocysts, pancreatic abscesses, pancreatic necrosis, pancreatic hemorrhage, pancreas divisum, chronic pancreatitis, pancreatic fistulas, pancreatic trauma, islet cell tumors, cystic neoplasms, ampullary carcinoma, and pancreatic cancer. Each chapter includes numerous black-and-white photographs, and a subject index concludes the volume.
•
Gastroenterology and Hepatology: The Comprehensive Visual Reference. Volume 8: Pancreas Source: Philadelphia, PA: Current Medicine. 1998. [200 p.]. Contact: Available from Current Medicine. 400 Market Street, Suite 700, Philadelphia, PA 19106. (800) 427-1796 or (215) 574-2266. Fax (215) 574-2270. E-mail:
[email protected]. Website: current-medicine.com. PRICE: $125.00 plus shipping and handling. ISBN: 0443078629. Summary: This atlas is one in an 8-volume collection of images that pictorially displays the gastrointestinal tract, liver, biliary tree, and pancreas in health and disease, both in children and adults. This volume includes 10 chapters on the pancreas. Topics covered include neurohormonal control of the pancreas, pathogenesis of pancreatic diseases, acute pancreatitis, chronic pancreatitis, surgery for chronic pancreatitis, developmental anomalies of the pancreas, pancreatic cancer, the rationale and application of radioligand imaging in gastroenterology, cystic fibrosis, and hereditary pancreatitis. The format of the atlas is visual images supported by relatively brief text. Tables, charts, diagrams, and photomicrographs are used extensively. A subject index concludes the volume.
Books
•
103
Evidence Based Gastroenterology and Hepatology Source: London, UK: BMJ Publishing Group. 1999. 557 p. Contact: Available from BMJ Publishing Group. BMA Books, BMA House, Tavistock Square, London WCIH 9JR. Fax 44 (0)20 7383 6402. E-mail:
[email protected]. Website: www.bmjbooks.com. PRICE: Contact publisher for price. ISBN: 0727911821. Summary: This book emphasizes the approaches of evidence based medicine in gastroenterology (the study of the gastrointestinal tract and gastrointestinal diseases) and hepatology (the study of the liver and liver diseases). The authors use clinical epidemiology to present the strongest and most current evidence for interventions for the major diseases of the gastrointestinal tract and liver. Thirty chapters are included: an introduction to evidence based gastroenterology and hepatology; gastroesophageal reflux disease (GERD); ulcer disease and Helicobacter pylori; ulcer disease and nonsteroidal antiinflammatory drugs; treatment options for non-variceal gastrointestinal hemorrhage; the diagnosis and treatment of functional dyspepsia (indigestion); the diagnosis, treatment, and prognosis of celiac disease (gluten intolerance); the treatment of Crohn's disease; the diagnosis, prognosis, and treatment of ulcerative colitis (UC); pouchitis after restorative proctocolectomy; metabolic bone disease in gastrointestinal disorders; colorectal cancer in UC and the role of surveillance; population based screening and surveillance for colorectal cancer; irritable bowel syndrome (IBS); the surgical treatment of gallstone disease; the prognosis and treatment of acute pancreatitis; hepatitis C; hepatitis B; the screening and treatment of alcoholic liver disease; hemochromatosis and Wilson disease; primary biliary cirrhosis (PBC); autoimmune hepatitis; primary sclerosing cholangitis (PSC); the prevention and treatment of portal hypertensive bleeding; ascites, hepatorenal syndrome, and spontaneous bacterial peritonitis; hepatic encephalopathy; hepatocellular carcinoma; fulminant hepatic failure; the prevention and treatment of rejection after liver transplantation; and the prevention and treatment of infection after liver transplantation. Each chapter features the grading of recommendations and levels of evidence used by the authors to note the research basis on which their clinical guidelines are formed. Chapters conclude with extensive reference lists; the text concludes with a subject index. A glossary of acronyms is also provided.
•
Clinical Practice of Gastroenterology. Volume Two Source: Philadelphia, PA: Current Medicine. 1999. 861 p. Contact: Available from W.B. Saunders Company. Order Fulfillment, 6277 Sea Harbor Drive, Orlando, FL 32887. (800) 545-2522. Fax (800) 874-6418 or (407) 352-3445. Website: www.wbsaunders.com. PRICE: $235.00 plus shipping and handling. ISBN: 0443065209 (two volume set); 0443065217 (volume 1); 0443065225 (volume 2). Summary: This lengthy textbook brings practitioners up to date on the complexities of gastroenterology practice, focusing on the essentials of patient care. This second volume includes 113 chapters in five sections: liver, gallbladder and biliary tract, pancreas, pediatric gastroenterology, and special topics. Specific topics include hepatic (liver) structure and function, jaundice, viral hepatitis, alcoholic liver injury, liver tumors, parasitic diseases of the liver, Wilson's disease, hemochromatosis, the pregnancy patient with liver disease, portal hypertension, hepatic encephalopathy, fulminant hepatic failure, liver transplantation, the anatomy of the gallbladder and biliary tract, gallstones, laparoscopic cholecystectomy (gallbladder removal), cholecystitis (gallbladder infection), primary sclerosing cholangitis, biliary obstruction, pancreatic anatomy and physiology, acute pancreatitis, pancreatic fistulas and ascites (fluid accumulation),
104
Acute Pancreatitis
chronic pancreatitis, cancer of the pancreas, endoscopic retrograde cholangiopancreatography, esophageal atresia, gastroesophageal reflux in infants and children, achalasia and esophageal motility disorders, caustic and foreign body ingestion, vomiting, chronic abdominal pain, gastritis and peptic ulcer disease in children, malabsorption syndromes in children, inflammatory bowel disease in children and adolescents, acute appendicitis, cystic fibrosis, constipation and fecal soiling (incontinence), hepatitis in children, liver transplantation in children, failure to thrive, pediatric AIDS, the gastrointestinal manifestations of AIDS, the evaluation and management of acute upper gastrointestinal bleeding, principles of endoscopy, eating disorders, nutritional assessment, enteral and parenteral nutrition, gastrointestinal diseases in the elderly and in pregnancy, nosocomial infections, and the psychosocial aspects of gastroenterology (doctor patient interactions). The chapters include figures, algorithms, charts, graphs, radiographs, endoscopic pictures, intraoperative photographs, photomicrographs, tables, and extensive references. The volume concludes with a detailed subject index and a section of color plates.
Chapters on Acute Pancreatitis In order to find chapters that specifically relate to acute pancreatitis, an excellent source of abstracts is the Combined Health Information Database. You will need to limit your search to book chapters and acute pancreatitis using the “Detailed Search” option. Go to the following hyperlink: http://chid.nih.gov/detail/detail.html. To find book chapters, use the drop boxes at the bottom of the search page where “You may refine your search by.” Select the dates and language you prefer, and the format option “Book Chapter.” Type “acute pancreatitis” (or synonyms) into the “For these words:” box. The following is a typical result when searching for book chapters on acute pancreatitis: •
Acute Pancreatitis: Prognosis and Treatment Source: in McDonald, J.W.D.; Burroughs, A.K.; Feagan, B.G., eds. Evidence Based Gastroenterology and Hepatology. London, UK: BMJ Publishing Group. 1999. p. 271293. Contact: Available from BMJ Publishing Group. BMA Books, BMA House, Tavistock Square, London WCIH 9JR. Fax 44 (0)20 7383 6402. E-mail:
[email protected]. Website: www.bmjbooks.com. PRICE: Contact publisher for price. Summary: This chapter on the prognosis and treatment of acute pancreatitis is from a book that emphasizes the approaches of evidence based medicine in gastroenterology (the study of the gastrointestinal tract and gastrointestinal diseases) and hepatology (the study of the liver and liver diseases). The authors of this chapter review the evidence available from the literature that examines the use of various prognostic instruments and the medical, surgical, and endoscopic treatment options available for acute pancreatitis. Most patients with acute pancreatitis will have a mild form and ultimately follow a benign clinical course, but up to 20 percent will develop severe pancreatitis with all its inherent morbidity (illness) and risk of mortality (death). Medical management remains the mainstay of treatment for patients with acute pancreatitis. Early reduction in the systemic response to pancreatitis might be achieved with drug therapy, but this has not been proven to be effective with the medications presently available. Antibiotic prophylaxis is likely to become part of the standard therapy for those with necrotizing pancreatitis. While total parenteral nutrition (TPN) is of little
Books
105
benefit for those with severe pancreatitis, early enteral feeding shows promise and should become the standard method of nutritional supplementation in these patients. The role of peritoneal lavage (washing out of the organ or peritoneal cavity) remains controversial and the patient population that may benefit from this intervention is not well defined. The surgical approach still remains controversial but, based on the evidence available, widespread necrosectomy (removal of the dead tissue) and lavage, or necrosectomy and open management probably results in a better overall outcome than the conventional surgical approach. 10 tables. 123 references.
107
CHAPTER 7. PERIODICALS AND NEWS ON ACUTE PANCREATITIS Overview In this chapter, we suggest a number of news sources and present various periodicals that cover acute pancreatitis.
News Services and Press Releases One of the simplest ways of tracking press releases on acute pancreatitis is to search the news wires. In the following sample of sources, we will briefly describe how to access each service. These services only post recent news intended for public viewing. PR Newswire To access the PR Newswire archive, simply go to http://www.prnewswire.com/. Select your country. Type “acute pancreatitis” (or synonyms) into the search box. You will automatically receive information on relevant news releases posted within the last 30 days. The search results are shown by order of relevance. Reuters Health The Reuters’ Medical News and Health eLine databases can be very useful in exploring news archives relating to acute pancreatitis. While some of the listed articles are free to view, others are available for purchase for a nominal fee. To access this archive, go to http://www.reutershealth.com/en/index.html and search by “acute pancreatitis” (or synonyms). The following was recently listed in this archive for acute pancreatitis: •
Antibiotic prophylaxis in severe acute pancreatitis may not improve outcomes Source: Reuters Industry Breifing Date: April 07, 2004
108
Acute Pancreatitis
•
Cimetidine ineffective for acute pancreatitis Source: Reuters Industry Breifing Date: July 23, 2002
•
Serum IL-10 and IL-11 concentrations reflect acute pancreatitis severity Source: Reuters Medical News Date: December 24, 1999
•
AIDS does not increase severity of acute pancreatitis Source: Reuters Medical News Date: March 18, 1999
•
Extracorporeal Membrane Oxygenation Efficacious For ARDS Linked To Acute Pancreatitis Source: Reuters Medical News Date: April 28, 1998
•
New Dipstick Test Effective For Acute Pancreatitis Screening In The ED Source: Reuters Medical News Date: June 19, 1997
•
Urinary Test Strip May Help Diagnose Acute Pancreatitis Source: Reuters Medical News Date: March 20, 1996
•
Octreotide Shows Promise In The Treatment Of Acute Pancreatitis Source: Reuters Medical News Date: August 14, 1995 The NIH
Within MEDLINEplus, the NIH has made an agreement with the New York Times Syndicate, the AP News Service, and Reuters to deliver news that can be browsed by the public. Search news releases at http://www.nlm.nih.gov/medlineplus/alphanews_a.html. MEDLINEplus allows you to browse across an alphabetical index. Or you can search by date at the following Web page: http://www.nlm.nih.gov/medlineplus/newsbydate.html. Often, news items are indexed by MEDLINEplus within its search engine. Business Wire Business Wire is similar to PR Newswire. To access this archive, simply go to http://www.businesswire.com/. You can scan the news by industry category or company name. Market Wire Market Wire is more focused on technology than the other wires. To browse the latest press releases by topic, such as alternative medicine, biotechnology, fitness, healthcare, legal, nutrition, and pharmaceuticals, access Market Wire’s Medical/Health channel at http://www.marketwire.com/mw/release_index?channel=MedicalHealth. Or simply go to Market Wire’s home page at http://www.marketwire.com/mw/home, type “acute pancreatitis” (or synonyms) into the search box, and click on “Search News.” As this service
Periodicals and News
109
is technology oriented, you may wish to use it when searching for press releases covering diagnostic procedures or tests. Search Engines Medical news is also available in the news sections of commercial Internet search engines. See the health news page at Yahoo (http://dir.yahoo.com/Health/News_and_Media/), or you can use this Web site’s general news search page at http://news.yahoo.com/. Type in “acute pancreatitis” (or synonyms). If you know the name of a company that is relevant to acute pancreatitis, you can go to any stock trading Web site (such as http://www.etrade.com/) and search for the company name there. News items across various news sources are reported on indicated hyperlinks. Google offers a similar service at http://news.google.com/. BBC Covering news from a more European perspective, the British Broadcasting Corporation (BBC) allows the public free access to their news archive located at http://www.bbc.co.uk/. Search by “acute pancreatitis” (or synonyms).
Newsletter Articles Use the Combined Health Information Database, and limit your search criteria to “newsletter articles.” Again, you will need to use the “Detailed Search” option. Go directly to the following hyperlink: http://chid.nih.gov/detail/detail.html. Go to the bottom of the search page where “You may refine your search by.” Select the dates and language that you prefer. For the format option, select “Newsletter Article.” Type “acute pancreatitis” (or synonyms) into the “For these words:” box. You should check back periodically with this database as it is updated every three months. The following is a typical result when searching for newsletter articles on acute pancreatitis: •
Following Endoscopic Therapy. Pancreatitis Patients Report Pain Relief Source: Gastroenterology and Endoscopy News. 51(10): 1, 41. 2000. Contact: Available from McMahon Publishing Group. 545 West 45th Street, 8th Floor, New York, NY 10036. (212) 957-5300. Website: www.mcmahonmed.com. Summary: This news article reports on a retrospective study that has demonstrated that endoscopic therapy can have significant long term benefits on patients with chronic pancreatitis (inflammation of the pancreas), and that the technique offers similar success rates to those of surgery, while being minimally invasive for the patient. The study revealed that more than 60 percent of patients with chronic pancreatitis or unexplained abdominal pain resulting from pancreatic sphincter dysfunction reported a greater than 50 percent decrease in their pain 16 months after endoscopic therapy. Complications of endoscopic pancreatic sphincterotomy (EPS) included pancreatitis (9 percent of patients), bleeding (4 percent of patients), and early stent occlusion (blockage) in 9 percent of patients. There were no deaths related to the procedure and no patient developed severe acute pancreatitis. The study results need to be evaluated further in a prospective fashion. The article includes the comments of one expert who cautions that
110
Acute Pancreatitis
the role of endoscopic therapy in pancreatic disease has always been controversial, especially because pancreatitis is a 'dreaded complication' of endoscopic therapy to the pancreas. •
Pancreatitis: Painful Attacks Should Not Be Ignored Source: Mayo Clinic Health Letter. 17(10): 4-5. October 1999. Contact: Available from Mayo Clinic Health Letter. Subscription Services, P.O. Box 53889, Boulder, CO 80322-3889. (800) 333-9037 or (303) 604-1465. Summary: This newsletter article from the Mayo Clinic reviews the problem of pancreatitis attacks, stressing that acute pancreatitis warrants immediate medical care to avoid complications that can be fatal. Acute pancreatitis attacks consist of a sudden pain in the upper abdomen that seems to go straight through to the back and that does not ease up. The author briefly reviews the physiology and functions of the pancreas, including production of the hormones insulin and glucagon, which help regulate metabolism; and production of pancreatic juices and enzymes that are delivered to the upper part of the small intestine (duodenum) to help digest fats, proteins, and carbohydrates. Inflammation of the pancreas disrupts these functions. Acute pancreatitis comes on suddenly when digestive juices from the pancreas escape the ducts leading to the small intestine and instead enter pancreas tissue itself, causing potentially severe damage. Acute pancreatitis is usually caused by either gallstones leaving the gallbladder and obstructing the pancreatic duct, or by excessive alcohol use. Most attacks of pancreatitis range from mild to moderate and may last only a couple of days. Treatment often involves a hospital stay and no food or drink by mouth (in order to rest the pancreas). By comparison, chronic pancreatitis (progressive inflammation and damage to the pancreas) is sometimes difficult to detect early. Most of the time it is caused by excessive alcohol use over many years. Treatment for chronic pancreatitis focuses on pain management and preventing attacks by avoiding alcohol, following a careful diet, and working closely with a health care provider. 1 figure.
Academic Periodicals covering Acute Pancreatitis Numerous periodicals are currently indexed within the National Library of Medicine’s PubMed database that are known to publish articles relating to acute pancreatitis. In addition to these sources, you can search for articles covering acute pancreatitis that have been published by any of the periodicals listed in previous chapters. To find the latest studies published, go to http://www.ncbi.nlm.nih.gov/pubmed, type the name of the periodical into the search box, and click “Go.” If you want complete details about the historical contents of a journal, you can also visit the following Web site: http://www.ncbi.nlm.nih.gov/entrez/jrbrowser.cgi. Here, type in the name of the journal or its abbreviation, and you will receive an index of published articles. At http://locatorplus.gov/, you can retrieve more indexing information on medical periodicals (e.g. the name of the publisher). Select the button “Search LOCATORplus.” Then type in the name of the journal and select the advanced search option “Journal Title Search.”
111
APPENDICES
113
APPENDIX A. PHYSICIAN RESOURCES Overview In this chapter, we focus on databases and Internet-based guidelines and information resources created or written for a professional audience.
NIH Guidelines Commonly referred to as “clinical” or “professional” guidelines, the National Institutes of Health publish physician guidelines for the most common diseases. Publications are available at the following by relevant Institute10: •
Office of the Director (OD); guidelines consolidated across agencies available at http://www.nih.gov/health/consumer/conkey.htm
•
National Institute of General Medical Sciences (NIGMS); fact sheets available at http://www.nigms.nih.gov/news/facts/
•
National Library of Medicine (NLM); extensive encyclopedia (A.D.A.M., Inc.) with guidelines: http://www.nlm.nih.gov/medlineplus/healthtopics.html
•
National Cancer Institute (NCI); guidelines available at http://www.cancer.gov/cancerinfo/list.aspx?viewid=5f35036e-5497-4d86-8c2c714a9f7c8d25
•
National Eye Institute (NEI); guidelines available at http://www.nei.nih.gov/order/index.htm
•
National Heart, Lung, and Blood Institute (NHLBI); guidelines available at http://www.nhlbi.nih.gov/guidelines/index.htm
•
National Human Genome Research Institute (NHGRI); research available at http://www.genome.gov/page.cfm?pageID=10000375
•
National Institute on Aging (NIA); guidelines available at http://www.nia.nih.gov/health/
10
These publications are typically written by one or more of the various NIH Institutes.
114
Acute Pancreatitis
•
National Institute on Alcohol Abuse and Alcoholism (NIAAA); guidelines available at http://www.niaaa.nih.gov/publications/publications.htm
•
National Institute of Allergy and Infectious Diseases (NIAID); guidelines available at http://www.niaid.nih.gov/publications/
•
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); fact sheets and guidelines available at http://www.niams.nih.gov/hi/index.htm
•
National Institute of Child Health and Human Development (NICHD); guidelines available at http://www.nichd.nih.gov/publications/pubskey.cfm
•
National Institute on Deafness and Other Communication Disorders (NIDCD); fact sheets and guidelines at http://www.nidcd.nih.gov/health/
•
National Institute of Dental and Craniofacial Research (NIDCR); guidelines available at http://www.nidr.nih.gov/health/
•
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); guidelines available at http://www.niddk.nih.gov/health/health.htm
•
National Institute on Drug Abuse (NIDA); guidelines available at http://www.nida.nih.gov/DrugAbuse.html
•
National Institute of Environmental Health Sciences (NIEHS); environmental health information available at http://www.niehs.nih.gov/external/facts.htm
•
National Institute of Mental Health (NIMH); guidelines available at http://www.nimh.nih.gov/practitioners/index.cfm
•
National Institute of Neurological Disorders and Stroke (NINDS); neurological disorder information pages available at http://www.ninds.nih.gov/health_and_medical/disorder_index.htm
•
National Institute of Nursing Research (NINR); publications on selected illnesses at http://www.nih.gov/ninr/news-info/publications.html
•
National Institute of Biomedical Imaging and Bioengineering; general information at http://grants.nih.gov/grants/becon/becon_info.htm
•
Center for Information Technology (CIT); referrals to other agencies based on keyword searches available at http://kb.nih.gov/www_query_main.asp
•
National Center for Complementary and Alternative Medicine (NCCAM); health information available at http://nccam.nih.gov/health/
•
National Center for Research Resources (NCRR); various information directories available at http://www.ncrr.nih.gov/publications.asp
•
Office of Rare Diseases; various fact sheets available at http://rarediseases.info.nih.gov/html/resources/rep_pubs.html
•
Centers for Disease Control and Prevention; various fact sheets on infectious diseases available at http://www.cdc.gov/publications.htm
Physician Resources
115
NIH Databases In addition to the various Institutes of Health that publish professional guidelines, the NIH has designed a number of databases for professionals.11 Physician-oriented resources provide a wide variety of information related to the biomedical and health sciences, both past and present. The format of these resources varies. Searchable databases, bibliographic citations, full-text articles (when available), archival collections, and images are all available. The following are referenced by the National Library of Medicine:12 •
Bioethics: Access to published literature on the ethical, legal, and public policy issues surrounding healthcare and biomedical research. This information is provided in conjunction with the Kennedy Institute of Ethics located at Georgetown University, Washington, D.C.: http://www.nlm.nih.gov/databases/databases_bioethics.html
•
HIV/AIDS Resources: Describes various links and databases dedicated to HIV/AIDS research: http://www.nlm.nih.gov/pubs/factsheets/aidsinfs.html
•
NLM Online Exhibitions: Describes “Exhibitions in the History of Medicine”: http://www.nlm.nih.gov/exhibition/exhibition.html. Additional resources for historical scholarship in medicine: http://www.nlm.nih.gov/hmd/hmd.html
•
Biotechnology Information: Access to public databases. The National Center for Biotechnology Information conducts research in computational biology, develops software tools for analyzing genome data, and disseminates biomedical information for the better understanding of molecular processes affecting human health and disease: http://www.ncbi.nlm.nih.gov/
•
Population Information: The National Library of Medicine provides access to worldwide coverage of population, family planning, and related health issues, including family planning technology and programs, fertility, and population law and policy: http://www.nlm.nih.gov/databases/databases_population.html
•
Cancer Information: Access to cancer-oriented databases: http://www.nlm.nih.gov/databases/databases_cancer.html
•
Profiles in Science: Offering the archival collections of prominent twentieth-century biomedical scientists to the public through modern digital technology: http://www.profiles.nlm.nih.gov/
•
Chemical Information: Provides links to various chemical databases and references: http://sis.nlm.nih.gov/Chem/ChemMain.html
•
Clinical Alerts: Reports the release of findings from the NIH-funded clinical trials where such release could significantly affect morbidity and mortality: http://www.nlm.nih.gov/databases/alerts/clinical_alerts.html
•
Space Life Sciences: Provides links and information to space-based research (including NASA): http://www.nlm.nih.gov/databases/databases_space.html
•
MEDLINE: Bibliographic database covering the fields of medicine, nursing, dentistry, veterinary medicine, the healthcare system, and the pre-clinical sciences: http://www.nlm.nih.gov/databases/databases_medline.html
11
Remember, for the general public, the National Library of Medicine recommends the databases referenced in MEDLINEplus (http://medlineplus.gov/ or http://www.nlm.nih.gov/medlineplus/databases.html). 12 See http://www.nlm.nih.gov/databases/databases.html.
116
Acute Pancreatitis
•
Toxicology and Environmental Health Information (TOXNET): Databases covering toxicology and environmental health: http://sis.nlm.nih.gov/Tox/ToxMain.html
•
Visible Human Interface: Anatomically detailed, three-dimensional representations of normal male and female human bodies: http://www.nlm.nih.gov/research/visible/visible_human.html
The NLM Gateway13 The NLM (National Library of Medicine) Gateway is a Web-based system that lets users search simultaneously in multiple retrieval systems at the U.S. National Library of Medicine (NLM). It allows users of NLM services to initiate searches from one Web interface, providing one-stop searching for many of NLM’s information resources or databases.14 To use the NLM Gateway, simply go to the search site at http://gateway.nlm.nih.gov/gw/Cmd. Type “acute pancreatitis” (or synonyms) into the search box and click “Search.” The results will be presented in a tabular form, indicating the number of references in each database category. Results Summary Category Journal Articles Books / Periodicals / Audio Visual Consumer Health Meeting Abstracts Other Collections Total
Items Found 17984 99 947 41 332 19403
HSTAT15 HSTAT is a free, Web-based resource that provides access to full-text documents used in healthcare decision-making.16 These documents include clinical practice guidelines, quickreference guides for clinicians, consumer health brochures, evidence reports and technology assessments from the Agency for Healthcare Research and Quality (AHRQ), as well as AHRQ’s Put Prevention Into Practice.17 Simply search by “acute pancreatitis” (or synonyms) at the following Web site: http://text.nlm.nih.gov.
13
Adapted from NLM: http://gateway.nlm.nih.gov/gw/Cmd?Overview.x.
14
The NLM Gateway is currently being developed by the Lister Hill National Center for Biomedical Communications (LHNCBC) at the National Library of Medicine (NLM) of the National Institutes of Health (NIH). 15 Adapted from HSTAT: http://www.nlm.nih.gov/pubs/factsheets/hstat.html. 16 17
The HSTAT URL is http://hstat.nlm.nih.gov/.
Other important documents in HSTAT include: the National Institutes of Health (NIH) Consensus Conference Reports and Technology Assessment Reports; the HIV/AIDS Treatment Information Service (ATIS) resource documents; the Substance Abuse and Mental Health Services Administration's Center for Substance Abuse Treatment (SAMHSA/CSAT) Treatment Improvement Protocols (TIP) and Center for Substance Abuse Prevention (SAMHSA/CSAP) Prevention Enhancement Protocols System (PEPS); the Public Health Service (PHS) Preventive Services Task Force's Guide to Clinical Preventive Services; the independent, nonfederal Task Force on Community Services’ Guide to Community Preventive Services; and the Health Technology Advisory Committee (HTAC) of the Minnesota Health Care Commission (MHCC) health technology